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Connectivity Biomarkers in
Neurodegenerative Tauopathies
Timothy Rittman
The primary tauopathies are a group of neurodegenerative diseases
affecting movement and cognition. In this thesis I study Progressive
Supranuclear Palsy (PSP) and the Corticobasal Syndrome (CBS), two
parkinsonian disorders associated with accumulation of hyperphos-
phorylated and abnormally folded tau protein. I contrast these two
disorders with Parkinson’s disease (PD), which is associated with the
accumulation of alpha-synuclein but has a genetic association with
the MAPT gene encoding tau.
Understanding the tauopathies to develop effective treatments will
require a better grasp of the relationships between clinical syndromes
and cognitive measures and how the anatomical and neurochemical
networks that underlie clinical features might be altered by disease.
I investigate simple clinical biomarkers, showing that a two-minute
test of verbal fluency is a potential diagnostic biomarker to distinguish
between PD and PSP and that the ACE-R and its subscores could
play a role in monitoring cognition over time in PD, PSP and CBS.
I assess the implementation of network analysis in Functional Mag-
netic Resonance Imaging (fMRI) data, introduce Maybrain software
for graphical network analysis and visualisation. I go on to show an
overlap between graph theory network measures and I identify three
main factors underlying graph network measures of: efficiency and
distance, hub characteristics, network community measures. I apply
these measures in PD, PSP and the CBS.
All three diseases caused a loss of functional connectivity in com-
parison to the control group that was concentrated in more highly
connected brain regions and in longer distance connections. In ad-
dition, widely localised cognitive function of verbal fluency co-varied
with the connection strength in highly connected regions across PD,
PSP and CBS. To take this further, I investigated specific functional
covariance networks.
All three disease groups showed reduced connectivity between the
basal ganglia network and other networks, and between the anterior
salience network and other networks. Localised areas of increased co-
variance suggest a breakdown of network boundaries which correlated
with motor severity in PSP and CBS, and duration of disease in CBS.
I explore the link between gene expression of the tau gene MAPT and
its effects on functional connectivity showing that the expression of
MAPT correlated with connection strength in highly connected hub
regions that were more susceptible to a loss of connection strength in
PD and PSP.
I conclude by discussing how tau protein aggregates and soluble tau
oligomers may explain the changes in functional brain networks.
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Chapter 1
Introduction
1.1 Neurodegenerative tauopathies
The tauopathies are an important group of diseases characterised by the patho-
logical accumulation of abnormally folded and hyperphosphorylated tau protein.
Primary tauopathies are neurodegenerative disorders that cause both motor and
cognitive impairments, the main syndromes associated with tauopathies being
Progressive Supranuclear Palsy (PSP), the Corticobasal Syndrome (CBS) and the
tau-associated behavioural and language syndromes of Frontotemporal dementia
(FTD). These disorders markedly reduce quality of life Schrag et al. [2003], cause
significant caregiver burden Knutson et al. [2008]; Mioshi et al. [2007]; Uttl et al.
[1998]; Williams et al. [2013] and reduce life expectancy.
Tau and related neuropathologies cause a growing social burden and economic
cost demanding an urgent response; the estimated global dementia expenditure in
2010 was US $604 billion for disease affecting 45.6 million people, set to increase
to 65.7 million people by 2030 and 115.4 million by 2050 Wimo and Prince [2010].
Understanding the primary tauopathies will therefore be crucial to tackling the
challenging issues faced by people with tauopathies, and to address the wider role
of tau in other neurodegenerative diseases such as Alzheimer’s disease.
In this chapter I will outline the clinical syndromes of PSP, CBS and the
merit of comparing these tau-associated syndromes with Parkinson’s disease (PD)
which shares clinical features but differs in its neuropathology. I will briefly dis-
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cuss their associated neuropathology and will go on to discuss how these syn-
dromes and their clinical features are a result of changes in underlying functional
brain networks, and that changes in these functional networks are a consequence
of cellular, molecular and genetic processes of disease. I will outline the potential
advantages of a network approach to understanding these diseases.
1.2 Progressive Supranuclear Palsy: the proto-
typical tauopathy
The classic Richardson syndrome of PSP was first described in 1964 Steele et al.
[1964] (although Dickens possibly preceded the description by 100 years Larner
[2002]), and has since been refined to encompass akinesia, rigidity, gait distur-
bance, postural instability, eye movement abnormalities, and a frontal dysex-
ecutive syndrome with apathy and reduced verbal fluency Litvan et al. [1996];
Rittman et al. [2013]; Williams et al. [2005].
The future development of therapeutics for tauopathies will depend on a bet-
ter understanding of the disease process since the current efforts to develop a
mechanistic and targeted treatment have been unsuccessful. This need has been
brought in to focus for PSP following the negative results in phase III clinical
trials of the novel therapies Davunetide Boxer et al. [2014]; Tolosa et al. [2014]
and Tideglusib Ho¨glinger et al. [2014] targeting tau pathology.
PSP was selected to assess Davunetide Gold et al. [2012]; Morimoto et al.
[2013], Tideglusib and other clinical trials targeting tau pathology Bensimon et al.
[2009]; Golbe [2014] because it can be considered the prototypical tauopathy.
Firstly, tau accumulates without the significant presence of other proteins such as
beta-amyloid, alpha-synuclein or TDP-43. Secondly, the Richardson’s syndrome
of PSP predicts underlying tau pathology in a high proportion of cases, 95% in
a large cohort study Bensimon et al. [2009] mirroring findings in our local brain
bank cohort. Thirdly, PSP crucially allows for the characterisation and potential
therapy of a tau-related disorder in vivo in humans.
One approach to better understand tau and its role in PSP is to draw a
comparison with other parkinsonian diseases, in particular:
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• the Corticobasal Syndrome (CBS) which has similar symptoms but a more
heterogeneous pathology including a primary tauopathy and Alzheimer’s
disease,
• Parkinson’s disease (PD) that overlaps in symptomatology but is associated
with alpha-synuclein pathology,
• Frontotemporal Dementia (FTD) of which 40% of the behavioural variant
is associated with primary tau pathology Rascovsky et al. [2011].
In this thesis I will focus on the parkinsonian disorders of PSP, CBS and PD.
1.3 Corticobasal Syndrome: tau and other neu-
ropathologies
Corticobasal Syndrome (CBS) shares with PSP the core clinical features of rigid-
ity and akinesia. Other clinical signs differ, including an asymmetric presenta-
tion, prominence of apraxia and dystonia, early myoclonus and the degree of
visuospatial impairment Armstrong et al. [2013]; Mathew et al. [2011]. Cognitive
involvement in CBS is variable, from language impairment (typically a non-fluent
aphasia) to an Alzheimer-like amnestic syndrome Kertesz and McMonagle [2010].
Throughout this thesis I will follow the current consensus of referring to the
clinical syndrome as Corticobasal Syndrome (CBS) and the pathologically proven
disease as Corticobasal Degeneration (CBD). CBD pathology is characterised by
tau aggregates, although in a distinct pattern from PSP; balloon neurons and
astrocytic plaques are the hallmarks of CBD pathology Dickson et al. [2002].
Concordance between the clinical diagnosis of CBS and underlying CBD
pathology is imperfect, with only half of those meeting clinical diagnostic cri-
teria for CBS showing the pathological disease of CBD at post-mortem. The
predominant non-CBD pathology causing CBS is Alzheimer’s disease, but also
found are PSP tau pathology and Frontotemporal lobar degeneration (FTLD)
tau pathology Ling et al. [2010]. Recent consensus criteria for CBS were devel-
oped from a review of 209 post-mortem confirmed cases of CBD to address the
poor clinicopathological correlation Armstrong et al. [2013] but have performed
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no better than previous efforts showing poor specificity and sensitivity, both from
our own cohort Alexander et al. [2014] and other groups Ouchi et al. [2013].
This heterogeneous mix of pathologies in CBS provides both a challenge to
identify a pathologically homogeneous cohort, and an opportunity to examine a
single syndrome arising from multiple underlying pathologies. Therefore a con-
trast can be made between the changes arising from the mixed pathologies un-
derlying CBS and those only found in the relatively discrete tauopathy of PSP.
1.4 Parkinson’s disease: alpha-synuclein and tau
PSP and CBS are often termed atypical parkinsonian syndromes because of the
shared clinical features of akinesia and rigidity with idiopathic Parkinson’s disease
(PD). Idiopathic PD, however, presents with a distinct syndrome characterised by
asymmetric rigidity, tremor and bradykinesia. Unlike PSP and CBS, the typical
course is slower and dementia emerges later, although almost half of subjects may
have cognitive deficits at presentation Yarnall et al. [2014]. Although present in
80% of people with PD after 10 years, Parkinson’s disease dementia develops
in only 52.8% of subjects after 8 years if not present at the time of diagnosis
Aarsland et al. [2003a] and is characterised by visuospatial impairment, apraxia
and hallucinations Williams-Gray et al. [2007, 2009].
Lewy Bodies are the main feature of PD pathology and are principally com-
posed of alpha-synuclein, with high clinicopathological correlation in specialist
centres using the Queen Square Brain Bank diagnostic criteria Gibb and Lees
[1988]; Hughes et al. [2002]. The contrast between PD and PSP is therefore a
useful one, since it allows for a comparison between two overlapping syndromes
with good clinicopathological correlation: PSP associated with tau aggregates,
and PD associated with alpha-synuclein aggregates.
Although tau aggregates are not a feature of PD neuropathology, genetic ev-
idence consistently points to a role for tau in the disease process. Firstly, the H1
haplotype of the tau gene MAPT increases the risk of PD Goris et al. [2007];
Williams-Gray et al. [2009], and secondly MAPT is one of the most significant
loci in genome-wide association studies of PD, far in excess of genes for more com-
monly associated proteins such as SNCA (encoding alpha-synuclein) and LRRK2
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International Parkinson Disease Genomics Consortium [2011]; Satake et al. [2009].
Moreover, tau polymorphisms increase the risk of dementia in PD Goris et al.
[2007]; Williams-Gray et al. [2009].
1.5 Frontotemporal lobar degeneration
The syndrome of Frontotemporal dementia (FTD) overlaps with features of both
PSP and CBS. Furthermore, the pathologies of PSP and CBD are classified as
subtypes of FTLD-tau pathology, alongside other patterns of pathology such as
argyrophilic grain disease and Pick’s Disease MacKenzie et al. [2010]. The clin-
ical syndrome of Frontotemporal Dementia is often associated with FTLD-tau,
though may also be associated with other molecular classes of FTLD pathology
including FTLD-TDP (Tar-domain binding protein), FTLD-UPS (ubiquitin pro-
teasome system), FTLD-FUS (fused in sarcoma) and FTLD-ni (no inclusions).
FTD syndrome is broadly divided in to the behavioural variant Piguet et al.
[2011] or the language variant (Primary Progressive Aphasia) Gorno-Tempini
et al. [2011]; Knibb et al. [2006].
The tau-associated disorders in the FTLD spectrum differ in the aggregation
of distinct tau isoforms. The two main groups of tau isoforms are denoted 3 repeat
(3R) tau or 4 repeat (4R) tau defined by the number of repeated sequences of
the microtubule binding domain in exon 10. Both PSP and CBD are associated
with 4R tau Arai et al. [2001]; Chambers et al. [1999], and FTD with 3R tau
aggregation. In comparison, healthy older adults and those with Alzheimer’s
disease have aggregation of both 3R and 4R tau Goedert et al. [1989]; Knopman
et al. [2003]; Lace et al. [2009]. In addition to tau, other proteins that may
aggregate in FTD include the Tar-domain binding protein-43 (TDP-43) Neumann
et al. [2006] and the Ribonucleic Acid (RNA)-binding protein FUS (Fused in
Sarcoma) Neumann et al. [2009]; Vance et al. [2009]. Mutations in the progranulin
gene are associated with accumulation of TDP-43 Baker et al. [2006]; Cruts et al.
[2006].
Recent consensus criteria for the FTLD spectrum Mackenzie et al. [2011] pro-
pose four classifications of TDP-43 pathology (types A-D), previously classified
as FTLD-U because of the presence of ubiquitin. Each pattern of pathology is
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associated with distinct phenotypes and genetic defects. For example, type A is
the commonest found type of pathology and is associated with behavioural vari-
ant FTD and Progressive non-fluency aphasia. This is a welcome move forward
to assist the link between pathology and clinical syndromes.
However, even the gold standard of histopathological examination at post-
mortem can be ambiguous with dual pathologies Dugger et al. [2014] or a lack of
sufficient evidence to support any pathological classification Hodges et al. [2004].
The pragmatic use of clinical criteria developed from careful clinical observation
can help an individual and their family plan for the future and aid clinicians
in identifying and treating specific symptoms. Despite clear limitations of clin-
icopathological correlation, their widespread use means that clinical syndromes
remain the basis for research criteria, and for this reason may in fact facilitate
the transfer of knowledge from the research realm to the clinic.
To facilitate the process of transferring knowledge about pathology to the clin-
ical realm, better biomarkers are needed to relate clinical syndromes to underlying
pathological changes, and better methods are required to study the commonali-
ties in pathogenesis. I will move on now to discuss the different levels of disease
that biomarkers might assess and how these measures can be used to understand
the processes of disease.
1.6 Biomarkers to measure levels of brain or-
ganisation
A biomarker is a quantifiable measure that changes in the context of disease and is
derived from the underlying disease process. For example, a blood test measuring
the white cell count is a biomarker for pneumonia, since it increases with disease
and measures the body’s inflammatory response to infection. However, testing
the knee reflex in PD is not a biomarker since it is does not change in the disease
and does not sample a neuropathological process of the disease.
Developing a novel biomarker requires an understanding of the underlying dis-
ease process. Furthermore, a range of disease biomarkers are likely to be required
to fully evaluate a disease across its entire course since diagnostic biomarkers
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and early disease biomarkers may be very different from mid- or late-stage dis-
ease biomarkers Zheng et al. [2006]. Novel biomarkers for tauopathies should
therefore reflect both the molecular changes of disease and be informative about
clinical syndromes.
In the next section I will discuss how deficits in specific and measurable cogni-
tive and motor clinical features underlie the classification of patients in to clinical
syndromes, and how these clinical deficits are a result of changes in anatomical
and functional brain networks Meyer-Lindenberg and Weinberger [2006]. I will go
on to assess how the changes in functional networks are driven by altered cellular
and molecular functions. The different levels of brain organisation and their rela-
tionships are shown in figure 1.1. Though the relationships between these disease
levels are inexact, it may be possible to identify patterns and general rules that
govern the link between neuropathology and clinical syndromes.
1.7 Clinical biomarkers
The diagnosis of a clinical syndrome depends on recognising a defined pattern
of clinical features. Clinical diagnosis remains the mainstay of diagnosis in PD,
PSP and CBS, and therefore characterising the changes in specific clinical dis-
ease features is important. Furthermore, specific changes in cognitive and motor
measures can be directly related to underlying pathology and therefore may be
considered as biomarkers of disease. To illustrate the role of a clinical biomarker,
I will use the example of stroke, where measuring grip strength using the maxi-
mum voluntary contraction predicts motor recovery Ward et al. [2003]. A stroke
in the territory of the middle cerebral artery is a discrete lesion causing a mo-
tor deficit and the measurement of grip strength increases as the lesion resolves.
Therefore the clinical measure of grip strength fulfils the properties of a biomarker
by reflecting the underlying pathology and changing in the context of disease.
In the same way, the pathologies underlying PD, PSP and CBS cause deficits
in the brain that can be measured using cognitive or motor scores, and these
deficits can be related to underlying neuropathological changes. Chapter 2 dis-
cusses two potential clinical biomarkers in more detail by examining cognition
with the Addenbrooke’s Cognitive Examination-revised (ACE-R) and saccadic
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Figure 1.1: Levels of organisation of the brain beginning with clinical syndromes.
Syndromic diagnoses are based on clinical features which can be measured by cognitive
and motor tests. These individual functions depend on the integrity of underlying
anatomical connections and neurotransmitter activity. A small number of proteins are
responsible for the cellular changes which underlie network dysfunction in disease, which
in turn are influenced by genetic and environmental factors. This figure demonstrates
the potential of measuring anatomical and functional systems in the brain to link
between pathology associated with specific proteins and the clinical features of disease.
Images in this figure are used courtesy of the Wellcome Trust, Heidi Cartwright, Peter
Artymiuk, T.Blundell and N Campillo.
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eye movements using saccadometry.
Correlating these measures with the neuropathology of PD, PSP and CBS is
not as straightforward as in the example of a stroke, since the changes in neurode-
generation are distributed through the brain. The distribution of neuropathology
in neurodegenerative diseases is not random, in fact, evidence suggests that neu-
rodegenerative pathologies mirror anatomically defined functional brain networks
Seeley et al. [2009]; Zhou et al. [2012]. Therefore, exploring the brain as a network
or series of networks may provide a more accurate picture of neuropathology in
PD, PSP and CBS than assessing focal changes in the brain.
1.8 The brain as a network
Considering the whole brain as a network is a concept dating back to the work of
Cajal and Freud (see figure 1.2). Cajal presented his neuron theory (quoting the
work of Freud among many others) at the Croonian lecture of the Royal Society
of Medicine in 1894 Cajal [1894], emphasising the central role of the neuron and
highlighting the importance of myelinated axons and their connections to the
function of the brain: “Si nous ne craignions pas d’abuser des comparaisons,
nous de´fendrions notre conception en disant que l’e´corce ce´re´brale est pareille
a` un jardin peuple´ d’arbres innomabrables, les cellules pyramidales, qui, graˆce
a` une culture intelligent, peuvent multiplier leurs branches, enfoncer plus loins
leur racines, et produire des fleurs et des fruits chaque fois plus varie´s et exquis.”
If we are not afraid of stretching the comparison, we would defend our concept
saying that the cerebral cortex resembles a garden populated by innumberable trees,
the pyramidal cells, which, thanks to an intelligent culture, can increase their
branches, push their roots further, and produce flowers and fruits at each turn
more varied and exquisite.
It is currently impractical and intractable to examine the connections between
each individual neuron and glial cell, and to assess the precise contribution of each
axon, dendrite, receptor or neurotransmitter individually, despite the ambitions
of the Human Brain Project. In his book on understanding the behaviour of
complex systems, such as the weather and the form of baseball players, Nate
Silver demonstrates the need for a principled simplification to extract the key
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Figure 1.2: The contributions of Freud and Cajal to modelling the brain as a net-
work. On the left is shown a figure from Freud’s work on the neuroanatomy of lan-
guages Freud [1891] (courtesy of Wellcome images). A translation of the caption reads:
“Anatomical schema of the Language Association Fields. To explain the ar-
rangement of the language centres. The cortical fields of the auditory, visual, arm and
speech muscles are shown schematically as circles; the interior of the language fields
are reached via associated tracks shown here as an array of lines. Where the latter are
cut across by the bundles from another origin, arises a “Centre” concerned with asso-
ciating elements. The bilateral representation of the auditory field is not drawn, partly
not to confuse the figure, partly because of uncertainty over the relationship between the
hearing field and understanding language. - The communication with the visual field is
also spatially decomposed in to two bundles, permitting the consideration that the read-
ing association uses eye movements in a particular way.” This suggests that Freud
considered higher cortical functions to be emergent properties based on a network of
overlapping fibres from cortical regions and that he was able to gain insights from a
topological rather than physical representation of the brain. Ramon y Cajal is shown
on the right standing in front of one of his drawings that demonstrates the intricate
brain connections and cellular morphology he was keen to explore (courtesy of Ting
Low and Wellcome Images).
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features and relationships between components whilst retaining a true likeness to
the whole functioning system Silver [2012]. The salient features in the brain are
spatiotemporal components, in that the brain has a temporal pattern of activity
that is distributed within a 3-dimensional space.
Gathering spatiotemporal information from the whole brain requires a non-
invasive imaging technique. Magnetic Resonance Imaging (MRI) provides such
an opportunity to examine the structure and activity of objects in vivo applied to
a wide range of applications including imaging the human body and particularly
neuroimaging Gaunt et al. [2013]; Mansfield and Pykett [1978].
Functional Magnetic Resonance Imaging (fMRI) imaging can sample brain
activity over time by taking advantage of neuronal discharges inducing changes
in the neurovasculature to attract blood flow, an association known as the Blood
Oxygen Level Dependent (BOLD) effect Kwong et al. [1992]; Ogawa et al. [1992].
Much of the FMRI literature has been based on providing a subject with a task
to stimulate neuronal activity and measuring the difference in the BOLD effect
that ensues. Whilst this approach is useful for specific questions, it rather ig-
nores the majority of the brain’s neuronal function. Early work sampling blood
and metabolites from the carotid artery and jugular vein suggest that non-task
specific activity accounts for over 95% of the brain’s metabolism Lennox [1931]
and that this baseline metabolism may differ in disease states Wortis et al. [1940].
There is a renewed and growing interest in exploring the relationships between
brain regions in this baseline metabolic state using task-free functional imaging
techniques Biswal et al. [1997] (often misleadingly labelled resting state; there
appears to be very little rest in the brain at any time). FMRI is particularly
suited to network analysis in humans given its good spatial resolution, coverage
across the whole brain and relative ease of acquisition.
Many neuropsychiatric diseases have been considered in the context of their
impact on widely distributed brain networks, including schizophrenia Fornito
et al. [2012]; Lynall et al. [2010], depression Anand et al. [2005]; Greicius et al.
[2007], epilepsy Chavez et al. [2010]; Luo et al. [2012]; Ponten et al. [2007]; Zhang
et al. [2011] and stroke Carter et al. [2010]; Park et al. [2011]. Assessing changes in
organisation of task-free brain activity in neurodegeneration has focused mainly
on Alzheimer’s disease. This work has suggested that loss of inter-hemispheric
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and anterior-posterior connections Babiloni et al. [2004] lead to disruption of the
brain’s normal efficient network structure Sanz-Arigita et al. [2010]. The pattern
of connectivity loss may correlate with impaired cognitive function Stam et al.
[2006].
Further work has suggested that changes in the whole brain network may
be explained by a targeted loss of highly connected hub regions Buckner et al.
[2009]; Stam et al. [2009]. The susceptibility of brain networks and hub regions
is explored in chapter 6.
Understanding the connected brain in this way requires a mathematical frame-
work to describe the salient features of the system whilst maintaining an overall
similarity to the real brain. One such mathematical framework is graph theory
Beineke and Wilson [2009], a mathematical theory dating back to the work of
Leonhard Euler Euler [1736]. The challenge solved by Euler was to find a path
between the mainland and two islands in the Pregel river linked by 7 bridges
without crossing any bridge more than once. Euler simplified the problem to
its salient features by modelling each island as a node and the bridges as edges.
This series of points and lines described the system sufficiently to enable Euler
to prove that no path existed that fulfilled the challenge. In particular, Euler
realised that for a solution to exist either 0 or a multiple of two nodes in his sys-
tem must have an odd number of connections, whereas all the nodes (or pieces of
land) were linked by an odd number of edges (or bridges). This solution was the
first demonstration that the topological description and properties of a system
can solve real world challenges.
An alternative approach to graph theory analysis is to examine networks dis-
coverable within the task-free brain activity. The networks are a series of sep-
arable spatio-temporal signatures termed functional covariance networks (also
called intrinsic functional connectivity networks, or resting state networks) that
closely resemble those found in task-based functional imaging Damoiseaux et al.
[2006]; Smith et al. [2009] and may have distinct underlying physiological prop-
erties, such as the association between glycolysis and the default mode network
Vaishnavi et al. [2010]. These physiological properties may be relevant to dis-
ease processes, for example linking cholinergic dysfunction in the default mode
network to memory loss in mild cognitive impairment Dickerson [2006].
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The investigation of brain networks has revealed that the vulnerability of
brain networks may be specific to diseases, for example the widely studied Default
Mode Network is targeted in Alzheimer’s disease Greicius et al. [2004] and the
Salience Network may be vulnerable in the syndrome of FTD Zhou et al. [2010]. In
keeping with the cellular physiological observations of early synaptic dysfunction,
it seems likely that structural change follows functional change, since functional
connectivity changes appear earlier in the disease process Gili et al. [2010] and
atrophy patterns seen in neurodegenerative diseases resemble functional intrinsic
connectivity networks in the healthy brain Seeley et al. [2009].
The changes in connected brain regions reflect the underlying cellular and
molecular neuropathology. In order to understand changes in network function,
it is essential to understand the impact of these changes. I will now discuss neu-
rodegenerative pathologies from the perspective of the pathogenic proteins that
characterise neurodegenerative disease and in particular their effect on synaptic
transmission.
1.9 Proteins and proteinopathies
The strong association between age and neurodegeneration suggests that cellular
stress mechanisms play a role in these diseases Akerfelt et al. [2010]; Green et al.
[2011]. In addition, findings from a range of neurodegenerative diseases implicate
mitochondrial dysfunction and oxidative stress Lin and Beal [2006], abnormalities
in the cell cycle Zhu et al. [2007], inhibition of the ubiquitin-proteasome pathway
Rubinsztein [2006] and impaired autophagy Harris and Rubinsztein [2012].
However, a relatively select group of proteins have dominated research in to
neurodegeneration because they form the aggregates that define neuropathologi-
cal disease. Reflecting the importance of these proteins that become hyperphos-
phorylated, misfolded and eventually form aggregates, the diseases they cause
are collectively known as proteinopathies Shelkovnikova et al. [2012]. As a conse-
quence, understanding the process of aggregation has been the starting point to
understand disease mechanisms and to develop disease modifying therapies. The
first protein to be isolated from senile plaques in Alzheimer’s disease was beta-
amyloid Masters et al. [1985], followed by tau from neurofibrillary tangles Brion
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and Passareiro [1985], alpha-synuclein from Lewy bodies Spillantini et al. [1997]
and ubiquitin from neurofibrillary tangles Lennox et al. [1988]. Other proteins
have been identified more recently including TDP-43 in motor neurone disease
and FTLD Neumann et al. [2006], and progranulin in genetic forms of FTD Baker
et al. [2006]; Gass et al. [2006]. However, the role of the protein aggregates is un-
certain, and they may even play a protective role by removing more toxic soluble
protein species Ross and Poirier [2005].
Indeed, a growing body of research suggests that the soluble forms of these
proteins may contribute to early neuropathology by forming small soluble ag-
gregates called oligomers. Most of the early work on oligomers focused on beta-
amyloid, showing that oligomeric beta-amyloid can act as a seed to promote native
beta-amyloid to form additional oligomers, a process known as templating Tseng
et al. [1999]. These oligomers act as a nucleus around which monomeric beta-
amyloid aggregates to form the classical senile plaques of Alzheimer pathology
Wu et al. [2010]. However, beta-amyloid oligomers are toxic in their own right
causing reduced hippocampal long-term potentiation Haass and Selkoe [2007];
Walsh et al. [2002]; Wang et al. [2002] and cognitive impairment in transgenic
animals Cleary et al. [2005]. Narayan et al 2014 showed that only small con-
centrations of oligomeric beta-amyloid are required to cause cellular dysfunction,
and that they activate a wide range of pathways that inhibit neuronal and synap-
tic function. Crucially, synaptic dysfunction occurred before cell loss, suggesting
oligomer-induced dysfunction may be among the earliest changes in neurodegen-
erative disease.
Although less studied than beta-amyloid, tau forms oligomers that are the
precursor to neurofibrillary tangles Maeda et al. [2006, 2007]. In a similar manner
to beta-amyloid, tau oligomers are capable of templating native protein to an
abnormal conformation Lasagna-Reeves et al. [2012] and can inhibit synaptic
function leading to poorer cognitive performance in a mouse model Lasagna-
Reeves et al. [2011].
The story of misfolded proteins took an intriguing twist when alpha-synuclein
aggregates were found in post-mortem foetal tissue implanted in the basal ganglia
of people with Parkinson’s disease Li et al. [2008]. Although it was possible that
abnormal protein had developed de novo in the implanted tissue, it seemed much
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more likely that abnormally folded alpha-synuclein had been transported in to
the cells Angot et al. [2012]; Kordower et al. [2011].
Since this first intriguing clue, it has been shown that beta-amyloid Nath
et al. [2012] and tau de Calignon et al. [2012] can also propagate between cells.
The mechanism of tau spread appears to be trans-synaptic, both in transgenic
mice expressing abnormal tau in the entorhinal cortex Liu et al. [2012], and in
susceptible mice injected with misfolded tau in the hippocampus Ahmed et al.
[2014]; Clavaguera et al. [2013].
The combination of early synaptic dysfunction and trans-synaptic spread
strongly infer that tau neuropathology follows the pathways imposed by neu-
ronal connections, adding weight to the argument that anatomically connected
brain regions are important in the pathogenesis of neurodegenerative diseases.
Indeed, the interaction between toxic proteins and anatomically connected net-
works has led to their associated diseases being termed nexopathies Warren et al.
[2013].
The development of abnormal proteins and associated neuropathology may
be influenced by environmental and genetic factors, which I will discuss in the
next section.
1.10 Genetic and environmental influences
Few environmental studies have the power to demonstrate small risk increases
related to the primary tauopathies. Despite the link between repeated head
injury and a disseminated tauopathy McKee et al. [2009], the link between spo-
radic neurodegenerative disease and head injury is inconsistent and weak Mayeux
et al. [1995]; Mortimer et al. [1985]; Plassman et al. [2000]. Chemicals such as
Annonacin Caparros-Lefebvre and Elbaz [1999]; Caparros-Lefebvre et al. [2002];
Escobar-Khondiker et al. [2007] and Rotenone Ho¨glinger et al. [2005] may trig-
ger a cerebral tauopathy but these are unlikely to be relevant to the idiopathic
disease.
Most tauopathies are sporadic. Within the FTLD spectrum, a suggestive
family history is reported in 30-50% of patients with Frontotemporal Dementia
Seelaar et al. [2011]. However, cases of PSP and CBS with Mendelian genetics
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are notable by their rarity with just a handful of published cases Delisle et al.
[1999]; Houlden et al. [2001]; Pastor et al. [2001]; Poorkaj et al. [2002]; Rohrer
et al. [2011]; Spillantini et al. [2000]; Stanford et al. [2000]. The tau gene MAPT
plays a role in sporadic disease, with carriers of the MAPT H1 haplotype being
more likely to develop PSP, CBS Baker et al. [1999] and PD Goris et al. [2007];
Williams-Gray et al. [2009].
Genome-wide association studies in PD have revealed over 20 loci explain-
ing at least 60% of the population attributable risk for the disease Do et al.
[2011]; International Parkinson Disease Genomics Consortium [2011]; Satake et al.
[2009]. Additionally, a genome-wide association study has highlighted risk genes
in PSP related to lysosome function, the endoplasmic reticulum and myelination
Ho¨glinger et al. [2011]. The significance of these pathways to tau neuropathology
requires further exploration. There have been no genome-wide association studies
in CBS.
Genetic and environmental influences mediate their effect by regulating the
expression levels of genes. Until recently, linking gene expression to brain regions
could only be circumstantial, for example by measuring imaging changes in in-
dividuals with known mutations Filippini et al. [2009] or by measuring variance
of Single Nucleotide Polymorphisms (SNPs) in a peripheral blood sample Meda
et al. [2014]. The publication of the Allen Brain Atlas Miller et al. [2014] has
changed the possibilities for this avenue of research by releasing regional microar-
ray expression data on 6 human subjects at post-mortem using approximately
58,000 probes covering around 20,000 genes, and RNA expression levels for a
small number of selected genes. This exciting dataset is new and relatively unex-
plored, but has the potential to aid the bridge between a local genetic and global
functional understanding of the brain in health and disease. I present initial
findings using the Allen dataset in chapter 8.
1.11 Conclusions
Given the complexity and uncertainty of tau-related disease processes, it is es-
sential to understand the idiopathic disease in vivo in humans. Crucial to this
aim will be a description and exploration of system-wide, whole brain changes
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in the tauopathies. I will relate the network changes to underlying pathology, ie
considering PD, PSP and CBS as nexopathies. These changes must be validated
by their explanation of clinical disease features such as cognitive and motor mea-
sures. The comparison between PSP, CBS and PD provides a unique opportunity
to contrast overlapping syndromes that arise from distinct underlying pathologies.
To address these issues I will begin in chapter 2 by exploring two potential
clinical biomarkers that measure cognition using the ACE-R, and saccadometry.
I will assess these biomarkers in terms of their diagnostic ability, demonstrating
that the verbal fluency scores from the ACE-R differentiate PSP from PD with
a high level of confidence, whereas derived measures of saccade latency differ
between groups but are not diagnostic. I will go on to draw conclusions on the
biological relevance of these biomarkers to understanding specific neural circuits,
in particular cortico-thalamocortical circuits.
I then move on to outline the methods of task-free functional imaging with its
associated preprocessing and network analysis in chapter 3. In order to measure
and visualise graph metrics in a single platform I have developed a new python
package called Maybrain which is presented in chapter 4. This package brings
together a wide range of network analysis tools with powerful 3-dimensional vi-
sualisation.
In chapter 5 I focus on global and local functional connectivity measures us-
ing graph theoretical analysis, and assess the independence and stability of graph
measures. I demonstrate that multiple graph measures are highly correlated and
are related to three main principal components related to small world character-
istics, hub properties and community structure.
I then examine the connection strength and graph characteristics of PD, PSP
and CBS in chapter 6. In particular, I show that PD, PSP and CBS lose connec-
tion strength which in PD and PSP is focused in hub regions. However, the global
efficiency of the brain’s functional network shows relatively little change, except
in CBS. I show that local changes in node-wise properties broadly follow a similar
pattern to the change in node-wise connection strength and hub susceptibility.
To explore the regional changes in topological organisation in chapter 7 I go
on to assess the community structure of the brain’s functional network in PD,
PSP and CBS by using a modular decomposition argument of a graph. I show
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that simple modularity measures may reflect changes in connectivity and effi-
ciency. I then assess defined functional covariance networks using Independent
Component Analysis showing a loss of between network connectivity with spe-
cific regions of reduced covariance, particularly in the basal ganglia and anterior
salience networks in PD, PSP and CBS. These changes are accompanied by areas
of increased covariance, particularly in brain regions bordering the default mode
network in PD and PSP, and the anterior salience network in PD, PSP and CBS.
Finally, I present an exploratory analysis using PD and PSP in chapter 8
exploring the link between hub susceptibility to neurodegenerative disease and
the expression of the tau gene MAPT. I show that hub regions of the brain that
are more susceptible to PD and PSP also show a greater expression of MAPT.
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Biomarkers in Neurodegeneration
In the introduction I have defined two properties of a biomarker: to detect a
change in the context of disease, and to reflect an underlying pathological pro-
cess. The pathological processes in neurodegenerative diseases differ depending
on the stage of disease Jack et al. [2010], therefore biomarkers may have differ-
ing roles depending on the stage of disease Zheng et al. [2006]. For example, a
biomarker ‘A’ might reflects the earliest stages of a diseases and would be helpful
in early diagnosis but may not reflect the progress of disease over time. Another
biomarker ‘B’ might change little in the early stages of disease, but reflect an
ongoing disease process and therefore play a role in monitoring a response to
therapy. The combination of biomarkers A and B would provide a more complete
picture of the disease process.
An ideal diagnostic biomarker would distinguish between groups so that a
diagnostic label may be applied to an individual. The assessment of such a
biomarker would therefore go beyond merely demonstrating group-level statisti-
cal difference; an analysis of the diagnostic accuracy is required using Receiver
Operator Curve (ROC) characteristics to assess the sensitivity and specificity of
the test.
Clinical disease measures offer potential early diagnostic biomarkers and lon-
gitudinal disease biomarkers. Although often overlooked in favour of so-called
‘wet’ biomarkers (ie blood tests and Cerebrospinal Fluid (CSF)), clinical dis-
ease measures offer relatively cheap and potentially powerful tools with which to
measure disease.
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One particularly challenging differentiation is between early Parkinson’s dis-
ease (PD) and Progressive Supranuclear Palsy (PSP) or Corticobasal Syndrome
(CBS). A simple test that is easy to administer, differentiates between parkinso-
nian disorders and identifies decline over time would be a welcome addition to
the clinical and research armoury. For clinicians such a test could reduce the high
rate of uncertainty, diagnostic delay and misdiagnosis, which are especially com-
mon for PSP. In research, the urgent need for new disease measures and better
diagnostic differentiation is highlighted by current progress toward neuroprotec-
tive and disease modifying therapies: early diagnosis and the ability to monitor
progression will be increasingly important with disease-specific treatments Shaw
et al. [2007].
In this chapter I examine two clinical biomarkers for their ability to differ-
entiate between PD, PSP and CBS: the Addenbrooke’s Cognitive Examination-
revised (ACE-R) Rittman et al. [2013] and saccadometry. In addition, the ACE-R
is examined for its capacity to track changes in disease over time. Subsequent
chapters will assess Functional Magnetic Resonance Imaging (fMRI) measures,
both as a biomarker and to test hypotheses of the pathogenesis of these disorders.
2.1 The Revised Addenbrookes Cognitive Ex-
amination in parkinsonian disorders
In addition to impairments of motor function, characteristic cognitive changes are
common in PD McColgan et al. [2012]; Yarnall et al. [2014], PSP Aarsland et al.
[2001]; Millar et al. [2006] and CBS Graham et al. [2003]; Kertesz and McMona-
gle [2010]. A candidate cognitive test to provide useful diagnostic information
is the Revised ACE-R. The ACE-R is a comprehensive and easily administered
pen-and-paper test of cognition which has been used in a number of neurode-
generative disease, including PD, Alzheimer’s disease Mioshi et al. [2006] and
Frontotemporal dementia (FTD) Alexopoulos et al. [2010]. It consists of a 100
point test divided in to five cognitive subdomains (table 2.1).
The ACE-R and verbal fluency have been found to distinguish between atyp-
ical parkinsonian disorders and Alzheimer’s disease Bak et al. [2005]. However,
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Cognitive domain Abilities tested Score
Attention and Concentration Orientation 18
Registration
Attention and concentration
Recall
Memory Anterograde memory 26
(name and address)
Retrograde memory
Recall (long delay)
Recognition
Verbal Fluency Letter fluency (p-words) 14
Category fluency (animals)
Language Comprehension 26
Repetition
Naming
Semantic knowledge
Visuospatial Copying drawings 16
Drawing a clock face
Perception
Table 2.1: The ACE-R test multiple cognitive domains, summed to a score of 100
points. The MMSE is extracted as a 30 point score from elements of the ACE-R.
this is rarely a clinical conundrum, the more common clinical dilemma is one of
differentiating PD from other parkinsonian disorders. Other cognitive tests have
been suggested to differentiate between PD and atypical parkinsonism Aarsland
et al. [2003b]; Pillon et al. [1995]. A small study using a battery of executive
tests, including verbal fluency, correctly identified 15 of 16 PSP subjects from
other parkinsonian disorders, but with wide confidence intervals Lange et al.
[2003].
The Mini-Mental State Examination (MMSE) Folstein et al. [1975] was de-
signed as a brief test of cognition and can be derived from components of the
ACE-R. Although the comparison between PSP and PD has not been made di-
rectly, studies suggest that MMSE scores overlap between control subjects and
both PD McColgan et al. [2012] and PSP Lagarde et al. [2013], therefore its role
in distinguishing between diseases may be limited.
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In this section I test the the hypothesis that the ACE-R, the ACE-R subscores
or the MMSE might be a useful biomarker in two distinct ways. Firstly, I assess
whether these cognitive tests differ between PD, PSP and CBS, both at a group
average level and in terms of receiver operator characteristic curves. Secondly
I assess whether the ACE-R can monitor disease progression over time in these
disorders.
2.1.1 Methods
2.1.1.1 Patient recruitment
Subjects were recruited with PD (n=86), PSP (n=30) and CBS (n=19). PD sub-
jects were newly diagnosed and recruited as part of the Parkinsonism: Incidence
and Cognitive Heterogeneity in Cambridgeshire (PICNICS) study. All PICNICS
study participants who had returned for a follow-up assessment at the time of
data analysis were included in this study, representing 37% of the overall PIC-
NICS study population. Patients were recruited from primary and secondary care
and assessed using a battery of cognitive and neurological tests, in addition to a
semi-structured interview. All patients fulfilled Queen Square Brain Bank criteria
for PD. PSP and CBS subjects were recruited from a regional tertiary referral spe-
cialist clinic at the Cambridge University Hospitals NHS Trust (Addenbrookes),
UK. This clinic encourages regional referral of all cases of PSP and CBS, from
movement disorders specialists and memory clinics. It is not restricted to those
with dementia or cognitive impairment. Standard diagnostic criteria were applied
for PSP Litvan et al. [1996] and CBS Mathew et al. [2011]. Of nine PSP patients
who proceeded to post mortem, all had neuropathological confirmation of PSP.
All patients gave written, informed consent and ethical approval was obtained
from the Cambridge 2 Research Ethics Committee, Cambridge, UK.
2.1.1.2 Data collection
Cognitive assessment using the ACE-R and MMSE was performed on two sepa-
rate occasions, at a baseline visit and again at a follow-up visit. For PD subjects,
a planned visit at approximately 18 months was arranged as part of the PICNICS
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study. For PSP and CBS subjects, the clinic visit closest to 18 months follow-
up was identified. Assessment was carried out in a quiet room by investigators
familiar with the ACE-R. Severity of movement disorder was assessed using the
Unified Parkinson’s Disease Rating Scale (UPDRS III). Collection of data in PSP
and CBS subjects began before widespread use of the recently revised Movement
Disorders Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS III),
therefore motor function was assessed using the original UPDRS III, whereas PD
subjects were evaluated with the MDS-UPDRS III. However, the two scales are
very similar and results are highly correlated (ρ=0.96) Goetz et al. [2008].
2.1.1.3 Statistical analysis
Between group differences at baseline were investigated using a one way Analysis
of Variance (ANOVA). Follow-up scores were normalised to a time interval of 18
months. Group difference for change in scores between visits was assessed using
a multiple measures ANOVA with fixed and random effects. Where appropriate
(as indicated in the results section), significance values were Bonferroni corrected
for multiple comparisons. All statistical analyses were performed in R statistical
software (version 2.14.1, cran.r-project.org).
ROC characteristics and associated statistics were generated using the pROC
package Robin et al. [2011]. An optimal threshold for each cognitive test per
pairwise comparison was identified using a closest top left algorithm:
T = min((1− sensitivities)2 + (1− specificities)2)
Confidence intervals were obtained for the Area Under the Curve (AUC), sensi-
tivity and specificity by a stratified bootstrap analysis with 5000 permutations.
Sensitivity was defined as the ratio between true positives and all those who car-
ried a diagnosis of interest (condition positive) for a given threshold, specificity
was defined as the proportion of false negatives among all those who did not
carry the diagnosis of interest (condition negative) for a given threshold. Pos-
itive Predictive Value (PPV) was defined as the ratio between the number of
true positive subjects and the total number of positive results (false positive and
true positives) for each diagnosis at a given threshold; Negative Predictive Value
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(NPV) was defined as the ratio between the number of true negative results and
the total number of negative results for each diagnosis at a given threshold.
2.1.2 Results
2.1.2.1 Demographics
Demographic details are shown in table 2.2. CBS subjects were younger than
both PD (p=0.004) and PSP subjects (p=0.001). PSP and PD groups did not
differ in age (p=0.3). The duration of symptoms reported by the patient or carer
at the first clinical assessment was shorter for PD subjects compared to PSP
(p=0.003) and CBS subjects (p<0.001). There were no significant differences
between groups in terms of baseline education, handedness or gender. ACE-R
scores and subscores for each group are shown in 2.1. There was a trend toward
more PD subjects taking levodopa than the other two groups, although those that
did took a similar dose. PD subjects were seen for follow-up on average at 19.0
months, slightly later than PSP (16.1 months, p=0.007) or CBS subjects (14.3
months, p<0.001). Cognitive scores at baseline and follow-up are summarised
in figure 2.1. The selection of PD patients matched the demographics of the
whole PICNICS study population in terms of age, gender, handedness, years of
education, MDS-UPDRS III, levodopa equivalent dose and ACE-R score (p>0.1
in all cases).
2.1.2.2 Diagnostic differentiation at baseline
At the baseline visit, a between group comparison showed a significant effect of
diagnosis on the ACE-R score for attention and concentration, fluency, language
and visuospatial subscores, but not for memory subscores (table 2.3). It should
be noted, however, that the distribution of values may violate the assumptions
of normality, particular in the control group where a ceiling effect may truncate
the upper distribution of some measures. This could result an increased type I
error rate.
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Figure 2.1: ACE-R total and subscores at baseline and follow-up after approximately
18 months for PD, PSP and CBS. The combined fluency score was generated from
summing over words generated for both letter and category fluency in one minute.
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PD PSP CBS p
Age (years) 69.0 70.9 62.0 0.005
Gender (male/female) 58/30 13/17 10/9 0.2
Handedness (right/left/ambidextrous) 74/13/1 29/1 16/3 0.5
Years of education 11.9 12.0 13.0 0.3
UPDRS III (on therapy) - 29.7 29.0 0.8
MDS-UPDRS III (on therapy) 30.5 - - -
Duration of symptoms at baseline 1.8 3.2 3.1 <0.0001
(years)
Percent on dopaminergic therapy 45.3 18.1 30 0.05
Mean levodopa dose of 273.6 220.0 266.7 0.7
those on medication (mg)
Table 2.2: Demographics for the study population recorded at the baseline visit.
p-values were based on F-tests using one-way ANOVA, or chi-squared, as appropriate.
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To investigate the effect of disease duration and delayed diagnosis between
groups, I took advantage of a feature in our data, that the time from first re-
ported symptom in the PD group at follow-up (3.3 years) was not significantly
different from the baseline symptom duration in the PSP (3.2 years) and CBS (3.1
years) groups. Hence, baseline PSP and CBS scores and follow-up PD scores were
at similar symptom duration, and could be compared directly. ANOVA results
for this comparison showed a similar pattern of significance in group differences,
except that pairwise comparisons of visuospatial scores were non-significant be-
tween PD and PSP (p=0.1), and between PD and CBS (p=0.2).
To investigate the predictive accuracy of each score for individual subjects, I
performed ROC analysis (figure 2.2). Detailed results are shown in table 2.4 for
all ACE-R scores and subscores where the AUC exceeded 0.85, and for the MMSE
as a comparison. Best differentiation was seen between PD and PSP subjects, in
particular the verbal fluency subscore. Subdividing the fluency score in to letter
and category components showed a diagnostic differentiation between PD and
PSP similar to the combined scaled score using letter fluency alone (threshold 7
words per minute, AUC 0.93, specificity 0.85, sensitivity 0.83, PPV 0.81, NPV
0.93), and slightly poorer differentiation using category fluency (threshold 13.5
words per minute, AUC 0.89, specificity 0.81, sensitivity 0.83, PPV 0.63, NPV
0.93).
2.1.2.3 Measuring change over time
An interaction between diagnosis and change in score between visits was seen
in the ACE-R total score, visuospatial subscore, attention and concentration
subscore, and MMSE (table 2.5). Post-hoc t-tests showed that ACE-R total scores
declined significantly in PD and CBS (see table 4). The decline was greatest in
CBS. There was greatest decline in visuospatial subscores in the CBS group,
although the PD and PSP groups also showed a significant fall. Only the CBS
group showed a significant decline in MMSE between visits. Analysis of follow-up
scores without normalisation for interval to follow-up showed an almost identical
pattern of significance, the only difference being a marginally significant difference
for ACE-R score between visits in the PSP group (p=0.04).
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Figure 2.2: ACE-R total and subscores at baseline and follow-up for PD, PSP and
CBS at between 9.8 months and 125.5 months, although all follow-up scores were
normalised to 18 months. The combined fluency score was generated from summing
over words generated for both letter and category fluency in one minute. Corresponding
specificity, sensitivity with PPV and NPV values are shown in table 2.4
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PD vs PSP
Cut-off Specificity Sensitivity PPV NPV
(95% CIs) (95% CIs)
ACE-R 83.5 0.87 (0.80-0.94) 0.70 (0.53-0.87) 0.66 0.89
MMSE 27.5 0.80 (0.72-0.88) 0.67 (0.50-0.83) 0.54 0.87
Fluency 7.5 0.93 (0.87-0.98) 0.87 (0.73-0.97) 0.81 0.95
Combined raw 20.5 0.89 (0.81-0.95) 0.87 (0.73-0.97) 0.74 0.95
fluencies
Visuospatial 14.5 0.84 (0.77-0.92) 0.73 (0.57-0.87) 0.63 0.90
PD vs CBS
Cut-off Specificity Sensitivity PPV NPV
(95% CIs) (95% CIs)
ACE-R 87 0.77 (0.67-0.85) 0.74 (0.53-0.89) 0.41 0.93
MMSE 25.5 0.94 (0.88-0.99) 0.37 (0.16-0.58) 0.58 0.87
Fluency 8.5 0.83 (0.74-0.91) 0.63 (0.42-0.84) 0.44 0.91
Combined raw 24.5 0.76 (0.66-0.84) 0.68 (0.47-0.89) 0.40 0.91
fluencies
Visuospatial 13.5 0.92 (0.85-0.98) 0.68 (0.47-0.89) 0.65 0.93
PSP vs CBS
Cut-off Specificity Sensitivity PPV NPV
(95% CIs) (95% CIs)
ACE-R 79.5 0.63 (0.42-0.84) 0.63 (0.47-0.80) 0.73 0.52
MMSE 27.5 0.58 (0.37-0.79) 0.67 (0.5-0.83) 0.71 0.52
Fluency 7.5 0.58 (0.37-0.79) 0.87 (0.73-0.97) 0.81 0.97
Combined raw 16.5 0.79 (0.58-0.95) 0.67 (0.5-0.83) 0.83 0.60
fluencies
Visuospatial 10.5 0.26 (0.11-0.47) 0.9 (0.8-1.0) 0.70 0.45
Table 2.4: ROC Characteristics for between diagnostic group comparisons at optimal
thresholds, determined using a closest top left algorithm. Corresponding ROC results
are shown in figure 2.2. PPV=Positive Predictive Value, NPV=Negative Predictive
Value.
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Table 2.5: Group differences for the change in ACE-R and subscores between baseline
and follow-up visit scores, normalised to a rate of change over 18 months. ns=non-
significant, p<0.1.
ANOVA results (interaction of visit and diagnosis)
DF F p
ACE-R 2 8.2 0.009*
MMSE 2 8.0 0.007*
Attention/ 2 6.3 0.04*
Concentration
Memory 2 1.2 ns
Fluency 2 4.0 ns
Language 2 2.6 ns
Visuospatial 2 15.5 <0.0001*
Combined raw fluencies 2 4.7 ns
Mean scores at each visit and post-hoc t-tests
PD
baseline follow-up p
ACE-R 90.1 88.0 0.04*
MMSE 28.5 28.1 0.1
Attention/ 17.7 17.4 ns
Concentration
Memory 21.5 21.6
Fluency 10.8 10.3
Language 24.9 24.0
Visuospatial 15.3 14.8 0.003*
Combined raw fluencies 29.5 29.6
UPDRS III - -
MDS-UPDRS III 30.5 41.0 <0.001*
PSP
baseline follow-up p
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ACE-R 75.5 69.5 0.05
MMSE 26.0 25.1 ns
Attention/ 16.4 15.5 ns
Concentration
Memory 19.6 18.3
Fluency 5.1 4.1
Language 22.0 21.0
Visuospatial 12.4 9.9 0.02*
Combined raw fluencies 14.6 12.3
UPDRS III 29.7 35.9 ns
MDS-UPDRS III - -
CBS
baseline follow-up p
ACE-R 79.3 68.4 0.001*
MMSE 26.0 25.1 0.004*
Attention/ 16.2 14.3 ns
Concentration
Memory 19.5 18.9
Fluency 8.3 6.5
Language 23.1 20.4
Visuospatial 12.1 8.3 0.0002*
Combined raw fluencies 23.4 18.9
UPDRS III 29.1 36.2 ns
MDS-UPDRS III - - -
2.1.3 Discussion
These data show that the ACE-R, and in particular its total score, verbal fluency
and visuospatial subscores, distinguished between PD and PSP, and to a lesser
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extent between PD and CBS. The differentiation between PD and PSP using ver-
bal fluency alone (specificity 0.92, sensitivity 0.87) outperforms previous reports
of diagnostic differentiation achieved using imaging methods alone Brenneis et al.
[2004]; Price et al. [2004]. In addition, our data suggest that the ACE-R may
be helpful for tracking disease progression over time, particularly in CBS. These
findings suggest that in the appropriate clinical context, the ACE-R may prove
useful as a biomarker in the diagnosis and tracking of parkinsonian disorders.
The good positive and negative predictive values, low cost and simplicity of
these cognitive biomarkers makes them especially useful where the cost and exper-
tise required for routine clinical Magnetic Resonance Imaging (MRI) or Positron
Emission Tomography (PET) is prohibitive. This includes many regions of the
world where imaging is not available Prince et al. [2011]. Cognitive tests have
the potential of being a safe, inexpensive and low-tech additions to the diagnostic
armoury that can be used in a range of clinical settings primary, secondary or ter-
tiary care and research studies. The ACE-R has even been validated in a number
of languages, although our findings would require replication in different popula-
tions to properly assess generalisation Alexopoulos et al. [2010]; Garc´ıa-Caballero
et al. [2006]; Yoshida et al. [2011].
Different parts of the cognitive assessment had different value in the differen-
tiation of PD, PSP and CBS. I focused on the ACE-R rather than the MMSE,
as it was superior in differentiating disorders (see ROC analysis in figure 2.2 and
table 2.4) and was more sensitive to decline over time. The role of verbal fluency
was particularly striking. Fluency deficits have been described in PD Henry and
Crawford [2004], PSP Millar et al. [2006]; Rosser and Hodges [1994] and CBS
Graham et al. [2003]. The decline in fluency can not be entirely attributed to
bradykinesia, since the silence between words is out of proportion to the minimal
slowing in motor aspects of word production. Interestingly, patients with PSP
or CBS may generate a small number of low frequency words (eg ‘perambula-
tor’) rather than high frequency words (eg ‘put’, ‘people’). This is supported
by evidence from functional imaging suggesting that verbal fluency is associated
with activation of a diffuse cortical network Shedlack et al. [1991] but with an
emphasis on Brodmann area 45 for lexical retrieval and Brodmann area 46 in
phonological processing during word generation Heim et al. [2009]. Subjects with
33
2. BIOMARKERS IN NEURODEGENERATION
brain lesions in the left dorsolateral frontal lobe were found to have impaired ver-
bal fluency if there were additional or solitary striatal lesions Stuss et al. [1998].
Neuropathology studies confirm that both of these sites are affected in PSP and
CBS Dickson et al. [2002, 2007]. Verbal fluency impairment has previously been
reported in the early stages of PD Williams-Gray et al. [2007], and is consistent
with the Braak staging hypothesis that predicts frontal lobe cortical pathology
Braak et al. [2003].
Verbal fluency therefore has the characteristics of a diagnostic biomarker be-
cause if reflects aspects of the underlying pathology and distinguishes between
PD and PSP. However, its role is limited as a dynamic biomarker since it did not
change over time. This is in keeping with a ceiling effect that has been observed
in many cognitive domains of people with PSP Ghosh et al. [2013].
Changes in higher visual processing are present in all three disorders, but take
different forms in each. PD subjects may experience hallucinations or mispercep-
tions - usually later in the disease process - that may be related to medication
side effects or impaired attentional processing Shiner et al. [2012]. CBS sub-
jects and, to a lesser extent PSP subjects, perform poorly on visuospatial tasks;
PSP subjects are impaired more with ‘object decision’ tasks, thought to be re-
lated to impairment in the ventral stream of visuospatial processing, whereas
CBS patients are typically worse on spatial location tasks, thought to relate to
the parietal atrophy disrupting the dorsal stream of visuospatial processing Bak
et al. [2006]. These previous findings are in broad agreement with my results; the
ACE-R visuospatial tests rely more on spatial abilities than object recognition
and is therefore likely to be more sensitive to the changes seen in CBS and PSP,
but is less likely to detect the misperceptions more commonly experienced in PD.
Statistically significant group differences in test scores do not necessarily in-
dicate clinically meaningful differences in test scores, especially in large studies.
For many of my results, I suggest that the differences between groups and over
time are both statistically significant and clinically meaningful. MMSE scores
declined by 2.7 points in the CBS group, which is close to the standard deviation
of 2.8 found in a large dementia population Clark et al. [1999], suggesting this
change is clinically significant. Large absolute differences were seen in both PSP
and CBS groups for total ACE-R score (PSP 6.0, CBS 10.9, of maximum score
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100) and visuospatial subscores (PSP 2.5, CBS 3.8, of maximum 16 points). Al-
though I do not have functional rating scales or measures of activities of daily
living, I suggest that the magnitude of these changes are likely to be clinically
significant. In contrast, the PD group showed much smaller changes in total
ACE-R score (1.9 points) and the visuospatial subscore (0.5 points), which lie
within the range of test variation (both inter-rater variance and subjects test-
retest) and are less likely to be clinically meaningful. In the context of PD, it
has recently been demonstrated that the ACE-R reflects functional changes; the
authors could identify the difference between a defined group of patients with PD
meeting criteria for Parkinson’s Disease-Mild Cognitive Impairment (PD-MCI)
using a cut-off of 89 (specificity of 84%, sensitivity 69%) McColgan et al. [2012],
however the relatively new concept of PD-MCI is still debated and as many as
40% of people with PD may have cognitive changes at diagnosis Yarnall et al.
[2014]. My findings would support the use of cognitive measures in diagnostic
criteria, although neuropathological correlation would be required to confirm this.
Group comparison in this study used clinical diagnostic criteria, which may
not always reflect underlying pathology. Clinical diagnostic criteria for PSP Lit-
van et al. [1996] tend to be specific, with a diagnostic accuracy of 92% subjects
in subjects meeting criteria Bensimon et al. [2009]. They may be insensitive to
PSP pathology in subjects with a PD-like syndrome Williams et al. [2005] or no
clinical disease Evidente et al. [2011]. In our cohorts, many PSP patients had
consented to brain donation in a regional brain bank, providing neuropathologi-
cal confirmation in 9 out of 9 cases, in keeping with the high clinicopathological
correlations in other centres.
There are several current clinical diagnostic criteria for CBS, recently reviewed
by Mathew et al 2011. They applied clinical criteria in early CBS, finding sen-
sitivities of 23.5-67.5%, increasing to 87.5-92.5% in later stage disease depend-
ing on the criteria applied. Diagnostic uncertainty is further reflected in the
ante mortem misclassification of CBS from post-mortem studies Alexander et al.
[2014]; Josephs et al. [2006]; Ling et al. [2010]. Our findings therefore support the
use of cognitive measures in diagnostic criteria for PD, PSP and CBS, although
further neuropathological correlation would be helpful to investigate the link be-
tween cognition and histological disease changes in more detail, and evaluating
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cognitive differentiation of atypical or intermediate syndromes which combine
features of PD, PSP and CBS.
In principle, one could apply more detailed neuropsychological tests. However,
an advantage of the ACE-R is ease of use, requiring short training for those
administering it. Usually a full test will take around 10 minutes in cognitively
well participants without akinesia, although it can be up to half an hour in
severely affected patients with PSP and CBS. Verbal fluency is an even briefer
test, taking just two minutes of testing time. Both the ACE-R and verbal fluency
could be assessed routinely in a general neurology or movement disorders clinic
and its utility has been shown in this study.
There are however several limitations to this study. The number of patients
and follow-up time were limited. Furthermore, the duration of symptoms was
shorter in the PD group, although correcting for this by comparing baseline PSP
and CBS scores with follow-up PD scores led to the same pattern of results.
Delayed diagnosis in PSP and CBS is common, with patients often receiving an
alternative diagnosis for one to two years, therefore recruiting PSP and CBS
patients at an earlier stage is challenging. I cannot exclude the possibility that
cognitive profiles would be different, and between group differences smaller, at
an earlier stage in the disease processes. Post-mortem confirmation of diagnosis
was not available in all subjects and so it is possible that for a small number of
subjects the diagnosis may be inaccurate. PD patients were seen for follow-up
slightly later than the other two groups. However, correcting for this difference
would augment rather than diminish my findings given the largest differences
over time were seen in the CBS group who had the shortest mean follow-up.
Low scores may arise for different reasons in the three groups. For example,
it is possible that apraxia or other features of a movement disorder impaired task
performance differentially between groups, particularly on visuospatial drawing
tasks and in CBS patients. However, the majority of subjects were relatively
early in the disease course, able to hold a pencil and draw sufficiently to reveal
the cognitive elements of the test.
The CBS group were younger than the other two groups, which is a potential
confound in this study. However, the main difference at baseline was between the
PD and PSP groups. Furthermore, the changes in the CBS group were greater
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over time for the other groups which would not be the expected result if age
played a significant role in determining the results.
There are also caveats to the use of the UPDRS III motor subscale to measure
motor severity. This scale does not capture all signs in the CBS phenotype,
omitting apraxia, alien limb phenomena, dysarthrophonia and mirror movements.
Although the principal axial and appendicular motor signs of PSP are included
in the UPDRS III, it should be borne in mind that the test was developed for
use in PD and that it may not be adequately balanced to sensitively grade the
progressive severity of PSP or CBS. The use of the UPDRS III should therefore
be seen as descriptive and not diagnostic of our study populations.
An alternative to a cognitive biomarker would be and objective and repeat-
able measure that did not rely on language, and focused on more physiological
characteristics of disease. Tracking saccadic eye movements may fulfil these cri-
teria.
2.2 Saccadometry in parkinsonian disorders
It has been proposed that measurement of saccadic eye movements may offer a
specific and sensitive biomarker for diagnosis and progression in PD Chan et al.
[2005]; Mosimann et al. [2005], PSP Antoniades et al. [2007]; Ghosh et al. [2013];
Rivaud-Pe´choux et al. [2000] and CBS Rivaud-Pe´choux et al. [2000]. However,
previous studies have focussed on group differences in saccade measures, rather
than the more important - and more difficult - ability of saccadic eye movements
to correctly classify individuals.
PD, PSP and CBS are associated with degeneration of two pathways involved
in saccade production: cortico-striato-thalamo-cortical and cortico-collicular ocu-
lomotor circuits Gold and Shadlen [2007]; Hikosaka et al. [2000]; Pierrot-Deseilligny
et al. [2004]; Shires et al. [2010]. Proximity and integration between cortico-
striato-thalamo-cortical circuits may lead to correlations between degeneration
in oculomotor, cognitive and motor function, supported by evidence from PSP
Ghosh et al. [2013] and subjects with Attention Deficit Hyperactivity Disorder
(ADHD) using structural imaging correlates Goto et al. [2010].
I therefore studied saccadic latency (time to initiation of a saccade) as a po-
37
2. BIOMARKERS IN NEURODEGENERATION
tential oculumotor biomarker of neurodegenerative parkinsonian disorders. An
advantage of saccadic latency is that it reflects not only the oculomotor compo-
nents of eye movements, but also executive decisions before initiation of a saccade
Goto et al. [2010]; Schall and Boucher [2007].
Saccadic latency is robust, and inverse values are normally distributed, making
it well suited for statistical comparison. It differs from saccadic velocity, which
represents only brain stem and peripheral effector mechanisms. Two distinct
populations of saccade latencies are observed in many people: a principal popu-
lation of normal latency saccades, and a subpopulation of early saccades. The
two populations reflect underlying decision processes and can be modelled as two
Gaussian latency distributions, captured in the Linear Approach to Threshold
with Ergodic Rate (LATER) model Carpenter and Williams [1995]. Parameters
of the LATER model accurately describe saccadic latency distributions under var-
ious neurological condition Carpenter and McDonald [2007]; Reddi et al. [2003].
The MMSE was used as a brief test of cognition, since the ACE-R was not
available in all subject cohorts. Verbal fluency was also collected, which correlates
with executive function in PD, PSP and CBS Henry and Crawford [2004]; Stuss
et al. [1998].
I approached the analysis in three ways reflecting different properties of an
ideal biomarker. Firstly, I assessed whether saccadic latency distribution mea-
sures between groups were statistically significant. Secondly, I assessed clinical
diagnostic utility by using cluster analysis and ROC characteristics to classify
individual subjects in to diagnostic groups. Finally, to explore the role of sac-
cadic latency measures as a biomarker of declining cognitive systems, I measured
correlations among saccadic latency variables and cognitive function within each
disease.
2.2.1 Methods
Patients were recruited from a regional specialist clinic for cognitive and move-
ment disorders. Control subjects were recruited from the volunteer panel at
the Medical Research Council Cognition and Brain Sciences Unit in Cambridge.
Written informed consent was obtained and the Cambridge 2 ethics committee
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approved the study. Patients were recruited as follows: 25 patients with PD
(mean age 65.3, range 49-79, Hoehn and Yahr stage 2-3, UK PD Brain Bank cri-
teria); 21 with PSP (mean age 68.3, range 58-84, National Institute for Neurolog-
ical Disorders-Society for Progressive Supranuclear Palsy (NINDS-SPSP) criteria
Litvan et al. [1996], pathologically confirmed in all nine cases with post-mortem
examination) and 14 with CBS (mean age 65.7, range 56-88, consensus criteria
Mathew et al. [2011]) and 36 healthy control subjects (mean age 71.1, range 57-84,
no relevant cardiac, neurological or psychiatric history). PD subjects were more
likely to be taking levodopa (33/40) than other groups (PSP 12/21, CBS 3/14,
controls 0/49) and more likely to be on a dopamine agonist (PD 7/40, PSP 1/24,
CBS 0/24 or controls 0/49), reflecting clinical practice and the greater efficacy of
dopaminergic drugs in PD. Subjects took their normal medication.
Horizontal saccades were recorded using a head-mounted infra-red oculo-
graphic device (Saccadometer Advanced, Ober Consulting, Poland). In brief,
subjects were positioned 1.5m from a wall in ambient light conditions, on to
which the saccadometer projected red laser-points of light centrally or at +10 de-
grees or -10 degrees azimuth. Following explanation of the procedure and a short
test run, a calibration run of 10 trials were performed. The saccadometer used a
step task paradigm. After a random interval 0.5-1.0s, the central fixation point
was extinguished and either the left or right target was presented. The latency of
the resulting saccade was measured (from target appearing to the eyes moving).
After an automatic calibration procedure, up to 300 trials were recorded from
each subject.
Results were preprocessed with LatencyMeter software (version 2.10, Ober
Consulting, Poland) using an automated algorithm to reject aberrant traces.
Mean proportions of rejected trials were similar across groups (control group
14.6%, PD group 15.6%, PSP group 16.1%, CBS group 14.7%). Latency analysis
was performed on subjects with >150 pre-processed saccades. Saccadic Pro-
gramming and Instrumentation Computer software (SPIC, version 15.iv.2010,
www.cudos.ac.uk/spic.html) fitted the LATER model using Kolmogorov-Smirnov
tests for two mixed Gaussian distributions of inverse latencies. The mean (µ) and
variance (σ) of reciprocal latency were estimated for the principal population, and
variance (Eσ) for the subpopulation of early saccades.
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Subjects undertook the MMSE and verbal fluency within 3 months of sac-
cadometry. Letter and category fluency (total number of p-words and animals
over 60 seconds) were recorded separately, then combined to give a single fluency
score.
Statistical analysis used OpenOffice.org Spreadsheet (version 3.2) and R sta-
tistical software (version 2.11). ANOVA and Analysis of Co-Variance (ANCOVA)
with saccade parameters as dependent variables used diagnostic group (with
four levels, unequal variance), with and without cognitive covariates respectively.
Cluster analysis used k-means to distinguish between a priori 4 diagnostic groups.
Entropy was calculated for each diagnosis (lower values indicate better cluster-
ing). ROC characteristics were generated using the pROC package for R Sing
et al. [2005].
2.2.2 Results
2.2.2.1 Group differences
Results of saccadometry for each diagnostic group are shown in figure 2.3. Be-
tween group differences were significant for the mean inverse saccadic latency µ
(F=6.64, df=3, p=0.004) and variance σ (F=3.41, df=3, p=0.02), but not the
variance of early saccades Eσ (F=0.56, df=3, p=0.65) indicating that part of
the variability of latency parameters can be explained by diagnosis. Significant
differences (p<0.05, Bonferroni corrected) between groups for post hoc pairwise
t-tests are in figure 2.3.
2.2.2.2 Diagnostic classification of individuals
Despite group differences in mean values, cluster analysis results showed poor
diagnostic separation (table 2.6). There was a slight improvement in entropy
with verbal fluency as an additional variable. However, entropy values remained
above 1 indicating poor clustering. With verbal fluency included, most PSP
patients lie in a single cluster (15/21 in cluster 2) alongside four CBS patients
and one control subject. PD and healthy subjects cluster mainly in group 4; CBS
patients were scattered among all four clusters. ROC analysis demonstrated poor
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Figure 2.3: LATER components of saccadic latency by diagnostic group. Latency
values are shown for each diagnostic group in terms of µ (median reciprocal latency), σ
(main slope, a measure of principal reciprocal latency variance), Eσ (variance of early
saccade latency variance). PD=Parkinson’s disease, PSP=progressive supranuclear
palsy, CBS=corticobasal syndrome.
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Cluster - based Cluster - based on µ,
on µ and σ σ and Verbal fluency
1 2 3 4 Entropy 1 2 3 4 Entropy
PD 2 6 8 9 2.01 3 0 5 17 1.52
PSP 1 9 3 8 1.81 2 15 3 1 1.36
CBS 1 2 9 2 1.56 1 4 8 1 1.54
Controls 0 3 7 26 1.37 0 1 5 30 1.14
Table 2.6: Cluster analysis of saccadic latency results. Low entropy values (ide-
ally less than 1) indicate better clustering. PD=Parkinsons disease, PSP=Progressive
supranuclear palsy, CBS=Corticobasal syndrome.
differentiation between PD vs PSP (AUC: µ=0.52, σ=0.59) and between PD vs
CBS (AUC: µ=0.75, σ=0.56).
2.2.2.3 Correlation with cognition
There were significant interactions between diagnosis and verbal fluency scores
for the mean inverse latency µ (F value=2.67, df=3, p=0.04) and variance σ (F
value=4.29, df=3, p=0.007), assessed using ANCOVA. Strong correlations were
seen in CBS for verbal fluency and µ (r=-0.36) and σ (r=-0.47) and in PSP for
verbal fluency and µ (r=-0.25). No interaction was observed between diagnosis
and verbal fluency for variance of early saccades Eσ (F=0.99, df=2, p=0.4). No
interactions with MMSE were observed (µ: F=1; σ: F<1; Eσ: F<1).
2.2.3 Discussion
Both in the clinic and for research, a diagnostic test would be extremely helpful
for the differential diagnosis of PD, PSP and CBS Litvan et al. [1998]; Williams
and Lees [2009]; Williams-Gray et al. [2007]. Latency measures of horizontal re-
flexive saccades have been proposed for this, and the data presented here confirm
significant between group differences in mean values of latency. However, this
was not sufficient for a role as a biomarker. I found that latency measures were
unable to reliably differentiate individual subjects according to their diagnosis,
either by cluster analysis or ROC analysis.
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The variance in saccadic latency σ was associated with cognitive measures of
verbal fluency. However, combining saccadic parameters with verbal fluency did
not improve the assignment of participants in to clinical diagnostic groups. This
suggests that a substantial overlap exists in saccadic latency between healthy and
parkinsonian subjects, and between diseases.
Closest to a coherent diagnostic cluster was cluster 2, with 15/21 patients
having PSP and four with CBS. The inclusion of CBS may be because of poor
classification or, more speculatively, the presence of PSP pathology underlying
a proportion of corticobasal syndrome cases Alexander et al. [2014]; Ling et al.
[2010]. The data presented here did not discriminate between PD and healthy
adults in contrast to earlier reports Chan et al. [2005]; Mosimann et al. [2005].
Saccadometry has several advantageous properties as a potential biomarker:
it is a rapid assessment (10-15 minutes), objective and non-invasive with excel-
lent reliability with repeated measurements in health and PD (within subject
across session correlation, r=0.85, data not shown) and minor effects of practice,
learning, strategy or need for parallel tests. These features, alongside the pro-
posed relationship to cognitive function, are strong advantages for any research
tool to study neurodegenerative disease. It may be useful to monitor disease pro-
gression, the effects of therapeutic interventions or cognitive decline in selected
patient groups. These results suggest saccadometry is not suitable for diagnostic
differentiation, however the method of measuring saccades used here relies on
simple reflexive horizontal saccades. It may be that a better diagnostic differ-
entiation may be achieved with related measures such as vertical saccades that
rely on a distinct pathway, or saccadometric measures such as inhibition or no-go
saccades.
2.3 Conclusions
Taken together, findings from the ACE-R and saccadometry highlight the poten-
tial of simple clinical measures to fulfil the functions of a biomarker. In particular,
both tests were able to reflect important aspects of disease syndromes, and to ex-
plain the underlying disease process. Furthermore, the verbal fluency score from
the ACE-R demonstrated potential as a diagnostic biomarker by differentiating
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between PD and PSP. Both ACE-R and saccadometry are relatively easy to
implement in a movement disorder or general neurology clinic.
The translation of the ACE-R test and saccadometry to clinical practice would
require additional resource in terms of time and training, though would not be be-
yond the scope of a tertiary referral service and may be practical for some general
neurology departments, particularly the verbal fluency component of the ACE-
R. The definition of a biomarker requires that it reflects underlying pathology.
Assessing clinical biomarkers in the manner of this chapter is heavily dependent
on the accuracy of clinical diagnosis from clinical history and examination. This
is particularly problematic for CBS which is a variable syndrome linked to a het-
erogeneous set of underlying neuropathologies Alexander et al. [2014]. This may
limit the application of similar clinical biomarkers to routine clinical practice if
support from neuropathology or other more direct measures of pathology (eg tau
or beta-amyloid PET imaging).
Indeed, the correspondence between these biomarkers and disease syndromes
and pathologies was imperfect. This is particularly seen in saccadometry, which
represents specific anatomical circuits, but failed to differentiate between PD,
PSP and CBS. A better understanding of the anatomical and functional networks
and pathways that underlie these clinical observations is required. I will now turn
to task-free fMRI to explore functional networks in greater detail.
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Chapter 3
Methods for Network Analysis of
Functional MRI data
The measurement of brain networks can be divided in to three main categories:
• structural connectivity measuring direct connections between brain regions,
eg Diffusion Tensor Imaging (DTI), structural covariance
• functional connectivity measuring the correlations or covariance between
the timeseries of brain regions,
• effective connectivity assessing the causal influences and directed functional
connections between brain regions, eg Grainger causality or Dynamic Causal
Modelling.
In this thesis I will focus on functional connectivity using Functional Magnetic
Resonance Imaging (fMRI). Measuring correlation or covariance between brain
regions is a challenge of multivariate analysis, in that the relationships between
multiple brain regions are being assessed simultaneously. In this chapter I will
outline two mathematical approaches to deal with the multivariate nature of fMRI
data by analysing the correlation between regions’ timeseries (graph theoretical
analysis) and the covariance of brain regions to specific functional covariance
networks using Independent Component Analysis (ICA).
The following chapters make use of network analysis of imaging and clinical
data in control, Parkinson’s disease (PD), Progressive Supranuclear Palsy (PSP)
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and Corticobasal Syndrome (CBS) cohorts. The demographic information of sub-
jects is presented first, followed by the image preprocessing and network analysis
methods that form the the basis for subsequent chapters.
3.1 Subject recruitment
The same cohort of subjects was used for all the imaging studies subsequently
described. 178 subjects (60 elderly controls, 30 PD, 56 PSP, 32 Corticobasal
Degeneration (CBD)) were recruited with written informed consent and with
approval from the local ethics committee (Cambridge 2). Of these, 23 were ex-
cluded because of unexpected brain lesions, imaging artefacts or after fMRI image
pre-processing revealed motion dependent confounds on connectivity measures.
Demographics for the remaining 148 subjects are shown in table 3.1. PSP and
CBS subjects were recruited through the Disorders of Movement and Cognition
Clinical at Addenbrookes hospital. PD subjects were recruited as part of a study
investigating Atomoxetine and Citalopram in a placebo controlled trial Ye et al.
[2014]. Age-matched control subjects were recruited from spouses of PSP and
CBS subjects, from the MRC Cognition and Brain Sciences Unit volunteer panel
and as part of the PD drug study. The drug trial excluded left handed subjects
leading to a small but statistically significant difference in handedness between
groups.
All subjects underwent a battery of cognitive and motor tests. Cognition was
assessed in all groups using the Mini-Mental State Examination (MMSE) Folstein
et al. [1975],
3.1.1 Image acquisition
All imaging was performed at the Wolfson Brain Imaging Centre, Cambridge, on a
3T Tim TRIO Siemens Magnetic Resonance Imaging (MRI) scanner. Medication
was not altered prior to scanning. Task-free echo-planar fMRI was acquired for
between 145 and 300 volumes (Repetition Time (TR) 2 secs, Echo Time (TE)
30ms, flip angle 78, whole brain acquisition, 3x3x3.75mm voxel) and structural
Magnetization-Prepared Rapid Acquisition with Gradient Echo (MPRAGE) scan
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Control PD PSP CBS DF F p
Number of subjects 53 28 41 26
Age 66.7 66.8 70.8 67.8 3 2.2 0.09
School leaving age 17.9 18.3 16.3 16.6 3 4.9 0.003
MMSE 29.0 28.4 24.5 22.4 3 16.9 2e-09
UPDRS III 20.8 36.7 34.5 2 12.4 2e-05
psprs 38.3
Control PD PSP CBS DF χ p
Gender (M/F) 23/30 14/14 20/21 15/12 3 1.1 0.8
Handedness (L/R) 1/52 0/28 3/38 4/22 3 8.2 0.04
Table 3.1: Demographics for all subjects included in the imaging analysis in chapters 5,
6, 7 and 8. Differences across the group were analysed using analysis of variance for con-
tinuous variables and chi-squared test for binary variables. MMSE=Mini-mental state,
UPDRS III=Unified Parkinson’s Disease Rating Scale, PSPRS=Progressive Supranu-
clear Palsy Rating Scale
in the same session. Cardiac and respiratory cycles were not recorded separately.
3.2 Image preprocessing
Raw fMRI data are not immediately amenable to analysis since they contain both
signal from neuronal activity and non-neuronal noise. These non-neuronal sig-
nals may be environmental noise, such as low frequency changes in the scanner’s
magnetic field Smith et al. [1999], physiological noise from respiration or cardiac
signal, or motion artefact as subjects move in the scanner van Dijk et al. [2011].
The goal of image preprocessing is to remove these noise components whilst main-
taining the underlying signal. fMRI in neurodegenerative disease presents two
specific preprocessing challenges: transforming brain scans of patients with sig-
nificant atrophy to standard template space, and dealing with head movements
within the scanner that may have an impact on the Blood Oxygen Level Depen-
dent (BOLD) signal. Here I outline solutions to these preprocessing challenges
in dealing with fMRI in older adults and those with neurodegenerative disease.
The preprocessing pipeline is shown in 3.1 and utilises a customised version of
the fMRI signal processing toolbox (www.brainwavelet.org) Patel et al. [2014].
Additional processes used FSL (version 5.0.0).
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The predominant source of noise in the T2* signal is physiological noise, with
the primary contributors being the cardiac and respiratory cycles Kru¨ger and
Glover [2001]. Cardiac and respiratory monitoring can be used in the de-noising
process, but were unavailable in this cohort. Although these cycles are regular,
the relatively sparse sampling rate of fMRI means that the effect on the BOLD
signal is aliased across low and high frequencies so that a simple band pass filter
is ineffective Shmueli et al. [2007]. However, the cardiac and respiratory cy-
cles correlate with pulse waves in the Cerebrospinal Fluid (CSF) Bhadelia et al.
[1997]; Klose et al. [2000], so regression of the CSF signal removes a considerable
proportion of physiological noise. Using a single regression step encompassing
CSF and the motion derivatives reduced the number of preprocessing steps and
therefore reduced the chance of introducing unwanted artefact. Environmental
noise is dominated by very low frequency and is readily removed by a high pass
filter Smith et al. [1999]. Global signal regression was not performed since it may
introduce artefactual negative correlations Murphy et al. [2009].
3.2.1 Normalisation
Normalising MRI images in older subjects can be challenging since brain shape
naturally varies between people, a difference that is enhanced by the atrophy and
small vessel disease that accompany age and neurodegenerative disease. However,
a group comparison design demands that subjects’ scans are transformed to a
common template, both to compare between subjects in common anatomical sites
and to enable comparison with other studies reporting in a standard coordinate
systems. Structural images illustrating the particular challenge of normalisation
in the current cohort is illustrated in figure 3.2. All subjects were normalised
to the commonly used Montreal Neurology Institute template (MNI) Mazziotta
et al. [1995].
The first step of normalisation is skull-stripping to remove artefact that might
be recognised as brain, including dura, skull, optic nerves and other soft tissues.
CSF around the outside of the brain will also be removed at this point. Standard
skull stripping tools such as the Brain Extraction Tool (BET) in FSL perform
poorly in atrophied brains for three main reasons: the contrast between cortex
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Figure 3.1: Preprocessing pipeline for structural and task-free functional images.
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Figure 3.2: Example images showing the challenges warping typical scans from elderly
controls, and neurodegenerative diseases to standard MNI space. The disease groups
show generalised atrophy with enlargement of the ventricles and sulci in addition to
more focal areas of atrophy, eg in the brainstem and frontal lobes of PSP subjects and
parietal lobes in CBS subjects. MNI=Montreal Neurology Institute template
and non-brain tissues may be poor, commonly used initial templates may be
inappropriate due to atrophy, and algorithms to find the centre of the brain do
not work in the context of severe atrophy.
To address these challenges, intensity normalisation and contrast enhance-
ment were applied using a method developed for use in dementia subjects for
Voxel-Based Morphometry (VBM) analysis Acosta-Cabronero et al. [2008]. This
process draws on functions to identify cortical boundaries and enhance grey-
white contrast (freesurfer, version 5.0.0), following which BET works effectively
in most cases. A process of quality control was still required and individually
customised parameters were used in some subjects to help BET find the centre
of the brain and to adjust the threshold for differentiating brain from non-brain.
In two subjects (one control, one PD) moderate sized dural artefacts remained
over the occipital and parietal lobes which affected subsequent normalisation, so
were manually removed.
The next step was to warp the structural scans to MNI space. For this, a two
stage process was applied, firstly to transform scans from native space to a study-
specific template, then to warp from study-specific space to MNI template space.
A study specific template was constructed from the structural images for each
disease group in combination with the control group, and for the control group
separately. Each template was generated using an iterative approach, starting
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with MNI space and successively warping and averaging each subject in turn.
This was repeated for 4 iterations to achieve convergence using VTK software
(version 4.0, scripts kindly provided by Marta Correia).
Each subject’s structural image was warped to the relevant study specific tem-
plate using a non-linear process using FSL FNIRT (12 DOF) Andersson et al.
[2010]. The warped images were visualised for quality control purposes and in-
dividual parameters adjusted as necessary. Co-registered and preprocessed func-
tional images were warped to the study specific space by applying the warping
matrix generated from the structural normalisation.
To complete normalisation, an inverse warp was generated from the trans-
formation from MNI space to study specific template space and applied to each
functional and structural image. A final quality control step visualised each image
to ensure good quality registration.
3.2.2 Motion correction
The importance of motion correction in network analysis came to the fore with
the publication of two papers suggesting subjects moving in the scanner had
a large impact on connectivity analysis Power et al. [2011]; Satterthwaite et al.
[2012]. It was suggested that even small movements in the scanner have an impact
on BOLD signal, and in connectivity analysis cause an artefactual increase in
connectivity proportional to the distance between brain regions. Standard motion
correction by realignment and regressing motion derivatives may be insufficient
to completely abolish motion effects.
However, subsequent reanalysis of the same dataset has shown that simple
measures can significantly reduce the impact of motion in the original datasets
Patel et al. [2014]. Firstly, applying a bandpass filter after motion correction
removes most of the artefactual changes. Secondly, despiking methods can further
reduce the impact of motion by removing large BOLD signal artefacts Jo et al.
[2013]. I applied a local median despiking algorithm that identifies and removes
large spikes in the BOLD response in comparison to temporally adjacent values.
Motion artefact is particularly evident at the periphery of the brain, ie at the
farthest distance from the fulcrum of the atlanto-axial joint. This noise may be
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represented in CSF surrounding the cortical folds. Given the subject-to-subject
variability in the sulcal width and volume of midline CSF between the frontal
lobes, the corresponding native space structural scan was loosely thresholded to
remove CSF and binarised to generate a mask. This mask was applied to the
native space functional scan prior to normalisation.
The effect of motion and other noise sources on BOLD signal and connectivity
was assessed in each individual using a range of objective and subjective measures.
Careful quality control for motion artefact was employed by:
• excluding subjects with greater than 5mm framewise displacement between
consecutive volumes of the fMRI scan
• excluding subjects showing correlation between motion and BOLD as as-
sessed by measuring wavelet correlation before and after scrubbing Power
et al. [2011]
• looking for large motion-induced artefacts on visualising a graph with a 3%
equidense threshold (ie multiple connections lying along a single plane)
In total, 30 subjects were removed. The numbers in each group are shown in
table 3.2. To assess the residual effect of motion at a group level, the correlation
between motion and connectivity was plotted against the inter-node distance in
figure 3.3, following Satterthwaite et al 2012. This was performed before and
after exclusion of subjects with excessive motion with the correlation coefficients
shown in table 3.2. All groups showed much lower effect of noise than reported
by Satterthwaite et al (r=-0.50) and all showed a further reduction in the effect
of motion after removal of outlying subjects.
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Figure 3.3: The dependency of motion artefact on the pysical distance between nodes.
This relationship improved in all groups after removal of subjects showing a large effect
of in-scanner motion on the measured BOLD response.
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Group r Before n Removed r After
Control -0.28 8 (13.3%) -0.22
PD -0.17 2 (15.3%) -0.15
PSP -0.22 14 (24.5%) -0.07
CBS -0.22 6 (18.8%) -0.22
Table 3.2: Correlation values (r) between the correlation of motion and connectivity
against the inter-node distance, after Satterthwaite et al. [2012]. This value describes
the group level effect of motion driven by distance between nodes.
3.3 Graph analysis
Considering brain regions as interconnected networks and applying graph the-
oretical analysis has been a useful technique to investigate brain networks in
health and neuropsychiatric disease Bullmore and Sporns [2009]. Graph theoreti-
cal analysis is a branch of mathematics that describes the topological relationship
between objects, in this case between brain regions. Here I will set out the general
definitions that underpin graph analysis. I will go on to assess different methods
to define network nodes by parcellating the brain, then describe the rationale be-
hind using wavelet correlation to generate an association matrix from functional
fMRI data, and thresholding techniques to construct a graph from association
matrices. Finally I will define the graph theoretical measures that are used in
subsequent chapters.
I will use standard set theory notation, interspersed with definitions follow-
ing notation used in Python to emphasise the practical implementation of these
methods in Python using the networkx package (see chapter 4).
The general definition for a graph is given as:
G = (V,E)
Where G is a graph of a set of V = {1, 2....N} nodes (also called vertices) and E
edges defined by the function {{u, v} |u, v ∈ V, u 6= v}.
Using the pythonic language of networkx, the groups of nodes and edges are
defined as dictionaries. A dictionary is a set of values mapped to a set of variables.
Within which each node or edge is allowed a dictionary of properties. Thus, the
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dictionary of nodes is represented as:
V = {0 : {xyz : (x, y, z)} , 1 : {xyz : (x, y, z)} ...N : {xyz = (x, y, z)}}
where x, y and z are the Euclidean coordinates for the centre of each node, and
the dictionary of edges is represented as:
E = {(0, 1) : {weight : w} , (0, 2) : {weight : w} ...(N,N − 1) : {weight : w}}
where w is the weight (or strength) of the connection, or alternatively 0 or 1 in
a binary network.
The first stage to defining a graph is to identify the network nodes. In brain
data this requires dividing brain regions using a parcellation scheme.
3.3.1 Parcellation
There is no standard choice for parcellating the brain in order to assess correlation
between all brain regions Fornito et al. [2013]. A balance must be struck between
functionally meaningful regions and maintaining an equal size so that all regions
contribute equally to the final network. Using an anatomically based parcellation
can be problematic, since the final regions may be of grossly different sizes and
cytoarchitecture may not always predict functional areas Amunts et al. [2000]. An
alternative is to use a random division of the brain, which creates nodes of equal
size and additionally allows for a higher resolution parcellation Hagmann et al.
[2008]. I applied a random parcellation scheme for these reasons. Although much
debated, the principles of topological organisation are similar between anatomical
and random parcellation schemes de Reus and van den Heuvel [2013].
Two parcellation templates were constructed from a grey matter segmenta-
tion of MNI space in to 500 and 100 roughly equally sized random parcels. Both
parcellation templates are used to assess the relationship between graph metrics
in chapter 5, and for subsequent chapters only the 500 node parellation is used.
Of the 500 parcels, 29 parcels were not sufficiently covered in some or all sub-
jects leaving 471 parcels. Of the 100 parcels, 4 parcels were removed leaving 96
parcels. Therefore, the resulting association matrices were sized either 500×500
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or 100×100, with each row or column representing the connections of a single
node, and each value in the matrix the connection strength of a single edge.
Once the nodes are defined, the edge strengths can be defined by using a
measure of correlation between the activity within two nodes. I will go on to
discuss the use of wavelet correlations to assess this correlation and define edge
weights.
3.3.2 Wavelet correlation as edge weights
The correlation between the frequency band activity from a wavelet decomposi-
tion of the activity in two regions can be used to define the strength of connection
between those regions. Here I will describe and justify below the particular type
of wavelets I have used to generate association matrices using task-free fMRI
data.
Unlike a simple Pearson correlation, wavelet analysis considers multiple fre-
quency bands as a multi-scaled spatiotemporal decomposition of a timeseries in
to a series of frequency bands called wavelet scales. An alternative would be to
use a Fourier transform as a spatiotemporal decomposition. However, brain se-
quences are jerky and irregular which better suits wavelet analysis since it takes
in to account the location of an observation within a timeseries so that a local
discontinuity or variation has an impact only on the local wavelet coefficient,
which would otherwise have an impact on all Fourier coefficients.
The simplest form of wavelet analysis calculates the difference dk between
each variable in a vector v, where k = 1...n/2 so that:
dk = y2k − y2k−1
To obtain the next scale j, requires calculating differences dj,l where l = 1...n/4
between the sum of adjacent values of v, so that:
ck = y2k + y2k−1
and therefore:
dj,l = cj,2l − cj,2l−1
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In this process dj,k are the wavelet coefficients and cj,k are known as scaling co-
efficients Nason [2010].The wavelet underlying this decomposition is called the
Haar wavelet, defined as:
ψ(x) =

1x ∈ [0, 1
2
),
−1x ∈ [1
2
, 1),
0 otherwise
Other classes of wavelets exist, of which the Daubechies wavelet is commonly
used since it is smoother than the Haar wavelet and therefore may fit real time-
series more closely. The choice and shape of wavelet defines a wavelet filter with
each wavelet scale defined by a dilation of the original wavelet. There are two main
families of Daubechies wavelets, defining asymmetrical or symmetrical wavelets;
for this analysis the most symmetrical wavelet was chosen, commonly known as
L8 because it includes 8 stationary moments.
A simple implementation of wavelet analysis as above is limited in that it
requires that the length of v is a multiple of 2 so that the complete timeseries
can not always be used. This is problematic, since the results are sensitive to the
starting point of the timeseries, whereas in reality a random sample from a con-
tinuous timeseries is being examined. Therefore, a modified implementation was
employed called the Maximal Overlap Discrete Wavelet Transform (MODWT).
Conceptually, the MODWT can be considered as a discrete sampling of a con-
tinuous wavelet function. A full explanation of the MODWT can be found in
Percival and Walden [2000], in brief the MODWT wavelet coefficients are defined
by:
W˜j,t ≡
Lj−1∑
l=0
h˜j,lvt−l mod N
where t = {0..N − 1}, L is the width of the scaling filter and
{
h˜j,l : l = 0...Lj − 1
}
are the jth level MODWT wavelet filter. The scaling coefficients are defined by:
V˜j,t ≡
Lj−1∑
l=0
g˜j,lvt−l mod N
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where {g˜j,l : l = 0...Lj − 1} are the jth level scaling filters.
Choosing the frequency band to study in fMRI is not straightforward, since
the BOLD signal is a smoothed representation of neuronal data, which is further
downsampled because the data are sampled discretely, in my data by a TR of
2 seconds. This may lead to higher frequency neuronal signal being aliased to
a lower frequency. An approach to this problem is to select the wavelet scale
with the strongest inter-regional correlations that reflect the expected physiol-
ogy pattern of the brain. The second wavelet scale encompassing the frequencies
0.0675-0.125Hz have been shown to have particularly strong inter-regional corre-
lations Achard and Bullmore [2007], and therefore this wavelet scale was used for
wavelet correlation.
The resulting matrix of pairwise correlation values between all nodes is called
an association matrix. In order to facilitate comparison between groups a Fisher’s
R to Z transform was applied to each association matrix so that the correlation
values are normally distributed. The resulting association matrix of Z values
can be investigated in its own right or used to provide the connection strengths
for a graph. Once an association matrix is constructed, graph metrics can be
assessed using all the values of the association matrix, or a threshold can be
applied to assess on the most important edges. I will now discuss the options for
thresholding an association matrix.
3.3.3 Thresholding an association matrix
Graph metrics can be assessed in a graph constructed from a thresholded associa-
tion matrix. This has theoretical advantages by selecting strongest and arguably
the ‘most important’ connections in a network. In addition, thresholding allows
some measures such as the path length to become tractable in large networks.
The simplest way to apply a threshold is to use an absolute threshold whereby
a single threshold is applied to all elements of an association matrix. Connections
below the threshold are ignored. However, the mean connection strength for two
subjects may differ so that the resulting graphs differ in the numbers of nodes
and edges. This difference prevents any meaningful comparison of these subjects.
An alternative is to apply a threshold adjusted for each individual such that a
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percentage of the total number of possible connections are made. This is known
as an equidense threshold. For example, a graph with 10 nodes would have a
total possible number of connections of 10 × (10 − 1) = 90 connections. A 5%
equidense threshold applied to this graph would result in 5 (rounded up from 4.5)
edges.
A disadvantage of using the two methods described is that the graph may be
disconnected such that the majority of nodes are contained within a single giant
component and one or more nodes may form their own separate network. This,
again, runs the risk of making a comparison between networks of different sizes.
A workaround for this challenge is to use a local thresholding algorithm rather
than a global thresholding algorithm Alexander-Bloch et al. [2010]. This al-
gorithm begins with the Minimum Spanning Tree (MST), defined as a graph
containing the minimum number of edges with the highest possible connection
strength such that all nodes are connected to at least one other node. The MST
is a special case of the Nearest Neighbour Graph (NNG): the first 1-NNG is the
MST, 2-NNG is a graph with the minimum number of connections and greatest
possible connection strength such that each node is connected to at least 2 other
nodes, and so on for k-NNG. The local thresholding algorithm proceeds by adding
nodes from increasing values of k until the requisite number of connections are
established. Local thresholding using the MST was adopted for all remaining
chapters.
3.3.4 Graph measures
The main advantage of using graph analysis is the ability to describe topological
properties of a network. A whole host of graph metrics exist, the two broadest
groups of metrics derived from the underlying principles of efficiency and commu-
nity. Below are formal definitions for all the graph measures used in subsequent
chapters.
The first set of graph measures I introduce will consider the topological effi-
ciency of the network by measuring aspects of the small world architecture. The
small world structure is common in biological networks and was first described
by Watts and Strogatz 1998 who generated a small world arrangement by re-
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arranging the connections of an ordered lattice. The resulting network has two
important properties, demonstrated in figure 3.4. Firstly, it has a relatively short
path length nearing that of a random network. Secondly, it has a relatively high
clustering coefficient nearing that of an ordered lattice.
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The simplest count of connections for a node is to count the number of edges,
call the degree:
k(u) =
∑
v
Au,v
An extension of the degree includes the weight of each edge to calculate con-
nection strength. Connection strength of an edge refers to the measured strength
of the connection using the correlation coefficient. Node-wise connection strength
is defined as:
S =

u1∑
v∈V |v 6=u1
v[weight],
u2∑
v∈V |v 6=u2
v[weight]...
un∑
v∈V |v 6=un
v[weight]

The cluster coefficient is based on the ratio between the number of connected
triangles in a graph δv to the number of connected triplets τv:
C(G) =
1
|V ′|
∑
v′∈V ′
δv
τv
This is often compared to the the average shortest path length because the
ratio between these measures captures the similarity of a network to the small
world arrangement. If Pu,v is the shortest path length between nodes u and v:
P (G) =
1
N(N − 1)
∑
u∈V
∑
v 6=u∈V
Pu,v
A way of expressing efficiency across the whole graph is to use the global
efficiency, defined for a graph G as the sum of the inverse shortest average path
lengths:
Eglob(G) =
1
N(N − 1)
∑
u6=v∈V
1
Pu,v
Using the same formula, the local efficiency for a node u is defined as the
efficiency for Gu, the subgraph of the neighbours of u:
Eloc(u) =
1
N
∑
u∈V
E(Gu)
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Figure 3.5: The hub and community graph measures can be considered conceptually
by considering the small world graph from figure 3.4, here arranged to accentuate the
hub and community structure. The yellow hub node is connected to multiple nodes
from both cluster 1 and cluster 2. Travelling from any node in cluster 1 to any node
in cluster 2 requires passing through the hub node, therefore the hub node has a high
centrality, by this definition the betweenness centrality. The middle node of cluster 2 is
connected to all but one node within the cluster, therefore is considered to have a high
within module degree. Because the hub node is part of both cluster 1 and cluster 2, it
would be considered to have a high participation coefficient.
Measures of the hub properties of a network assess the connection strength
defined above, and the importance of a node within the network called centrality.
Centrality assesses paths associated with a node, shown in figure 3.5.
I assessed three centrality measures that define different contributions of hub
nodes to the overall network topology. Betweenness centrality is defined where
s 6= u ∈ V and v 6= u ∈ V , so that σ(s, v) is the number of shortest paths between
s and v. σ(s, v|u) is the number of s, v paths that pass through u:
cB(u) =
∑
s,v∈V
σ(s, v|u)
σ(s, v)
The betweenness centrality may be misleading in sparse graphs since almost all
connections pass through just a handful of nodes.
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Closeness centrality is based on distance, where γ(u, v) is the average distance
between u and v. Since correlations were used to defined edge weights with values
between -1 and 1, the distance for a node u was defined as 2−u[weight] + 0.0001
(including a small adjustment ensure the distance was non-zero):
cC(u) = 1/(N − 1)
∑
v 6=u∈V
γ(u, v)
The eigenvector centrality is the basis for the well known page rank algorithm
Page [1998] used by Google in search results. In essence, eigenvector centrality
assigns a value based on the node’s own centrality and that of its neighbours.
This result is provided by finding the eigenvectors (λ) of the adjacency matrix
A, so that Ac = λc. Full details of the eigenvector centrality can be found in
Ruhnau [2000]:
The small world network is particularly robust to random attacks to the net-
work. The robustness of a network can be measured as the percentage of nodes
that can be removed before the network starts to exponentially decay, called a
percolation number Albert et al. [2000]. To measure this, the largest connected
component S of a network is identified and its sized measured as 〈s〉. Random
nodes are removed from the network so that 〈s〉 decreases. The value of 〈s〉
reaches a threshold where it starts to decline rapidly, at which point the perco-
lation threshold pc is defined as the number of nodes removed. Because this is
a stochastic process, multiple iterations are required to obtain a true value for
pc. To provide a more accurate measurement at each iteration, the percolation
threshold is smoothed with a sliding window.
In addition to measures related to efficiency and connectivity, I assess mea-
sures of the graph community structure. A community is defined as an intercon-
nected group of nodes forming a discrete group within the overall graph. These
measures depend on implementing a community detection algorithm to label each
node as belonging to a community. There are a number of community measures
available, however one of the most widely used is the algorithm introduced by
Newman et al 2006. The Newman algorithm has been implemented in a wide
range of biological networks and is efficient in large datasets. The algorithm opti-
mises the measurement of modularity for a network where modularity is defined
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as the sum of degree for nodes in a community, less the degree for a random
distribution of edges. The sum of degree for nodes within a defined community is
Au,v and the expected number of edges if randomly distributed is kukv. Therefore
the modularity Q is defined as:
Q =
1
4m
∑
u,v
(
Au,v − kukv
2m
)
susv
where m is the total number of edges in the network and community assignments
for each node are denoted su and sv. Further details of how the algorithm is
implemented, in particular by assessing the eigenvalues for the matrix of node-
wise modularity scores can be found in Newman et al 2006. The optimised global
modularity score can be used as a graph measure in its own right.
Using the Newman community detection method, each node is assigned a
community membership. These memberships can be used to define other graph
measures. Firstly, the participation coefficient is a measures of how many edges
a node has in its own community rather than other communities Guimera` et al.
[2005]. This is defined as:
PCu = 1−
Nm∑
s=1
(κus
ku
)2
Where κus is the number of links for a node within its own community and ku is
the degree of the node.
An alternative is to consider only the connections within the community to
which a node belongs, measured by the within module degree. This measures the
mean connection strength all edges of a node within its own community:
Wi =
1
κus
Ns∑
u=1
(Su,v)
3.4 Independent Component Analysis
In addition to connections between regions, one can decompose brain activity
in to a series of covariance networks of interconnecting regions using spectral
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analysis such as ICA Calhoun et al. [2001]; Comon [1994]; Hyva¨rinen and Oja
[2000]. ICA is an extension of Principal Component Analysis (PCA) and is based
on the concept that there exists within data a series of co-varying structured
components. In PCA these components are assumed to be orthogonal and non-
overlapping, but this is not the case in ICA where they are merely assumed to
be maximally independent in their higher order moments. In its simplest form,
ICA is simply a linear statistical model given by:
y = Mx+ v
where y are observed BOLD signal values in a 4-dimensional fMRI scan that
depend on a set of ICA components defined in the square matrix M , and where x
is a constant and v is noise. In the context of neuroimaging data, each row of M
is a spatial map representing either an intrinsic functional connectivity network
or a structured noise component.
Since each subject has their own set of voxel-wise timeseries, there are two
ways to generate a group ICA. The first is to concatenate each subject’s timeseries
in to a single long timeseries termed temporal concatenation ICA. The alternative
is to arrange the timeseries in parallel and assess variance within the data across
subjects and across time, termed tensor ICA. In task studies temporal concate-
nation ICA is more appropriate since all subjects are exposed to identical stimuli
at the same point of the experiment. However, in the task-free state a temporal
concatenation ICA approach is more appropriate since there is no reason to ex-
pect synchrony of timeseries between patients for each timepoint of the scanning
period.
In order to investigate network covariance, functional networks were identified
using group ICA with FSL’s melodic tool. To enable networks to be compared
between pairs of groups, a group ICA was performed for each pairwise group, eg
Controls with PD. Examples are shown in figure 3.6. Network labels were assigned
to independent components using a semi-automated approach, comparing the
difference between mean within and without network values in each independent
component using a binary network mask generated in an independent population.
These network labels were confirmed visually, with visual assessment considered
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superior to the automated values. The network templates used for this process
were defined in an independent young control group, available from the FIND
lab (http://findlab.stanford.edu/research.html) Shirer et al. [2011]. The majority
of networks were accurately identified by both visual and automated methods,
although the anterior salience network was most often incorrectly identified using
the automatic approach alone.
Statistical assessment of network covariance was performed using a dual re-
gression approach Filippini et al. [2009] illustrated in Figure 3.7. The first step in
dual regression took the spatial maps from the group ICA against single subjects’
fMRI images to produce a series of timeseries, one per component. These time-
series were regressed against the same individuals’ timeseries to produce subject-
specific spatial maps representing a single independent component. The individ-
ual spatial maps were then used for statistical inference by applying a general
linear model using permutation testing in FSL’s randomise tool.
Effect size for differences in network covariation were obtained by taking pa-
rameter estimates in the first stage of the dual regression, masked by regions of
significance identified by statistical inference.
In order to assess the interaction between network covariance and clinical
scores within each diagnostic group, group ICA and dual regression were re-
peated to include only individuals in a single diagnostic group. Clinical scores
were included as an additional variable in the statistical inference stage of dual
regression.
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Figure 3.6: Example ICA components representing functional covariance networks.
These components were generated using group-level temporal concatenation ICA and
network components identified using a semi-automated method; firstly a goodness of
fit score was calculated for each network to each component, secondly visual selection
of networks was used to confirm the selected networks of interest. The images are
arbitrarily thresholded at between 3 and 6 units. DMN=Default Mode Network
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Figure 3.7: Pairwise group comparison between diagnostic groups used ICA and
dual regression. All subjects’ fMRI scans are used in temporal concatenation group
ICA to generate a series of timeseries-independent spatial components. Automated
goodness-of-fit identified components representing networks of interests. These were
taken forward to dual regression. Individual subject maps are identified by regression
against the component of interest’s timeseries. These were taken forward to group-wise
comparison using a generalised linear model.
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3.5 Terminology summary
I will refer to the strength of connections identified by graph analysis as func-
tional connectivity and the strength of connections identified by ICA as functional
covariance. This subtle but important difference reflects the distinction between
the graphical approach that starts with a spatial decomposition going on to ex-
amine timeseries correlations, and the ICA method that begins with a frequency
decomposition and goes on to generate spatial maps. Graph theory therefore
takes in to account only the timeseries from the two regions of interest to cal-
culate a single connectivity value between them. In contrast, ICA takes in to
account the activity across a widely distributed network to evaluate the place of
a single voxel within the network of interest. The relevance of this distinction
will become clearer in later chapters where the results from these two methods
are compared.
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Chapter 4
Network analysis in Python: the
Maybrain package
Brain network analysis is rapidly becoming a standard part of imaging research.
This growing field requires high quality, flexible tools. Despite this, no existing
package has effectively brought together all the tools necessary for interrogation,
manipulation and visualisation of brain imaging data using graph analysis. The
Maybrain package was developed to build on existing available network tools with
a focus on visualisation, network manipulation, a wide range of metrics and ease-
of-use. In this introduction I will review the currently available packages, before
moving on to discuss the advantages of using a pythonic and object-oriented
solution with integrations to existing network analysis tools and visualisation
capabilities.
A widely used existing network software for neuroimaging data is the brain
connectivity toolbox (https://sites.google.com/site/bctnet/) Rubinov and Sporns
[2010], written in Matlab with a Python version
(https://github.com/aestrivex/bctpy) recently made available. However, it is
not designed for visualisation and the range of graph metrics available is limited.
The graph analysis toolbox (http://ncnl.stanford.edu/tools.html) is a wrapper
for the brain connectivity toolbox with visualisation via the the BrainNet viewer
(www.nitrc.org/projects/bnv) Xia et al. [2013]. GRETNA
(https://github.com/sandywang/GRETNA) is another Matlab-based tool that
71
4. NETWORK ANALYSIS IN PYTHON: THE MAYBRAIN
PACKAGE
analyses only functional imaging data, including image preprocessing and pro-
vides a small number of graph metrics.
Using these Matlab-based tools, graph properties such as edge distance must
be stored in separate objects. The connectome viewer
(www.connectomics.org/viewer) Gerhard et al. [2011] is a visualisation toolbox
written in Python that allows a variety of properties to be associated with the
graph and was designed primarily to handle Diffusion Tensor Imaging (DTI) data.
The designers have attempted to introduce a single format for image analysis, but
a large amount of data is required that may not be relevant to simple topological
analysis. Manipulating the networks within these objects is not straightforward,
which might be relevant, for example to simulate a disease process.
A project which attempts to provide a platform for simulating disease states
is the Virtual Brain (www.thevirtualbrain.org/tvb/zwei). This software platform
generates functional imaging timeseries from structural (DTI) data and has the
ability to perform network analysis on the generated timeseries. For this spe-
cific task the software is extremely powerful, but it is perhaps too complex for
relatively simple questions about topological changes in disease.
Outside of the neuroimaging world, network analysis packages include the
Bioinformatics Toolbox (www.mathworks.co.uk/help/bioinfo/network-analysis-and-
visualization.html) in Matlab that is designed for gene-gene and protein-protein
interactions and Biolayout Express (www.biolayout.org), a standalone application
written for visualising very large biological networks and observing flow through
networks.
Arguably the most flexible network analysis tool with the widest range of
available metrics is the networkx (https://networkx.github.io) package in Python,
perhaps only rivalled by the cross-platform igraph (http://igraph.org) project.
The advantage of networkx is it use of object-oriented coding. Object-oriented
code defines a particular class of object which can have certain properties assigned
to it. These properties may be numeric, strings (ie text), or lists. Objects may
also contain functions that specify how the object might change.
In networkx, the ability to store network properties in a single object makes
full use of the dictionary class in Python which is a mapped list of variables to
other variables, lists or objects. Networkx defines each graph as a dictionary of
72
4. NETWORK ANALYSIS IN PYTHON: THE MAYBRAIN
PACKAGE
nodes and edges, with the properties for each node and edge stored as dictionar-
ies. This simple structure enables intuitive expansion of the graph and simple
storage of node properties. The advantage of the networkx graph construct be-
comes particularly clear when applying a dynamic process to the graph, such as
a random attack model (see chapter 6 figure 6.22). Identifying sets of nodes or
edges for more complex models by a particular property, such as edge weight,
becomes trivial.
Therefore the networkx graph object was used within a brain class to be the
primary object in Maybrain. Even within the wide range of graph measures
available in networkx, there are a few measures commonly used in neuroimaging
data that are not included. In particular, assessment of network community
structures are not well provided for. I therefore integrated the pythonic version
of the brain connectivity toolbox to add community measures and have added a
measure of robustness (percolation threshold) within Maybrain.
A rapidly responsive and straightforward 3-dimensional visualisation is an es-
sential part of neuroimaging analysis. Mayavi2
(http://code.enthought.com/projects/Mayavi2) is used in the Connectome Viewer
and is an obvious choice to allow real-time visualisation of brain networks. Visu-
alisation in Maybrain is made simple to use by linking the control of a Mayavi2
object with a clean Graphical User Interface (GUI).
The input for Maybrain is an association matrix. A choice of thresholding
methods are provided to enable no threshold, or global and local thresholds to
generate either weighted or unweighted graphs.
4.1 Methods
The essential features for a neuroimaging network analysis toolbox would include
a simple input format, with easy visualisation of data and simplicity in apply-
ing network measures. In addition, further desirable features would include the
output of data in a simple format for statistical analysis or in a neuroimaging
format for further visualisation. The package would be based on a flexible and
expandable basis. Finally, such a package would be open source to allow free
use and a community-based extension of capabilities. Maybrain seeks to address
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Figure 4.1: A screen shot of Maybrain’s GUI showing a functional graph network
with a local threshold of 3% connection density applied shown in blue. Highlights in
red are shown for edges with a weight >0.2.
these features.
The core of Maybrain defines two Python classes: one containing information
and functions relating to the brain object, and the other handling plotting. The
main object defined by the former is a networkx graph containing nodes and edges
that constitute the brain object. The plotting class uses Mayavi2 to visualise the
data in 3D. The program is able to render multiple brain objects and render
standard templates, such as Montreal Neurology Institute template (MNI).
A screen shot of the GUI workspace is shown in 4.1 providing functionality
to identify nodes or edges by their properties and to readily visualise the results.
Whilst the GUI is helpful to rapidly visualise images and apply simple high-
lights, both the graph object and plotting object can be controlled more pow-
erfully using the command line. A sample of code is shown below that collects
graph network measures from 1 to 10% equidense thresholds by applying a local
threshold.
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from maybrain import mayBrainTools as mbt # import maybrain
from maybrain import mayBrainExtraFns as extras # import output and
other functions
parcelFile = "parcel_500_xyz.txt" # file containing spatial properties
thresholdtype = "local" # thresholding type
adjMatFile = "wave_cor_mat_level_2d_500.txt" # Association matrix
delim=" " # delimiter for input file
a = mbt.brainObj() # define a brain object
appVal = False # output file overwrites
# iterate through thresholds from 1% to 10%
for e in [v for v in range(1,11)]:
ofb = ’_’.join(["brain", thresholdtype, str(e), "d2"+"_"]) # origin
of the output file
propDict = {"edgePC":str(e)} # added columns of information for the
output file
# import association matrix
a.importAdjFile(adjMatFile, delimiter=delim,
excludedNodes=excludedNodes)
a.localThresholding(edgePC=e) # apply local thresholding
a.removeUnconnectedNodes() # remove unconnected nodes
a.binarise() # convert to a binary (unweighted) graph
a.importSpatialInfo(parcelFile) # read spatial information
#### small worldness metrics ####
degs = mbt.nx.degree(a.G) # take graph measure for degree
extras.writeResults(degs, "degree", ofb, propDict=propDict,
append=appVal) # write results
clustCoeff = mbt.nx.average_clustering(a.G) # cluster coefficient
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extras.writeResults(clustCoeff, "clusterCoeff", ofb,
propDict=propDict, append=appVal)
del(clustCoeff)
pl = mbt.nx.average_shortest_path_length(a.G) # path length
extras.writeResults(pl, "pl", ofb, propDict=propDict, append=appVal)
del(pl)
ge = extras.globalefficiency(a.G) # global efficiency
extras.writeResults(ge, "ge", ofb, propDict=propDict, append=appVal)
del(ge)
le = extras.localefficiency(a.G) # local efficiency
extras.writeResults(le, "le", ofb, propDict=propDict, append=appVal)
del(le)
appVal=True # output file appends
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Maybrain is able to output selected brain regions used in a network parcel-
lation as nifti files for further visualisation (for an example, see chapter 6 figure
6.3 showing the distribution of connection strengths).
To allow for community feedback and contribution, the code used in Maybrain
is released under the GNU GPL v3 open source license and is hosted on github
(https://github.com/rittman/maybrain.git). The project pages also contain doc-
umentation for the available functions.
4.2 Discussion
Maybrain is a novel Python-based open source package to visualise and analyse
brain imaging data using graph network tools. The Python language provides
a wealth of resources suitable for network analysis and visualisation. However
integrating the different packages available and learning which are most useful
is challenging. It is important not to reinvent the wheel for analysis but pull
together existing tools where possible. In this vein, Maybrain integrates and
adds to networkx, the pythonic brain connectivity toolbox and Mayavi2.
Maybrain easily deals with multi-modal data through its use of the asso-
ciation matrix as an initial input file so that Functional Magnetic Resonance
Imaging (fMRI), DTI, Magnetoencephalography (MEG) or Electroencephalogra-
phy (EEG) data can all be analysed and compared in a similar manner. Current
literature lacks any consensus on preprocessing brain imaging data Fornito et al.
[2013]; Patel et al. [2014] and generating an adjacency matrix from an associa-
tion matrix Alexander-Bloch et al. [2010]; Rubinov and Sporns [2010], therefore
Maybrain requires a generic input file to leave the user a decision on applying
preprocessing options. A range of thresholding possibilities are available to re-
flect the lack of consensus around thresholding association matrices to generate
graphs.
Accurate visualisation is achieved easily with corresponding spatial informa-
tion and a standard imaging space in nifti format. Furthermore, the conversion of
standard nifti files to isosurfaces for rendering gives a viewer capable of visualising
imaging data processed through very different methods.
Other imaging packages provide support for specific needs. The closest to
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Maybrain in terms of approach is the Connectome Viewer, a similarly open source
package that lacks some features to assist flexible dynamic modelling. The re-
quired format of the Connectome Viewer is restrictive in the properties allowed
and I would argue that there is a steep learning curve to understand the file
format which is non-intuitive. However, because both Maybrain and the Connec-
tome Viewer are Python based and depend on similar underlying packages (eg
networkx, Mayavi2 and numpy), the two packages could potentially be integrated
in a common workflow with a little effort.
Visualising networks can be overlooked as an important tool for imaging neu-
roscience. Many neurological disease have been considered mainly in terms of
the localisation of pathology, driven by early studies of focal lesions such as those
causing epilepsy in humans and animals Ferrier [1873]; Hughlings Jackson [1873].
Psychiatric and developmental diseases have been considered in terms of network
disruption for a much longer period of time Fleschig [1901], particularly since
the advent of functional neuroimaging Friston and Frith [1995]. As is so often
the case, a full understanding will likely require both localisation and network
analysis. Therefore the accurate 3 dimensional rendering of a network in situ
is an important part of interpreting its significance and function. The use of
Mayavi2 as an imaging viewer allows high quality images to be produced with
easy customisation and multiple renders on a single plot.
In this thesis I demonstrate the utility of Maybrain, which was used to assist
quality control in imaging preprocessing (chapter 3), and in subsequent chapters
using with graph theory analysis for graph generation, measuring graph metrics,
applying a random attack model and for visualisation (chapters 6 and 7. Chap-
ter 8 where genetic data is integrated with functional brain network measures
provides an example of the powerful integration of additional network properties
using Maybrain.
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Chapter 5
Graph metrics of functional brain
networks: stability and
independence
Graph theoretical analysis is a popular and powerful tool to investigate com-
plex networks, including social networks Baraba´si et al. [2002], biological systems
Stelzl and Wanker [2006] and transport networks Guimera` and Amaral [2005].
The usual approach to interpreting graph measures relies on a priori hypothe-
ses in which selected graph metrics are considered to explain unique aspects of
network topology. However, it may not be appropriate to interpret all graph
measures independently. Firstly, network measures may be related because they
are derived from common underlying graph measures, for example the global ef-
ficiency Latora and Marchiori [2001] and betweenness centrality Freeman [1977]
are both derived from the average shortest path length. Secondly, network mea-
sures may overlap because they reflect overarching topological properties that
determine the relationship between otherwise independent measures.
The non-independence between graph metrics may be particularly relevant
to neuroimaging data since the brain is a spatial network constrained by the
dimensions of the cranium and the arrangement of gyral folds. This arrangement
leads to specific properties, such as the relationship between connectivity strength
and distance Barthe´lemy [2011]; Ve´rtes et al. [2012].
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Many spatial networks in biology follow a network architecture known as the
small world network Milgram [1967]; Watts and Strogatz [1998]. Small world
networks are efficiently arranged with many short-range connections and rela-
tively few long-range connections that shorten the topological path length be-
tween otherwise unconnected regions. The result is a network with relatively
short topological paths between nodes comparable to that of a random network,
whilst maintaining a locally clustered arrangement comparable to that in an or-
dered network. The long-range connections that facilitate this organisation are
usually concentrated in highly connected hubs Achard et al. [2006]; Sporns et al.
[2007].
The highly connected hubs that contribute to a small world architecture can
be identified both by their large number of strong connections (high connection
strength) and because they lie along a large number of paths within the graph
(high centrality). Hubs may be play a role in a wide range of diseases, including
coma Achard et al. [2012], Alzheimer’s disease Buckner et al. [2009]; de Haan
et al. [2012a] and schizophrenia Crossley et al. [2014].
Hubs can also be defined by their participation in local communities of nodes,
ie groups of nodes that are interconnected. In the context of network communi-
ties, hub regions can be defined as local hubs with many connections to a single
community (high within module degree), or as regional hubs with a relatively
large number of connections between communities (a high participation coeffi-
cient) Power et al. [2013]. Moreover, the community structure of a network can
be studied in its own right in order to interrogate how the whole network may be
divided in to functional modules, and to identify unique topological characteris-
tics associated with individual communities Girvan and Newman [2002].
The properties of the brain’s community structure can be captured at a global
level by exploring properties such as how likely a network is to break in to commu-
nities (modularity), or at a local level by assessing measures such as the number
and strength of connections within a particular community (within module de-
gree). Community properties are relevant to neuropsychiatric diseases such as
schizophrenia and Alzheimer’s disease Alexander-Bloch et al. [2010]; de Haan
et al. [2012b]. However, the brain’s functional network community and small
world properties may depend on the methods applied to functional timeseries
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data to construct a graph.
One challenge in constructing a graph is the lack of consensus on how many
connections to include when using functional brain data from humans van Wijk
et al. [2010]. This is because the entire network is not mapped, unlike sim-
pler neural systems such as the nematode worm Varshney et al. [2011]. Two
approaches commonly employed to address this issue are: applying a threshold
such that each graph has a specified connection density; analysis of unthresh-
olded networks. A related challenge is choosing the parcellation scheme used to
identify graph nodes. This may influence network characteristics in functional
brain imaging data Zalesky et al. [2010].
In this chapter I address the individual and combined explanatory power for
commonly used graph measures in the context of functional neuroimaging data.
In particular I will:
• investigate the independence of graph measures by assessing the correlation
between measures and applying an hierarchical cluster analysis,
• measure graph metrics at different thresholds and make a comparison made
between results from thresholded and unthresholded graphs,
• explore whether small-world, hub and community measures form unique
factors in the functional brain network using Principal Component Analysis
(PCA),
• apply two parcellation schemes including 100 or 500 nodes to assess whether
the relationship between graph metrics differ.
I will address these questions in a healthy population of older adults.
5.1 Methods
The control subject group described in chapter 3 were used for this analysis.
In brief, this group consisted of 53 individuals (mean age 66.7) who underwent
task-free Functional Magnetic Resonance Imaging (fMRI) imaging (Repetition
Time (TR) 2 sec, minimum of 145 volumes, 3x3x3.75mm voxels). Following
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preprocessing, association matrices were constructed using wavelet correlation
using parcellation schemes of 500 and 100 parcels. In the 500 node parcellation,
29 nodes were insufficiently covered in some or all subjects to leave 471 nodes,
and in the 100 node parcellation 4 nodes were discarded to leave 96 nodes. For
simplicity, I will refer to the parcellation schemes as 500 nodes and 100 nodes
respectively.
Graph analysis was carried out using Maybrain (see chapter 4). Local equidense
thresholds between 1% and 10% were applied. Since the hub participation coeffi-
cient, modularity and hub within module degree are often reported in thresholded
weighted graphs, I collected both thresholded binary and thresholded weighted
equivalents of these measures.
To define hub regions the connection strength was calculated for each node,
defined as the sum of weighted connection strengths for all edges of a node. A
threshold of connection strength was applied of 1.5 standard deviations above
which a node was denoted a hub. This resulted in ten hub regions using the
500 node parcellation and two nodes using a 100 node parcellation, in both cases
located in the posterior parietal and parieto-occipital regions in keeping with
previous reports Sporns et al. [2007]; Tomasi and Volkow [2011].
Graph metrics were chosen to provide a wide range of commonly used whole
brain and node-wise metrics. In addition, hub measures were assessed by taking
the mean of node-wise metrics in the selection of defined hub nodes. The graph
measures collected are listed in table 5.1.
All statistical analysis was carried out using R statistical software version
3.1.0. The stability between thresholds for each graph measure was assessed by
measuring the covariance between thresholds and across subjects. To identify
the relationship between graph measures an hierarchical clustering algorithm was
applied.
To assess whether underlying factors explained graph measures, a factor anal-
ysis was performed using the PCA method. In order to assess the number of
factors present in the data, the eigenvalues for each component were plotted as
a scree plot. There are various methods to estimate the number of factors in
PCA, so I took two approaches. Firstly I used calculated estimates of the elbow
in the scree plot using the acceleration factor and optimal coordinates Raˆıche
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Graph measure Abbreviation
Average shortest path length path length
Average shortest path length (weighted) path length Wt
Average cluster coefficient clust coeff
Average cluster coefficient (weighted) clust coeff Wt
Modularity modularity
Global efficiency glob eff
Global efficiency (weighted) glob eff Wt
Robustness (percolation threshold) robustness
Median edge distance (whole graph) Med distance
Mean hub cluster coefficient hub clust coeff
Mean hub cluster coefficient (weighted) hub clust coeff Wt
Mean hub closeness centrality hub close cent
Mean hub closeness centrality (weighted) hub close cent Wt
Mean hub degree hub degree
Mean hub connection strength (ie weighted degree) hub conn’ strength
Mean hub eigenvector centrality hub eig cent
Mean hub eigenvector centrality (weighted) hub eig cent Wt
Mean hub local efficiency hub loc eff
Mean hub local efficiency (weighted) hub loc eff Wt
Mean hub edge distance hub edge distance
Mean hub betweenness centrality hub betw’n cent
Mean hub betweenness centrality (weighted) hub betw’n cent Avg
Mean hub within module degree hub w’in mod deg Wt
Mean hub within module degree (weighted) hub w’in mod deg Wt
Mean hub participation coefficient hub part’n coeff
Mean hub participation coefficient (weighted) hub part’n coeff Wt
Number of modules n modules
Number of modules (weighted) n modules Avg
Table 5.1: Graph measures collected and abbreviations used in this chapter. All the
community measures used the Newman algorithm (see chapter 3). A weighted metric
was measured in a thresholded graph with weights retained for edges surviving the
threshold. For community based weighted measures, an average value was obtained
across weighted thresholded graphs between 1 and 10% connectivity, denoted by Avg.
83
5. GRAPH METRICS OF FUNCTIONAL BRAIN NETWORKS:
STABILITY AND INDEPENDENCE
et al. [2013]. secondly I applied thresholds generate from the mean eigenvalue
and parallel analysis that finds the 5th and 95th decile of eigenvalues for random
data with the same dimensionality. In parallel analysis the cut-off is determined
when the parallel eigenvalue is greater than the observed eigenvalue. I applied a
lower cut-off of three factors based on the expectation of factors for small world
characteristics, hub properties and community properties.
5.2 Global and hub-wise graph metrics
The stability of global and hub-wise graph metrics between equidense thresholds
is shown in figure 5.1. Small world, distance and hub characteristics showed the
highest covariance across equidense thresholds: path length (σ=0.80-1.0), cluster
coefficient (σ=0.80-1.0), global efficiency (σ=0.78-1.0), robustness (σ=0.76-0.99).
This indicates that a graph measure in these metrics taken at, for example, a 1%
equidense threshold is likely to reflect the same measure taken at a 10% equidense
threshold. In addition, the median edge distance (σ=0.83-1.0) showed similarly
strong correlations, as did hub measures: degree (σ=0.85-1.0), closeness centrality
(σ=0.82-1.0), eigenvector centrality (σ=0.73-1.0), local efficiency (σ=0.83-1.0),
betweenness centrality (σ=0.72-1.0), median distance (σ=0.85-1.0).
In terms of measures based on community identification, modularity (σ=0.77-
0.99) and weighted within module degree (σ=0.97-0.1) were strong correlated
between thresholds, whereas other community derived measures were less well
correlated, including participation coefficient (σ=-0.39-0.45), weighted partici-
pation coefficient (σ=-0.19-0.78), number of modules (σ=-0.28-0.63), weighted
number of modules (σ=-0.26-0.62). These measures tended to show the greatest
consistency between thresholds in the range of 7-10% connectivity.
Taken together, these findings suggest that the choice of threshold has little
impact on measures of small world architecture, distance and hubs. However,
thresholding has a much greater impact on some measures dependent on commu-
nity structure, particularly in binary graphs.
I explored the independent explanatory value of graph measures by assess-
ing the covariance between graph measures and a hierarchical cluster analysis
was applied separately for thresholded and unthresholded measures (see figure
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Figure 5.1: The correlation of global and hub-wise graph metrics at equidense thresh-
olds between 1% and 10% measured in the 500 node parcellation scheme. The plot
shows that for most graph measures the values obtained across a range of thresholds
are consistent. However, community measures are less consistent between thresholds,
particularly for binary measures and at thresholds less than 5%. The x and y axis
indicate the thresholds. Each matrix presented is symmetrical with off-diagonal values
representing the correlation between a graph measure at a range of thresholds, and
diagonal values representing the correlation at the same threshold (ie, σ=1) are blank.
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5.2). For thresholded graph metrics, the strongest cluster showed high covariance
(σ>0.83) between small world properties, ie cluster coefficient, path length and
global efficiency. Robustness and modularity also co-varied strongly (σ>0.83)
with these small world properties, consistent with the known properties of small
world networks Achard et al. [2006]; Pan and Sinha [2009]; Wang and Chen [2002].
At the next level, small world properties co-varied with both hub closeness cen-
trality, (σ>0.83) and median edge distance (σ>0.82). The median edge distance
inversely co-varied with path length (σ=-0.71) , concordant with long distance
connections shortening the global topological path length Achard et al. [2006];
Kaiser and Hilgetag [2006].
Although hub closeness centrality lay in the small world cluster, it co-varied
with other hub measures of degree (σ=0.84) and centrality measures of hub eigen-
vector centrality (σ=0.78) and hub median edge length (σ=0.91). These hub
properties formed a second major cluster. Notably, the hub participation coeffi-
cient and hub within module degree were not included in this cluster, indicating
a qualitative difference between hub measures based on community organisation
and hub measures based on connection strength and path length.
Two aspects of community organisation co-varied modestly with small world
measures; the weighted hub participation coefficient (σ=0.72-0.83), and the hub
within module degree (σ=0.46-0.53). The remaining community organisation
measures formed a loosely covariant cluster (σ=-0.13-0.34). These findings would
suggest that measures of community are relatively independent of each other.
The first major cluster in the unthresholded analysis included small world
metrics of global efficiency, path length and local efficiency (absolute σ=0.99
for all pairwise correlations), reflecting the changes in the thresholded analysis
(5.2). These small world measures were closely related to hub closeness centrality
(σ=0.97-0.99) and the hub eigenvectory centrality (absolute σ=0.66-0.73) in the
hierarchical analysis. The second main cluster included the cluster coefficient
with hub measures of hub cluster coefficient, hub connection strength and hub
within modular degree. However, in contrast to the thresholded analysis the
modularity was related to other community derived measures of hub participation
coefficient and the number of modules. Perhaps surprisingly the hub betweenness
centrality was also included in this loosely related group of measures. These
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Figure 5.2: The upper figure shows the correlation between global and hub-wise
graph metrics using a 500 node parcellation scheme. A list of abbreviations can be
found in table 5.1. Correlations between small world measures (path length, cluster co-
efficient, global efficiency, robsutness) form identifiable clusters in both thresholded and
unthresholded measures. In addition, hub measures form a distinct cluster, although
some hub measures also correlate with small world measures (cluster coefficient, close-
ness centrality, edge distance, weighted participation coefficient). There are relatively
lower correlations between unthresholded measures (denoted by T ) and their unthresh-
olded counterparts (denoted by U ). For cluster analysis, graph metrics were split in to
binary and weighted graph measures.
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findings reinforce the three main groupings of small world, hub and community
measures. However, they also imply that weighted and unweighted metrics such
as modularity and degree/connection strength are not immediately comparable
in their relationship to other graph measures.
Indeed, there was only moderate covariance between measures in binary thresh-
olded graph measures and weighted unthresholded networks (σ=0.06-0.69), other
than between weighted and binary modularity (σ=0.96) and between weighted de-
gree (connection strength) and binary degree (σ=0.78). This demonstrates more
directly that analysis of binary measures can not immediately be interpreted as
equivalent to the corresponding weighted measure.
To assess whether underlying factors existed to explain the groupings of graph
metrics, a PCA was performed that included graph measures at equidense thresh-
olds from 1% to 10% and the weighted equivalent where available. Calculated
measures of the number of factors in the data suggested between one and three
factors (scree plot in figure 5.3). The first three components were examined based
on the hypothesis that three factors would be present in the data: small world
measures, hub measures and community measures.
The first three components are shown in figure 5.4 and explained 76.5% of the
variance in the data (table 5.2). The first two components represent small world
and hub metrics in thresholded binary graphs.
The first two components clearly represent the two main groups of small
world measures (including distance) and hub measures. The third component
is predominantly weighted graph measures from unthresholded graphs, including
the number of modules calculated in weighted and thresholded graphs. The
contributions of each graph measure to the first three principal components are
shown in table 5.3, table 5.4 and table 5.5.
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Figure 5.3: A scree plot showing the first 20 principal components of global and hub-
wise graph measures. The plot shows that the first three components explain greater
than 75% of the variance within the data, with calculated estimates of 1-3 relevant prin-
cipal components. Measures were collected in a graph generated from a 500 node grey
matter parcellation, including both unthresholded measures and measures thresholded
at 1 to 10% equidense local thresholds. The estimates for the number of components are
displayed using methods to calculate the scree elbow (optimal coordinates and accelera-
tion factor) and for absolute cut-offs (eigenvalue mean, parallel analysis). OC=optimal
coordinates, AF=acceleration factor.
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Figure 5.4: Component loadings are shown for the first three principal components
incorporating global and hub-wise graph measures using a 500 node grey matter par-
cellation. The first component includes metrics reflecting both small world properties
and hub properties measured in thresholded graphs. The second component has more
variance contributed by hub properties, including the community derived measure of
within module degree. The third component represents measures collected in weighted
graphs, and the number of modules in unthresholded graphs.
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5.3 Node-wise graph metrics
In general, node-wise measures were more variable than global measures, probably
because they are subject to regional variation not captured at the global level.
However, the overall pattern of differences was similar.
Measures of node centrality showed high correlation between thresholds shown
in figure 5.5 including closeness centrality (σ=0.51-0.99), eigenvector centrality
(σ=0.24-0.99) and betweenness centrality (σ=0.24-0.97). Degree (σ=0.51-0.99)
and local efficiency (σ=0.53-0.99) also showed high correlation between thresh-
olds. Community measures such as the participation coefficient (σ=0.08-0.23)
showed poor consistency across thresholds with the weighted equivalent a little
better (σ=0.11-0.50), similar to the behaviour of hub-wise equivalents of these
measures.
The covariance between node-wise measures was, in general, less strong than
for whole brain measures (figure 5.6). Hierarchical analysis of threhsolded bi-
nary measures revealed three major cluster. The small world measures of edge
distance, degree and local efficiency formed a cluster with eigenvector centrality
(absolute σ=0.68-0.86). Surprisingly the cluster coefficient usually consided to be
a central part of a small world network was found in a separate cluster with the
hub measurements of closeness centrality and betweenness centrality (absolute
σ=0.48-0.67). The community derived measures of participation coefficient and
within module degree formed a distinct and loosely coherent cluster (absolute
σ=0.11-0.18).
In the unthresholded measures, connection strength and eigenvector centrality
were related in a cluster with the cluster coefficient and within module degree
(σ=0.31-0.79). The second cluster was made up of centrality measures of be-
tweenness centrality, participation centrality and closeness centrality, alongside
local efficiency (absolute σ=0.02-0.87). These results are not as clear cut as the
thresholded nodewise or whole graph measures, suggesting that unthresholded
and weighted graph measures are more independent than metrics obtained by
other approaches.
Factor analysis of node-wise graph measures using PCA showed a first com-
ponent representing small world characteristics and distance. However, variance
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in the subsequent components was distributed more evenly (figure 5.7 and table
5.6). The spread of variance is reflected in the disagreement among measures for
the number of factors. I have displayed the first 12 factors in 5.8. The first com-
ponent represents graph measures derived from connection strength and path
length. The second and third components represents measures centrality, but
subsequent components are not clearly linked to specific measures. Therefore
loadings for the only the first three are shown in tables 5.7, 5.8 and 5.9.
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Figure 5.5: The correlation of node-wise graph metrics measured at between 1% and
10% equidense thresholds using a 500 node grey matter parcellation. The x and y axis
indicate the thresholds. Each matrix presented is symmetrical with off-diagonal values
representing the correlation between a graph measure at a range of thresholds, and
diagonal values representing the correlation at the same threshold (ie, σ=1) are blank.
The observed patterns are similar to those seen in global metrics (figure 5.1), though
the correlation values are slightly lower.
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Figure 5.6: Correlations between node-wise graph metrics measured using a 500 node
grey matter parcellation. are shown in the upper plot, with corresponding hierarchical
cluster analysis shown in the lower plots. The plot shows that a group of hub nodes
and small world measures that covary in the top left region of the correlation plot
representing thresholded graph measures (denoted by (T)) and a less strongly covarying
structure in the lower right area of the plot of unthresholded graph measures (denoted
by (U)). Clusters in the correlation matrix reflect those identified in the hierarchical
cluster analysis shown in the lower figures. For cluster analysis, graph metrics were
split in to binary and weighted graph measures.
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Figure 5.7: A scree plot showing the first 20 principal components of node-wise graph
measures using a 500 node grey matter parcellation. Although the first 3 components
explain greater than 75% of the variance, there are a number of components explain-
ing greater than 1% of the variance, leading to differing numbers for the estimate of
component number. Therefore the first 20 components are plotted in 5.8. Measures
were collected in a graph generated from a 500 node grey matter parcellation, includ-
ing both unthresholded measures and measures thresholded at 1 to 10% equidense
local thresholds. The estimates for the number of components are displayed using
methods to calculate the scree elbow (optimal coordinates and acceleration factor) and
for absolute cut-offs (eigenvalue mean, parallel analysis). OC=optimal coordinates,
AF=acceleration factor.
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Figure 5.8: Loading factors for the first 12 principle components of node-wise graph
metrics using a 500 node grey matter parcellation. In line with global measures, the first
component represent small world measures and hub measures. However the clustering
coefficient does not load strongly on to this component, in keeping with the hierar-
chical clustering analysis. The second component is predominantly derived from the
cluster coefficient and the within module degree, and the third component the commu-
nity measures of within module and weighted participation coefficient. The remaining
components are less clearly interpretable suggesting they may not be relevant.
101
5. GRAPH METRICS OF FUNCTIONAL BRAIN NETWORKS:
STABILITY AND INDEPENDENCE
E
q
u
id
en
se
th
re
sh
ol
d
(%
)
W
t’
d
1
2
3
4
5
6
7
8
9
10
cl
os
e
ce
n
t
-0
.0
6
-0
.0
9
-0
.1
0
-0
.1
1
-0
.1
1
-0
.1
1
-0
.1
1
-0
.1
1
-0
.1
1
-0
.1
2
-0
.1
2
cl
u
st
co
eff
0.
02
0.
06
0.
07
0.
08
0.
08
0.
08
0.
08
0.
08
0.
07
0.
07
0.
07
d
eg
re
e
-0
.0
8
-0
.1
0
-0
.1
2
-0
.1
3
-0
.1
4
-0
.1
4
-0
.1
4
-0
.1
5
-0
.1
5
-0
.1
5
-0
.1
5
ei
g
ce
n
t
-0
.0
9
-0
.0
8
-0
.1
0
-0
.1
1
-0
.1
2
-0
.1
3
-0
.1
3
-0
.1
3
-0
.1
3
-0
.1
3
-0
.1
3
lo
c
eff
-0
.0
1
-0
.0
8
-0
.1
0
-0
.1
1
-0
.1
2
-0
.1
3
-0
.1
3
-0
.1
3
-0
.1
4
-0
.1
4
-0
.1
4
ed
ge
d
is
ta
n
ce
-0
.0
9
-0
.1
1
-0
.1
2
-0
.1
3
-0
.1
3
-0
.1
3
-0
.1
3
-0
.1
3
-0
.1
3
-0
.1
3
b
et
w
’n
ce
n
tr
al
it
y
-0
.0
1
-0
.0
8
-0
.0
9
-0
.1
0
-0
.1
1
-0
.1
1
-0
.1
1
-0
.1
1
-0
.1
1
-0
.1
1
-0
.1
1
w
it
h
in
m
o
d
d
eg
W
t
-0
.0
5
-0
.0
5
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
p
ar
t’
n
co
eff
-0
.0
3
-0
.0
3
-0
.0
3
-0
.0
2
-0
.0
3
-0
.0
2
-0
.0
2
-0
.0
1
-0
.0
1
-0
.0
2
p
ar
t’
n
co
eff
W
t
-0
.0
4
-0
.0
3
-0
.0
3
-0
.0
3
-0
.0
3
-0
.0
3
-0
.0
3
-0
.0
2
-0
.0
2
-0
.0
2
-0
.0
1
T
a
b
le
5
.7
:
P
C
A
n
o
d
e-
w
is
e
co
m
p
on
en
t
1
d
er
iv
ed
fr
om
gr
ap
h
m
ea
su
re
s
m
ea
su
re
d
in
a
50
0
n
o
d
e
gr
ey
m
at
te
r
p
a
rc
el
la
ti
o
n
.
T
h
is
co
m
p
on
en
t
p
re
d
om
in
an
tl
y
re
fl
ec
ts
sm
al
l
w
or
ld
an
d
h
u
b
m
ea
su
re
s,
al
th
ou
gh
si
gn
ifi
ca
n
tl
y
th
e
cl
u
st
er
co
effi
ci
en
t
w
h
ic
h
is
u
su
al
ly
co
n
si
d
ed
a
sm
al
l
w
or
ld
m
et
ri
c
d
o
es
n
ot
lo
ad
st
ro
n
gl
y
on
to
th
is
co
m
p
on
en
t.
102
5. GRAPH METRICS OF FUNCTIONAL BRAIN NETWORKS:
STABILITY AND INDEPENDENCE
E
q
u
id
en
se
th
re
sh
ol
d
(%
)
W
t’
d
1
2
3
4
5
6
7
8
9
10
cl
os
e
ce
n
t
-0
.0
1
-0
.0
9
-0
.1
1
-0
.1
2
-0
.1
2
-0
.1
1
-0
.1
1
-0
.1
1
-0
.1
0
-0
.0
9
-0
.0
8
cl
u
st
co
eff
0.
19
0.
08
0.
12
0.
15
0.
16
0.
17
0.
17
0.
17
0.
17
0.
17
0.
17
d
eg
re
e
0.
06
0.
08
0.
08
0.
07
0.
06
0.
05
0.
05
0.
04
0.
04
0.
03
0.
03
ei
g
ce
n
t
0.
03
0.
06
0.
06
0.
06
0.
05
0.
05
0.
05
0.
04
0.
04
0.
03
0.
03
lo
c
eff
-0
.0
2
0.
11
0.
11
0.
11
0.
11
0.
10
0.
09
0.
09
0.
08
0.
08
0.
07
ed
ge
d
is
ta
n
ce
0.
02
0.
02
0.
01
0.
01
0.
00
-0
.0
0
-0
.0
0
-0
.0
1
-0
.0
1
-0
.0
1
b
et
w
’n
ce
n
tr
al
it
y
0.
02
-0
.0
3
-0
.0
5
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
w
it
h
in
m
o
d
d
eg
W
t
0.
16
0.
16
0.
16
0.
15
0.
15
0.
15
0.
15
0.
15
0.
14
0.
14
p
ar
t’
n
co
eff
-0
.0
8
-0
.1
3
-0
.1
2
-0
.1
1
-0
.1
2
-0
.1
0
-0
.1
1
-0
.0
7
-0
.0
6
-0
.0
6
p
ar
t’
n
co
eff
W
t
-0
.1
3
-0
.0
6
-0
.0
7
-0
.0
9
-0
.0
8
-0
.0
8
-0
.0
8
-0
.0
9
-0
.0
7
-0
.0
6
-0
.0
8
T
a
b
le
5
.8
:
P
C
A
n
o
d
e-
w
is
e
co
m
p
on
en
t
2
d
er
iv
ed
fr
om
gr
ap
h
m
ea
su
re
s
m
ea
su
re
d
in
a
50
0
n
o
d
e
gr
ey
m
at
te
r
p
a
rc
el
la
ti
o
n
.
T
h
is
co
m
p
on
en
t
is
p
re
d
om
in
an
tl
y
co
m
p
os
ed
of
th
re
sh
ol
d
ed
m
ea
su
re
s
of
cl
u
st
er
co
effi
ci
en
t,
an
d
th
e
w
it
h
in
m
o
d
u
le
d
eg
re
e,
a
n
d
th
e
u
n
th
re
sh
ol
d
ed
w
ei
gh
te
d
cl
u
st
er
co
effi
ci
en
t.
T
h
is
su
gg
es
ts
th
at
th
is
co
m
p
on
en
t
re
fl
ec
ts
th
e
to
p
ol
og
y
of
lo
ca
l
co
n
n
ec
ti
o
n
s.
103
5. GRAPH METRICS OF FUNCTIONAL BRAIN NETWORKS:
STABILITY AND INDEPENDENCE
E
q
u
id
en
se
th
re
sh
ol
d
(%
)
W
t’
d
1
2
3
4
5
6
7
8
9
10
cl
os
e
ce
n
t
0.
09
0.
06
0.
06
0.
07
0.
08
0.
08
0.
09
0.
10
0.
09
0.
08
0.
08
cl
u
st
co
eff
0.
11
0.
03
0.
02
0.
01
0.
00
-0
.0
1
-0
.0
2
-0
.0
2
-0
.0
3
-0
.0
3
-0
.0
4
d
eg
re
e
0.
23
-0
.0
7
-0
.0
9
-0
.0
9
-0
.0
8
-0
.0
7
-0
.0
6
-0
.0
5
-0
.0
4
-0
.0
3
-0
.0
2
ei
g
ce
n
t
0.
13
-0
.0
3
-0
.0
2
-0
.0
0
0.
00
0.
01
0.
01
0.
02
0.
02
0.
03
0.
03
lo
c
eff
0.
03
-0
.0
7
-0
.0
8
-0
.0
9
-0
.0
9
-0
.0
8
-0
.0
7
-0
.0
6
-0
.0
5
-0
.0
5
-0
.0
4
ed
ge
d
is
ta
n
ce
-0
.1
0
-0
.1
1
-0
.1
1
-0
.1
0
-0
.0
9
-0
.0
8
-0
.0
7
-0
.0
6
-0
.0
5
-0
.0
5
b
et
w
’n
ce
n
tr
al
it
y
0.
00
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
6
-0
.0
5
-0
.0
5
-0
.0
4
-0
.0
3
-0
.0
2
-0
.0
2
w
it
h
in
m
o
d
d
eg
W
t
0.
17
0.
18
0.
19
0.
20
0.
20
0.
20
0.
20
0.
20
0.
20
0.
20
p
ar
t’
n
co
eff
0.
05
0.
06
0.
07
0.
07
0.
12
0.
08
0.
10
0.
11
0.
12
0.
11
p
ar
t’
n
co
eff
W
t
0.
16
0.
04
0.
07
0.
08
0.
10
0.
11
0.
11
0.
13
0.
13
0.
13
0.
11
T
a
b
le
5
.9
:
P
C
A
n
o
d
e-
w
is
e
co
m
p
on
en
t
3
d
er
iv
ed
fr
om
gr
ap
h
m
ea
su
re
s
m
ea
su
re
d
in
a
50
0
n
o
d
e
gr
ey
m
at
te
r
p
a
rc
el
la
ti
o
n
.
T
h
is
co
m
p
on
en
t
p
re
d
om
in
an
tl
y
re
fl
ec
ts
th
e
th
re
sh
ol
d
ed
w
it
h
in
m
o
d
u
le
d
eg
re
e
an
d
th
e
co
n
n
ec
ti
on
st
re
n
gt
h
(u
n
th
re
sh
o
ld
ed
an
d
w
ei
gh
te
d
d
eg
re
e)
as
w
el
l
la
s
th
e
p
ar
ti
ci
p
at
io
n
co
effi
ci
en
t.
T
h
es
e
co
m
p
on
en
ts
ar
e
al
l
d
er
iv
ed
fr
om
co
n
n
ec
ti
o
n
st
re
n
g
th
w
it
h
in
an
d
b
et
w
ee
n
m
o
d
u
le
s.
104
5. GRAPH METRICS OF FUNCTIONAL BRAIN NETWORKS:
STABILITY AND INDEPENDENCE
5.4 Analysis with 100 parcels
To assess whether the resolution of the grey matter parcellation would influence
the results, the analysis presented above was repeated with a parcellation scheme
of 100 grey matter regions. In general terms the patterns were similar, although
the underlying factors of small worldness and hub properties were less distinct.
The correlations of global and hub-wise graph measures between thresholds are
shown in figure 5.9.
Robustness (also called the percolation threshold) is the proportion of nodes
removed beyond which a network starts to fragment (see chapter 3). In the 100
node parcellation there was an unusual pattern to the robustness results with a
reversal of the correlation between 2% and 3% equidense thresholds. A U-shaped
curve for the value of robustness at lower thresholds explains this appearance
(figure 5.10). This artefact is likely to represent two aspects of the method used
to construct the graphs. Firstly, a 1% network is sparse when using only 96
nodes in a parcellation. Secondly, the local thresholding method begins with a
Minimum Spanning Tree (MST) which enforces connectivity to the graph so that
global measurements can be collected in fully connected graphs. Therefore, the
graph constructed at 1% or 2% equidense thresholds are close to the MST. There
are likely to be fewer network regions susceptible to disconnection because the
degree of nodes across the MST is homogeneous, so that the graph is paradoxically
more stable than expected at extremely low percentage connectivity values.
Correlations between graph measures in figure 5.11 demonstrate a reduced
distance between graph measures compared to the 500 node parcellation.
Factor analysis using PCA identified three components using 3 of the 4 cal-
culated methods (figure 5.12 and table 5.10). As before, the first three factors
were examined based on the hypothesis of three underlying factors, namely small
world properties, hub properties and community properties.
The PCA results in figure 5.13 demonstrate a similar, if not greater overlap
between small world measures and hub measures compared to the 500 node par-
cellation. This is reflected in lower PCA variance for the first three components
(table 5.10) and less distinct separation in the loading values shown in in table
5.11, table 5.12 and table 5.13.
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Figure 5.9: Correlation between global graph measures at 1% to 10% equidense local
thresholds using a 100 parcellation scheme. The x and y axis indicate the thresholds.
Each matrix presented is symmetrical with off-diagonal values representing the correla-
tion between a graph measure at a range of thresholds, and diagonal values representing
the correlation at the same threshold (ie, σ=1) are blank. Correlations were lower, ap-
proaching zero or even reversed in graphs at very low thresholds (1% and 2%). This is
particularly noticeable in robustness where an artefact of the small network size may
explain the switch of correlations, demonstrated in figure 5.10. The hub cluster coef-
ficient and hub cluster coefficient are unrecordable at a 1% threshold since the graph
consists only of the minimum spanning tree, therefore there are no triangle structures
within the graph.
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Figure 5.10: Values for robustness in a graph of 100 parcels, each line represents an
individual subject. The U-shape curve at low thresholds results in a flipping of the cor-
relation between 2% and 3% equidense thresholds and the resulting rather artefactual
appearing results in figure 5.9.
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Figure 5.11: Correlation between global and hub-wise graph metrics using a 100
parcellation scheme. The upper figure shows the correlation between graph metrics.
This plot shows a similar pattern of correlations in the 100 node parcellation as the 500
node parcellation, although the absolute correlation values are lower. There is a clear
small world cluster of both thresholded metrics (denoted by (T) and unthresholded
metrics denoted (U). There is a more loosely coherent group of hub metrics, some
of which also correlate with small world measures. The cluster analysis also shows
clusters of small world metrics in both thresholded and unthresholded graph measures,
although the unthresholded cluster coefficient is included in a separate cluster with hub
measures. The community derived measures form a loosely coherent cluster in both
thresholded and unthresholded analysis.
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Figure 5.12: A scree plot showing the first 20 principal components of global and
hub-wise graph measures. Measures were collected in a graph generated from a 100
node grey matter parcellation, including both unthresholded measures and measures
thresholded at 1 to 10% equidense local thresholds. The estimates for the number of
components are displayed using methods to calculate the scree elbow (optimal coor-
dinates and acceleration factor) and for absolute cut-offs (eigenvalue mean, parallel
analysis). OC=optimal coordinates, AF=acceleration factor.
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Figure 5.13: Component loadings are shown for the first three principal components
incorporating global graph measures using a 100 node parcellation. The first compo-
nent broadly represents efficiency and small world measures. The second component
represents both hub and small world properties, and is less distinct than for the 500
node parcellation. The strongest loadings on to the third component are from the
cluster coefficient.
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The correlation between thresholds for node-wise graph metrics using a 100
node parcellation are shown in figure 5.14 showing marked similarity to measures
from the 500 parcellation schema. Correlations between graph metrics are shown
in figure 5.15, again demonstrating striking similarity to the pattern found using
the 500 parcellation.
In keeping with node-wise analysis using 500 parcels, factor analysis using 100
parcels revealed one relatively strong component explaining 39.6% of the variance
associated with measures of efficiency and distance in figures 5.16 and 5.17 and
table 5.14. The next two components reflected centrality and subsequent com-
ponents less amenable to interpretation. A summary of the principal component
analysis for node-wise graph metrics is shown in table 5.14. Based on calculated
cut-offs, the first eleven components’ loading values are shown in figure 5.17. Sim-
ilar to the 500 node analysis, only the first three principal components showed
clear patterns of associated graph metrics and the loadings are shown in tables
5.15, 5.16 and 5.17.
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Figure 5.14: Correlation between node-wise graph measures at 1% to 10% equidense
local thresholds using a 100 parcellation scheme. The results are consistent with those
generated using a 500 node parcellation. Small world and centrality measures were
strongly coherent across thresholds, however the participation coefficient derived from
community detection had much lower correlations between thresholds. The x and y
axis indicate the thresholds. Each matrix presented is symmetrical with off-diagonal
values representing the correlation between a graph measure at a range of thresholds,
and diagonal values representing the correlation at the same threshold (ie, σ=1) are
blank. The cluster coefficient is unrecordable at a 1% threshold since the graph consists
only of the minimum spanning tree, therefore there are no triangle structures within
the graph.
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Figure 5.15: The upper figure shows the correlation between node-wise graph met-
rics collected using a 100 node grey matter parcellation. The pattern of correlation
between metrics is similar to that seen using the 500 node parcellation, although the
absolute correlation values are slightly less. The pattern of hierarchical clustering is
also essentially identical to the results using a 500 node parcellation.
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Figure 5.16: A scree plot showing the first 20 principal components of node-wise
graph measures. Measures were collected in a graph generated from a 100 node grey
matter parcellation, including both unthresholded measures and measures thresholded
at 1 to 10% equidense local thresholds. The estimates for the number of components are
displayed using methods to calculate the scree elbow (optimal coordinates and accelera-
tion factor) and for absolute cut-offs (eigenvalue mean, parallel analysis). OC=optimal
coordinates, AF=acceleration factor.
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Figure 5.17: Component loadings are shown for principal components incorporating
node-wise graph measures using a 100 node parcellation. The loadings of the first three
components are very similar to those obtained using a 500 node parcellation scheme,
suggesting that there is very little difference in the contribution of graph metrics to
main topological properties of the brain between the two parcellation schemes.
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5.5 Discussion
Global graph measures of small world and hub characteristics showed remark-
ably high correlation across equidense thresholds. However, detecting communi-
ties within networks showed considerable variability between thresholds so that
community-based graph measures taken at different thresholds of the associa-
tion matrix can not be considered equivalent. Furthermore, I have shown that
graph measures in thresholded networks do not reliably reflect their unthresh-
olded counterparts. I did, however, find substantial overlap in the explanatory
value of multiple graph measures, in particular measures of small world charac-
teristics and distance were not independent, but rather were both elements of a
single principal component.
These findings broadly support the traditional approach to graph analysis
of measuring small world properties distinct from community measures Bull-
more and Sporns [2009]; Newman [2006]. Small world derived efficiency mea-
sures applied to neuroimaging data have demonstrated small world characteristics
with minimal wiring cost Achard et al. [2006]. These data validate the ‘small-
worldness’ or ‘efficiency’ concept in functional neuroimaging data and are consis-
tent with the observed relationship between small world properties and euclidean
distance Crossley et al. [2014]; Ve´rtes et al. [2012]. There is a remarkably strong
correlation between small world measures and the robustness and modularity of
the brain’s functional network. In addition, small world features remained stable
at different parcellation resolutions in keeping with previous findings employing
a wide range of parcellation schemes Fornito et al. [2010].
There were a group of hub measures explaining information about functional
brain organisation beyond the contribution to either a small world architecture
or community structure. However, the hub factor only included measures of con-
nection strength and path length derived centrality measures, not the alternative
hub characteristic of the participation coefficient derived from a community de-
tection algorithm. There is no standard definition to define hubs and therefore
hubs were defined in the simplest form based on connection strength alone. Other
definitions of hub regions include centrality measures, or use motifs (which can
not be used in undirected networks) Sporns et al. [2007]. However, these appear
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to produce similar spatial distribution of hubs when compared to hubs defined
solely using a measures of connection strength Tomasi and Volkow [2011]. The
participation coefficient has been proposed as an alternative method to node de-
gree to identify hub regions, as it may be less susceptible to changes in network
size Power et al. [2013]. The calculation of participation coefficient is a ratio of
node degree and within module degree, and the within module degree in turn
depends on a calculated modular organisation Guimera` and Amaral [2005]. Our
findings suggest that the number of modules identified in a given brain network
is highly dependent on the graph threshold applied, making these measures par-
ticularly unstable in thresholded binary networks. Therefore a definition of hubs
using the participation coefficient is likely to be unstable between thresholds.
My findings do not address the question of whether thresholded or unthresh-
olded measures are the best way to analyse functional brain data. The main
arguments in favour of applying a threshold are the selection of the strongest,
and therefore the most important, connections and the ability to measure small
world metrics in relatively large networks. However proponents of the weighted
unthresholded approach argue that information is lost since many connections
are not included in the analysis and the strength of each connection is not al-
ways taken in to account; analysing unthresholded weighted graphs may have
advantages such as comparing functional with structural imaging Honey et al.
[2009].
In conclusion, I have established the relationship between a variety of graph
measures. These relationships will be used to interpret results in subsequent
chapters where graph measures are applied to control subjects in relation to
Parkinson’s disease (PD), Progressive Supranuclear Palsy (PSP) and Corticobasal
Syndrome (CBS). In particular, chapter 6 applies small world and hub measures,
and chapter 7 uses community graph measures. Based on the results presented
above, the following chapters use a 500 node parcellation and I will retain the
definition of a hub as a node with connection strength 1.5 standard deviations
above the network mean.
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Chapter 6
Functional brain networks
This chapter assesses the effect of Progressive Supranuclear Palsy (PSP), Corti-
cobasal Syndrome (CBS) and Parkinson’s disease (PD) on the brain’s functional
network, focusing particularly on connection strength, distance and the small
world architecture. Examining functional connectivity in this way can provide
insights in to disease, for example by showing that people with schizophrenia
have generally weaker connections than control subjects Lynall et al. [2010]. A
loss of functional connectivity appears to be the earliest change in amnestic mild
cognitive impairment, a precursor to Alzheimer’s disease, Minati et al. [2014] and
is detectable before structural Magnetic Resonance Imaging (MRI) changes Gili
et al. [2010].
The brain’s functional network can be assessed by examining association ma-
trices constructed from the pairwise correlations between brain regions’ time-
series. Each value of an association matrix represents the connection strength of
an edge (connection), and the sum of each line in the association matrix is the
connection strength for a single node (brain region).
In this chapter I examine the changes in connection strength with respect to
the euclidean distance between nodes for a number of reasons. Firstly, the brain
is a spatially embedded network so there may be a link between the pattern of
connection loss and the physical distance between nodes Barthe´lemy [2011]. Sec-
ondly, PSP and CBS are associated with tau pathologies, and tau supports axonal
integrity by stabilising microtubules. Since phosphorylated tau in these diseases
disrupts the ability of tau to perform this function Lindwall and Cole [1984], I
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test the hypothesis that neurons with the longest axons to be preferentially tar-
geted. This would be measured as a weakening of the longest distance connections
in the functional networks. Finally, previous evidence from Alzheimer’s disease
supports the hypothesis that neurodegenerative diseases target long-distance con-
nections Sanz-Arigita et al. [2010]. I have established in chapter 5 that measures
of the small world architecture are the greatest contributor to the brain’s network
topology. Studies of Alzheimer subjects suggest that the small world arrangement
of the brain’s functional network may break down in disease Sanz-Arigita et al.
[2010]; Stam et al. [2009]. It has been proposed that the loss of a small world
architecture is related to targeted hub pathology in Alzheimer’s disease Buckner
et al. [2009]; Stam et al. [2009].
The principal hypothesis for this chapter is that PD, PSP and CBS would show
a reduction in connection strength focused around hub regions, with a preferential
loss of long distance rather than short distance connections. The changes would
be expected to result in a less efficient, ie less small world, network architecture.
To test this hypothesis, the first section of analysis in this chapter examines
differences in functional connectivity by examining the association matrices be-
tween diagnostic groups. I then assess whether hub regions are more susceptible
to loss of functional connectivity and the relationship between functional connec-
tivity and distance. I go on to assess whether there are changes in the efficient
small world architecture in PD, PSP and CBS, both at a global level, and at
the level of individual nodes. Finally, in order to assess the relevance to clinical
syndromes, the global network changes are correlated with measures of clinical
disease.
6.1 Methods
The analysis in this chapter is based on task-free functional MRI imaging from 152
subjects; controls (n=53), PD (n=29), PSP (n=43) and CBS (n=27). All subjects
underwent a battery of cognitive and motor examination, including verbal fluency
testing, the Mini-Mental State Examination (MMSE) Folstein et al. [1975] and
the Unified Parkinson’s Disease Rating Scale (UPDRS III). Although MMSE is
not the ideal cognitive test in these disorders (see chapter 2) it was available in
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all subjects whereas the Addenbrooke’s Cognitive Examination-revised (ACE-R)
was only available in a proportion of the PSP and CBS subjects. Verbal fluency
testing required subjects to generate as many words as possible in a minute
beginning with a specified letter (P, F, A or S) for letter fluency, or in a specified
category (animals, clothing, fruit) for category fluency.
Acquisition, preprocessing, association matrix and graph construction are de-
scribed in the methods chapter 3. All graph metrics were obtained using the
Maybrain package (see chapter 4) in unweighted unthresholded graphs and in
binary thresholded graphs. A representation of the brain’s functional network for
each diagnostic group is shown in figure 6.1. In keeping with previous reports,
visual inspection shows that the densest connections were in the visual cortex
and motor cortex Achard et al. [2006].
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To assess whether the distribution of connectivity in the graphs was consistent
with previously published studies, I explored the connectivity distribution of the
mean association matrix for each diagnostic group, shown in figure 6.2. In keeping
with previous reports Achard et al. [2006], the distribution best fitted a truncated
power law with a gamma distribution given by:
P (k) = kα−1ek/kβ
where k is the connection strength, α describes the shape of the distribution and β
is a scaling constant to ensure the distribution area is equal to 1. Table 6.1 shows
that the Akaike’s information criteria (AIC) was lowest for the truncated power
law in all groups implying a better fit. The differences in both shape parameter
α and scaling factor β suggest a difference in the distribution of connectivities
between the control and disease groups, which is explored in more detail below.
Hub regions were identified using the same criterion used in chapter 5, ie nodes
with a connection strength at least 1.5 standard deviations above the mean. To
avoid bias when assessing hub properties between groups, the control group were
divided in to two groups of 26 and 27 subjects. The first group was used to
define hub regions, the second group used for group comparisons. Ten brain
regions were identified as hub areas. The distribution of connection strength in
the subset of controls used to define the hub nodes is shown in figure 6.3 and is in
broad agreement with other studies investigating hub regions in human functional
brain networks Sporns et al. [2007]; Tomasi and Volkow [2011]; Zuo et al. [2011].
Analysis on a single subject took approximately 24 hours to run, therefore
all analysis was parallelised on the Camgrid computing grid that uses Condor
management software to distribute tasks on servers across the University of Cam-
bridge. Statistical analysis was carried out using R statistical software (version
2.14.1).
Because graph measures are not independent, and in some cases highly cor-
related (see chapter 5) it would be inappropriate to apply a conservative p-value
correction such as Bonferroni. Even False Discovery Rate (FDR) may risk type
I statistical error. With this in mind and given the exploratory nature of this
work, I have reported all p-values uncorrected.
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Figure 6.2: The connectivity distribution for each group. expressed as the log of cu-
mulative connection strength against the log of connection strength (k). The truncated
power law best fits the distribution in all groups suggesting that there are many nodes
with a small connection strength and relatively few with a large connectivity strength.
AIC
α β Power law Exponential power law Truncated power law
Control 14.6 8.1 6755 5347 4471
PD 28.8 2.8 6487 5105 3899
PSP 21.5 4.2 6494 5121 4067
CBS 20.7 4.3 6649 5239 4177
Table 6.1: Parameters of fit to the connectivity distribution in figure 6.2 for power
law, exponential power law and truncated power law distributions. The results show
that the truncated power law fits best in all groups. However, the shape of the curve
described by α and β differ in the control group compared to PD, PSP and CBS,
suggesting a difference in the distribution of connection strengths. AIC = Akaike’s
information criteria, α describes the shape of the curve and β is a scaling factor.
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Figure 6.3: The distribution of connection strengths used to define hubs in the control
group. In keeping with previous studies, the hubs regions are primarily located in
posterior regions of the brain, in particular the precuenues and posterior cingulate
cortex, and in regions of the occipital cortex. The distribution shown here is generated
from half the control group to avoid bias in group comparison. The distribution using
the whole control group and the other half of the control group were almost identical.
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6.2 Connection strength and hubs
To establish whether PD, PSP and CBS alter global functional connection strength,
the mean value of the subjects’ association matrices were compared between
groups using t-tests, shown in 6.2. All disease groups had large and significant
decreases in connection strength compared to control subjects, although there
were no differences in connection strength between diagnostic groups.
Contrast Mean connection strength Proportion p t
group 1 group 2 change (%)
Control/PD 0.24 0.16 32.7 0.00021 3.9
Control/PSP 0.24 0.19 23.9 0.0071 2.8
Control/CBS 0.24 0.19 24.1 0.014 2.5
PD/PSP 0.16 0.19 -13.1 ns -1.1
PD/CBS 0.16 0.19 -12.8 ns -1.0
PSP/CBS 0.19 0.19 0.2 ns 0.0
Table 6.2: Differences in weighted (unthresholded) connection strength between di-
agnostic groups. Subjects in the PD, PSP had a large number of nodes that were
significantly less connected than the control group, and all three diagnostic groups of
PD PSP and CBS had edges that were significantly less connected than the control
group. However, there were very few differences in individual nodes or edges between
the PD, PSP and CBS groups. Significant differences were assessed using a t-test. ns
= non-significant p>0.1.
To investigate whether nodes and edges differed in connectivity, pair-wise
t-tests were performed for node-wise and edge-wise connection strengths. Cor-
rections for multiple comparisons were carried out for each pair-wise comparison
for 471 nodes and 221370 edges assuming dependency between measures using
the FDR Benjamini and Yekutieli [2001]. The decreases in node-wise and edge-
wise connectivity in PD, PSP and CBS compared to controls shown in table 6.3
reflect the widespread loss of global connectivity in table 6.2, although the CBS
group had many fewer significant nodes and edges that either PD or PSP. The
distributions of nodes differing in connectivity strength between control and dis-
ease groups are shown in figure 6.4. The pattern of connection strength loss in
PD and PSP largely reflect the pattern of connection strength observed in figure
6.1 with an anterior-posterior gradient of nodes that lose connection strength.
However, the temporal lobes and basal ganglia are also regions in both PD and
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PSP where connection strength loss is observed. These patterns imply that loss of
connection strength is not confined to a single region in these two syndromes, and
may reflect a loss of connection strength in the most highly connected regions, ie
hub regions.
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In order to assess whether hub regions were particularly sensitive to a loss of
connectivity, the proportion of hub nodes and hub edges (defined as an edge ad-
jacent to at least one hub) were assessed. Tables 6.4 and 6.5 show that hub nodes
and hub edges were most susceptible to connectivity loss in PSP and PD. The
differences were not significant in CBS, although are difficult to interpret since
only 4 nodes and relatively few edges (0.52%) differed significantly in connection
strength from controls.
Hubs Non-hubs χ2 p
sig/non-sig (%) sig/non-sig (%)
PD 12/0 100.0 280/208 57.4 7.1 0.0077
PSP 10/2 83.3 97/392 19.8 24.5 7.6e-07
CBS 0/12 0.0 9/480 1.8 0.0 1
Table 6.4: The proportion of hub nodes with a significant decrease (p<0.05, FDR
corrected) in connection strength. This table demonstrates a predominant loss of con-
nection strength in hub nodes for both the PD and PSP groups. There are too few
nodes in the CBS group with a significant difference in connection strength to comment
on the proportion of hub nodes with a change in connection strength. Between group
difference was assessed using the chi-squared test. sig=number of nodes differing sig-
nificantly between groups; non-sig=number of nodes not differing significantly between
groups.
Hub edges Non-hub edges χ2 p
sig/non-sig (%) sig/non-sig (%)
PD 1572/10320 13.2 13284/226322 5.5 1199.3 8.6e-263
PSP 870/11022 7.3 7180/232426 3.0 680.8 4.5e-150
CBS 62/11830 0.5 1852/237758 0.8 9.2 0.0025
Table 6.5: The proportion of hub edges with a significant decrease (p<0.05, FDR
corrected) in connection strength. PD, PSP and CBS groups all showed an excess of
hub edges with a decrease in connection strength. A hub edge is one that is adjacent
to (ie connected to) at least one hub node. Between group difference was assessed
using the chi-squared test. sig=number of nodes differing significantly between groups;
non-sig=number of nodes not differing significantly between groups.
To assess whether the connection strength of hub nodes could be used as a
diagnostic biomarker to distinguish control from disease subjects, I performed
Receiver Operator Curve (ROC) analysis. However, the results in figure 6.6 show
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only modest group differentiation, arguing against the use of connection strength
as a diagnostic biomarker for individual subjects.
Although these results imply hub regions were susceptible to functional con-
nectivity loss, the definition of a hub is not fixed. Indeed, figure 6.7 shows that the
connection strength is a continuum in the control and disease groups and suggests
that investigating differences in connection strength may provide further insight
in to functional connectivity loss in PD, PSP and CBS. Since hubs may have the
longest distance connections, I went on to assess changes in connection strength
and edge distance.
To explore the susceptibility associated with connection strength and edge
distance in PD, PSP and CBS the edge-wise connection strength was plotted
against edge distance for the control group, and the change in connection strength
assessed for each edge, shown in figure 6.8. Of note, the proportion of change
in connection strength is shown in this plot, thereby correcting for the initial
connection strength of each edge.
The strongest connections in the control group were relatively short distance
connections, predominantly within the visual cortex and precuneus. There were
a group of moderately long distance connections with slightly greater than av-
erage connection strength appearing towards the top right of the plots in figure
6.8; the distribution of connectivity loss suggest that this group of edges is most
susceptible to connectivity loss in all three disease groups, and that both connec-
tion strength and distance may play a role in susceptibility to neurodegenerative
pathology.
To assess whether the node-wise loss of connectivity could be predicted by the
edge-wise properties of connection strength and distance, the node-wise connec-
tion strength and node-wise cumulative distance (sum of the distances for edges
adjacent to a node) was correlated against the proportion of node-wise loss of
connectivity, shown in the plots on the right of figure 6.8. The node weight, not
the distance, correlated strongly with the loss of connectivity in PD, PSP and
CBS, suggesting that connection strength rather than edge distance underlies the
susceptibility of functional hub regions to the effects of neurodegeneration.
To assess the clinical relevance of the change in functional connectivity, the
connection strength in all disease groups were correlated with cognitive and motor
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Figure 6.6: ROC analysis for the hub connection strengths. These results show
a relatively poor differentiation between controls and disease groups using the hub
connection strength alone.
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Figure 6.7: Distribution of node-wise connection strength in controls, PD, PSP and
CBS. The distribution of hubs in the three groups suggests that rather than a clearly
differentiable set of hub nodes, there is a continuum of connection strength. There are
clear differences between the distribution of the control group and the three atypical
parkinsonian disorders.
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Figure 6.8: The plots on the left show correlations between edge-wise connectivity
strength and edge distance in the control group, with each point coloured to display
the proportional loss of connectivity in PD, PSP and CBS. These plots show a group of
moderately long distance and moderately highly connected hub nodes lose the greatest
proportion of connectivity. The plots on the right show that the node-wise proportional
loss of connectivity correlates with the node-wise connection strength of the control
group, but not the node-wise cumulative distance, except for a statistically signifant
correlation in the PSP group that is likely to represent a type II statistical error.
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Figure 6.9: Correlations between connectivity strength and clinical scores. The plots
show linear correlations for letter and category fluency, both of which correlated with
connection strength when the three diagnostic groups were combined using Analysis
of Variance (letter fluency p=0.02, category fluency p=0.02, see table 6.6), although
individually the correlation values for each diagnostic group were not significant for
these measures. The correlation contrasts with measures of motor disease severity
(UPDRS III) and symptom duration which did not correlate with connection strength.
disease measures using analysis of variance. The results in figure 6.9 and table 6.6
show that a decline in verbal fluencies was associated with a loss of connection
strength in PD, PSP and CBS. Post-hoc correlations for individual diagnostic
groups are shown in 6.7. The link between connectivity in hub regions and verbal
fluency scores is consistent with the distribution of verbal fluency across multiple
brain regions involved in executive function.
In keeping with previous findings, measures of verbal fluencies differed between
PD, PSP and CBS Rittman et al. [2013]. However, there was no interaction be-
tween verbal fluency measures and connection strength indicating that connection
strength alone does not explain the difference in severity of verbal fluency loss
between diseases.
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6.3 Global and hub-wise graph theoretical mea-
sures
To assess the impact of neurodegenerative disease and the associated loss of con-
nectivity on the brain’s functional network organisation, I investigated measures
of global network topology and efficiency including the path length, cluster coeffi-
cient and global efficiency shown in figure 6.10 and table 6.8. The PD group had
a marked reduction in the average shortest path length, reflected in an increased
in the global efficiency. In addition, the PD group had an increased cluster co-
efficient. Taken together, these suggest that the PD group in comparison to the
control group is more similar to a small world network, with the favourable at-
tributes of both a random network (short path length) and an ordered network
(high clustering). Both the CBS and PSP groups have a similar increase in the
clustering coefficient, however the CBS group shows the opposite effect in the
path length with an increased values. This implies that the CBS group has a
more ordered brain network than the control group.
PD, PSP and CBS all caused a significant reduction of the median edge dis-
tance. Although the distance did not correlate with the proportional loss of con-
nectivity, this finding suggests that distance may play a role in the susceptibility
of individual connections.
To investigate measures of global hub integrity, node-wise measures of con-
nectivity, centrality and distance were averaged across the set of hub nodes. The
aggregated hub properties were markedly reduced in PD, PSP and CBS (figures
6.11 and table 6.9), specifically in connection strength and local efficiency, and of
hub centrality measures of closeness centrality and betweenness centrality. The
eigenvector centrality was significantly reduced in both PSP and CBS. These
findings demonstrate that loss of functional connectivity in hub regions leads to
changes in the topological properties of these regions within the brain’s functional
network.
To investigate the influence of thresholding on group differences, I assessed
the effect of thresholds on graph measures and the interaction between the main
effect of diagnosis and threshold, shown in tables 6.8 and 6.9. For the majority
of graph measures there was a significant or near-significant interaction between
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the main effect of diagnosis and threshold, although not always in the same
direction. For example, the difference in connection strength between the control
group and disease groups is greater at increasing thresholds (figure 6.11), whereas
the difference in path length appears greater at lower thresholds (figure 6.10).
These findings indicate that measuring at a range of thresholds is important for
a complete picture of graph metric changes in disease groups.
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Figure 6.10: Between group differences in graph metrics at between 1% and 10% local
equidense thresholds. The PD group demonstrated significant differences in comparison
to the control group by an decrease in median edge distance (p=0.013) and an increase
in robustness (p< 0.00001), with the CBS group also demonstrated a decrease in median
edge distance (p=0.015), but conversely a decrease in robustness (p=0.0091). The
PSP group demonstrated no significant difference in any of the graph measures in
comparison with the control group. The decrease in median edge distance suggest a
loss of long range connections in the PD and CBS groups. The increased robustness
could reflect a randomisation of the network structure, which has some support from the
slight (though not significant) reduction in cluster coefficient. The increased robustness
in the CBS group may conversely reflect an increasingly ordered network, supported
by non-significant trends towards increased path length and an increased clustering
coefficient.
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Figure 6.11: Hub-wise graph measures taken in graphs at between 1% and 10% local
equidense thresholds. The plot suggest that hub measures are more sensitive to differ-
ence between diagnostic groups and control subjects than other whole graph metrics.
Hub metrics that differed between the control group and all diagnostic groups were
the hub degree (PD p=0.024, PSP p=0.0015, CBS p=0.014), hub local efficiency (PD
p=0.018, PSP p=0.00074, CBS p=0.014), hub betweenness centrality (PD p=0.0038,
PSP p=0.001, CBS p=0.023) and hub edge distance (PD p=0.036, PSP p=0.012, CBS
P=0.023). The hub connection strength differed between the control group and PD
(p=0.037), and the eignevector centrality differed between the control group and PSP
(p=0.0095) and CBS (p=0.008).
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Neither small world nor hub properties differed between disease groups, sug-
gesting that the broad changes in topology resulting from PD, PSP and CBS are
similar. However, it may be that regional (ie node-wise) topological properties
differed in their distribution. Therefore, I went on to assess node-wise graph
theoretical properties.
6.4 Node-wise graph metrics
Node-wise graph analysis allows for the identification of local changes in network
topology that are not captured by a more global assessment. To assess whether
node-wise graph metrics differed between control, PD, PSP and CBS, a repeated
measures ANOVA was performed for each node (accounting for repeated mea-
surements at each equidense threshold between 1% and 10%) and the results
were corrected for multiple comparison using the FDR Benjamini and Yekutieli
[2001]. The results are shown for comparison between control and disease groups
for degree (figure 6.12), closeness centrality (figure 6.14), eigenvector centrality
(figure 6.16), cumulative edge distance (figure 6.18) and local efficiency (6.20),
with corresponding between disease groups in figures 6.13, 6.15, 6.17, 6.19, 6.21
respectively.
The disease groups declined in all node-wise graph metrics compared to con-
trols reflecting the pattern of change in connection strength seen in figure 6.4.
Specifically, there were decreases of graph properties in the precueneus, parietal
and parieto-occipital regions.
However, there was a corresponding increase in node-wise graph properties in
differing regions for each disease group. This was most evident in the measure-
ment of eignvector centrality:
• the PD group had increased centrality in the basal ganglia and inferior
frontal regions,
• the PSP group had increased centrality in the cerebellum, basal ganglia,
medial frontal and supplementary motor cortex and bi-temporal regions,
• the CBS group had increased centrality in the basal ganglia, inferior frontal
and bi-temporal regions.
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For PSP and CBS, the changes described above were also reflected in the
distribution of between disease group differences. The comparison of PD with
both PSP and CBS resembled the comparison with the control group, suggesting
that the PD group are more similar to controls in their topological characteristics
than either PSP or CBS. For example the eigenvector centrality is much greater
for PD against both PSP or CBS in the precuneus and parietal lobe. The PD
group had a similar pattern with PSP and CBS for degree, edge distance and
local efficiency.
157
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.1
2
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
d
eg
re
e
d
iff
er
ed
b
et
w
ee
n
co
n
tr
ol
an
d
d
is
ea
se
gr
ou
p
s.
T
h
e
n
o
d
e
d
eg
re
e
w
a
s
d
ec
re
as
ed
in
P
D
,
P
S
P
an
d
C
B
S
m
ai
n
ly
in
p
ar
ie
ta
l
an
d
o
cc
ip
it
al
lo
b
e
re
gi
on
s
in
a
si
m
il
ar
p
at
te
rn
in
al
l
gr
ou
p
s.
T
h
e
re
g
io
n
s
o
f
in
cr
ea
se
d
d
eg
re
e
in
th
es
e
gr
ou
p
s
ar
e
in
ce
re
b
el
la
r,
b
as
al
ga
n
gl
ia
an
d
fr
on
ta
l
lo
b
e
re
gi
on
s.
T
h
e
re
su
lt
s
w
ou
ld
b
e
co
n
si
st
en
t
w
it
h
a
lo
ss
of
d
eg
re
e
in
h
u
b
re
gi
on
s.
In
te
rp
re
ta
ti
on
of
re
gi
on
s
of
in
cr
ea
se
d
d
eg
re
e
is
m
or
e
ch
al
le
n
gi
n
g,
b
u
t
th
es
e
re
su
lt
s
d
em
o
n
st
ra
te
th
at
ch
an
ge
s
in
th
e
fu
n
ct
io
n
al
co
n
n
ec
ti
v
it
y
n
et
w
or
k
ar
e
d
is
tr
ib
u
te
d
ac
ro
ss
th
e
w
h
ol
e
b
ra
in
.
R
es
u
lt
s
w
er
e
o
b
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
ac
ro
ss
eq
u
id
en
se
th
re
sh
ol
d
s
fr
om
1%
to
10
%
.
T
h
e
n
o
d
e
si
ze
is
sc
al
ed
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3%
eq
u
id
en
se
th
re
sh
ol
d
.
158
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.1
3
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
d
eg
re
e
d
iff
er
ed
b
et
w
ee
n
P
D
,
P
S
P
an
d
C
B
S
gr
ou
p
s
T
h
e
co
m
p
a
ri
so
n
b
et
w
ee
n
P
D
,
P
S
P
an
d
C
B
S
h
ig
h
li
gh
t
d
is
ti
n
ct
p
at
te
rn
s
of
d
eg
re
e
in
ea
ch
gr
ou
p
.
T
h
e
co
m
p
ar
is
on
b
et
w
ee
n
P
D
an
d
th
e
tw
o
o
th
er
g
ro
u
p
s
is
si
m
il
ar
to
th
e
co
m
p
ar
is
on
b
et
w
ee
n
d
ia
gn
os
ti
c
gr
ou
p
s
an
d
th
e
co
n
tr
ol
gr
ou
p
.
H
ow
ev
er
,
th
e
P
S
P
gr
ou
p
h
av
e
a
g
re
a
te
r
d
eg
re
e
in
p
ri
m
ar
y
m
ot
or
se
n
so
ri
m
ot
or
co
rt
ex
an
d
th
e
su
p
p
le
m
en
ta
ry
m
ot
or
ar
ea
,
w
it
h
a
lo
ss
of
d
eg
re
e
in
in
fe
ri
or
fr
o
n
ta
l
re
g
io
n
s.
T
h
e
C
B
S
gr
ou
p
h
av
e
re
d
u
ce
d
d
eg
re
e
in
a
m
or
e
w
id
es
p
re
ad
d
is
tr
ib
u
ti
on
w
it
h
re
d
u
ce
d
d
eg
re
e
in
p
ri
m
ar
y
se
n
so
ri
m
o
to
r
co
rt
ex
,
su
p
p
le
m
en
ta
ry
m
ot
or
ar
ea
an
d
ce
re
b
el
lu
m
.
R
es
u
lt
s
w
er
e
ob
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
a
cr
o
ss
eq
u
id
en
se
th
re
sh
ol
d
s
fr
om
1%
to
10
%
.
T
h
e
n
o
d
e
si
ze
is
sc
al
ed
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3
%
eq
u
id
en
se
th
re
sh
ol
d
.
159
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.1
4
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
cl
os
en
es
s
ce
n
tr
al
it
y
d
iff
er
ed
b
et
w
ee
n
co
n
tr
ol
an
d
d
is
ea
se
gr
ou
p
s
T
h
e
n
o
d
e-
w
is
e
fi
n
d
in
gs
in
cl
os
en
es
s
ce
n
tr
al
it
y
ar
e
si
m
il
ar
to
th
os
e
u
si
n
g
d
eg
re
e,
w
h
ic
h
re
fl
ec
ts
th
e
ov
er
la
p
b
et
w
ee
n
th
es
e
tw
o
m
et
ri
cs
d
is
cu
ss
ed
in
ch
ap
te
r
5.
R
es
u
lt
s
w
er
e
ob
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
ac
ro
ss
eq
u
id
en
se
th
re
sh
ol
d
s
fr
om
1
%
to
1
0
%
.
T
h
e
n
o
d
e
si
ze
is
sc
al
ed
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3%
eq
u
id
en
se
th
re
sh
ol
d
.
160
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.1
5
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
cl
os
en
es
s
ce
n
tr
al
it
y
d
iff
er
ed
b
et
w
ee
n
P
D
,
P
S
P
an
d
C
B
S
gr
ou
p
s.
T
h
e
co
m
p
a
ri
so
n
b
et
w
ee
n
P
D
an
d
th
e
ot
h
er
tw
o
gr
ou
p
s
is
si
m
il
ar
,
su
gg
es
ti
n
g
th
at
th
e
p
at
te
rn
of
ch
an
ge
in
cl
os
en
es
s
ce
n
tr
al
it
y
is
d
is
ti
n
ct
in
P
D
co
m
p
ar
ed
w
it
h
P
S
P
an
d
C
B
S
.
R
es
u
lt
s
w
er
e
ob
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
ac
ro
ss
eq
u
id
en
se
th
re
sh
o
ld
s
fr
om
1%
to
10
%
.
T
h
e
n
o
d
e
si
ze
is
sc
al
ed
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3%
eq
u
id
en
se
th
re
sh
o
ld
.
161
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.1
6
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
ei
ge
n
ve
ct
or
ce
n
tr
al
it
y
d
iff
er
ed
b
et
w
ee
n
co
n
tr
ol
an
d
d
is
ea
se
g
ro
u
p
s.
T
h
e
p
at
te
rn
of
ch
an
ge
in
P
D
,
P
S
P
an
d
C
B
S
co
m
p
ar
ed
w
it
h
th
e
co
n
tr
ol
gr
ou
p
is
si
m
il
ar
to
th
os
e
in
ot
h
er
n
o
d
e-
w
is
e
co
m
p
a
ri
so
n
s,
d
em
on
st
ra
ti
n
g
a
d
ec
re
as
e
in
ce
n
tr
at
li
ty
in
p
ar
ie
ta
l
an
d
o
cc
ip
it
al
re
gi
on
s
w
it
h
in
cr
ea
se
d
ce
n
tr
al
it
y
in
th
e
te
m
p
o
ra
l
lo
b
e,
su
b
co
rt
ic
al
re
gi
on
s
an
d
th
e
in
fe
ri
or
fr
on
ta
l
lo
b
e.
R
es
u
lt
s
w
er
e
ob
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
a
cr
o
ss
eq
u
id
en
se
th
re
sh
ol
d
s
fr
om
1%
to
10
%
.
T
h
e
n
o
d
e
si
ze
is
sc
al
ed
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3
%
eq
u
id
en
se
th
re
sh
ol
d
.
162
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.1
7
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
ei
ge
n
ve
ct
or
ce
n
tr
al
it
y
d
iff
er
ed
b
et
w
ee
n
P
D
,
P
S
P
an
d
C
B
S
gr
ou
p
s.
T
h
e
p
a
tt
er
n
s
of
d
iff
er
en
ce
s
b
et
w
ee
n
P
D
,
P
S
P
an
d
C
B
S
ar
e
d
is
ti
n
ct
an
d
su
gg
es
t
li
n
k
s
to
th
e
cl
in
ic
al
sy
n
d
ro
m
es
.
T
h
e
P
D
gr
o
u
p
d
em
o
n
st
ra
te
lo
w
er
ce
n
tr
al
it
y
in
th
e
ce
re
b
el
lu
m
an
d
in
cr
ea
se
d
ce
n
tr
al
it
y
in
th
e
b
as
al
ga
n
gl
ia
an
d
m
ed
ia
l
te
m
p
or
op
ar
ie
ta
l
ju
n
ct
io
n
w
h
ic
h
co
u
ld
b
e
li
n
ke
d
to
th
e
b
as
al
ga
n
gl
ia
p
at
h
ol
og
y
of
P
ar
k
in
so
n
’s
d
is
ea
se
.
In
co
n
tr
as
t,
th
e
P
S
P
gr
ou
p
h
av
e
lo
w
er
ce
n
tr
a
li
ty
in
th
e
in
fe
ri
or
fr
on
ta
l
re
gi
on
s
in
su
b
je
ct
s
w
it
h
a
fr
on
ta
l
d
y
se
x
ec
u
ti
v
e
co
gn
it
iv
e
sy
n
d
ro
m
e,
w
h
er
ea
s
th
e
C
B
S
gr
ou
p
h
av
e
d
ec
re
a
se
d
ce
n
tr
al
it
y
in
p
ri
m
ar
y
an
d
su
p
p
le
m
en
ta
ry
m
ot
or
co
rt
ex
in
th
e
co
n
te
x
t
of
a
sy
n
d
ro
m
e
w
it
h
p
ro
m
in
en
t
ap
ra
x
ia
a
n
d
th
e
a
li
en
li
m
b
p
h
en
om
en
on
.
R
es
u
lt
s
w
er
e
ob
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
ac
ro
ss
eq
u
id
en
se
th
re
sh
ol
d
s
fr
o
m
1
%
to
1
0
%
.
T
h
e
n
o
d
e
si
ze
is
sc
al
ed
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3%
eq
u
id
en
se
th
re
sh
ol
d
.
163
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.1
8
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
cu
m
u
la
ti
ve
ed
ge
d
is
ta
n
ce
d
iff
er
ed
b
et
w
ee
n
co
n
tr
ol
an
d
d
is
ea
se
g
ro
u
p
s.
T
h
e
ch
an
ge
in
P
D
,
P
S
P
an
d
P
S
P
of
cu
m
u
la
ti
ve
ed
ge
d
is
ta
n
ce
is
si
m
il
ar
to
ot
h
er
n
o
d
e-
w
is
e
gr
ap
h
m
et
ri
cs
,
d
em
on
st
ra
ti
n
g
re
d
u
ce
d
ed
ge
d
is
ta
n
ce
in
p
ar
ie
ta
l
an
d
o
cc
ip
it
al
re
gi
on
s,
an
d
in
cr
ea
se
d
ed
ge
d
is
ta
n
ce
as
so
ci
at
ed
w
it
h
n
o
d
es
in
th
e
b
a
sa
l
g
a
n
g
li
a
,
fr
on
to
p
ar
ie
ta
l
ju
n
ct
io
n
an
d
in
fe
ri
or
fr
on
ta
l
lo
b
es
.
R
es
u
lt
s
w
er
e
ob
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
a
cr
o
ss
eq
u
id
en
se
th
re
sh
ol
d
s
fr
om
1%
to
10
%
.
T
h
e
n
o
d
e
si
ze
is
sc
al
ed
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3
%
eq
u
id
en
se
th
re
sh
ol
d
.
164
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.1
9
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
cu
m
u
la
ti
ve
ed
ge
d
is
ta
n
ce
d
iff
er
ed
b
et
w
ee
n
P
D
,
P
S
P
an
d
C
B
S
g
ro
u
p
s.
T
h
e
d
iff
er
en
ce
s
b
et
w
ee
n
P
D
,
P
S
P
an
d
C
B
S
b
ea
r
a
si
m
il
ar
it
y
to
th
os
e
ob
ta
in
ed
u
si
n
g
ei
ge
n
ve
ct
or
ce
n
tr
al
it
y,
h
ow
ev
er
th
e
ch
a
n
g
es
ar
e
a
m
or
e
d
iff
u
se
in
th
e
P
S
P
gr
ou
p
,
so
th
at
th
e
P
S
P
gr
ou
p
h
as
re
d
u
ce
d
ed
ge
d
is
ta
n
ce
at
th
e
fr
on
to
p
ar
ie
ta
l
ju
n
ct
io
n
in
ad
d
it
io
n
to
ce
re
b
el
la
r
re
gi
on
s.
R
es
u
lt
s
w
er
e
ob
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
ac
ro
ss
eq
u
id
en
se
th
re
sh
o
ld
s
fr
o
m
1%
to
10
%
.
T
h
e
n
o
d
e
si
ze
is
sc
al
ed
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3%
eq
u
id
en
se
th
re
sh
o
ld
.
165
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.2
0
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
lo
ca
l
effi
ci
en
cy
d
iff
er
ed
b
et
w
ee
n
co
n
tr
ol
an
d
d
is
ea
se
gr
ou
p
s.
T
h
e
ch
a
n
g
e
in
P
D
,
P
S
P
an
d
P
S
P
of
lo
ca
l
effi
ci
en
cy
is
si
m
il
ar
to
ot
h
er
n
o
d
e-
w
is
e
gr
ap
h
m
et
ri
cs
,
d
em
on
st
ra
ti
n
g
re
d
u
ce
d
ed
g
e
d
is
ta
n
ce
in
p
ar
ie
ta
l
an
d
o
cc
ip
it
al
re
gi
on
s,
an
d
in
cr
ea
se
d
ed
ge
d
is
ta
n
ce
as
so
ci
at
ed
w
it
h
n
o
d
es
in
th
e
b
as
al
ga
n
gl
ia
,
fr
on
to
p
a
ri
et
a
l
ju
n
ct
io
n
an
d
in
fe
ri
or
fr
on
ta
l
lo
b
es
.
R
es
u
lt
s
w
er
e
ob
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
ac
ro
ss
eq
u
id
en
se
th
re
sh
o
ld
s
fr
o
m
1
%
to
10
%
.
T
h
e
n
o
d
e
si
ze
is
sc
al
ed
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3%
eq
u
id
en
se
th
re
sh
o
ld
.
166
6. FUNCTIONAL BRAIN NETWORKS
F
ig
u
re
6
.2
1
:
N
o
d
es
ar
e
sh
ow
n
fo
r
w
h
ic
h
th
e
lo
ca
l
effi
ci
en
cy
d
iff
er
ed
b
et
w
ee
n
P
D
,
P
S
P
an
d
C
B
S
gr
ou
p
.
T
h
e
n
o
d
e-
w
is
e
ch
an
ge
s
b
et
w
ee
n
P
D
,
P
S
P
an
d
C
B
S
in
lo
ca
l
effi
en
cy
ar
e
si
m
il
ar
to
th
os
e
of
cu
m
u
la
ti
ve
ed
ge
d
is
ta
n
ce
an
d
d
eg
re
e.
R
es
u
lt
s
w
er
e
ob
ta
in
ed
u
si
n
g
a
re
p
ea
te
d
m
ea
su
re
s
A
N
O
V
A
ac
ro
ss
eq
u
id
en
se
th
re
sh
ol
d
s
fr
om
1%
to
10
%
.
T
h
e
n
o
d
e
si
ze
is
sc
a
le
d
b
y
th
e
d
iff
er
en
ce
b
et
w
ee
n
gr
ou
p
s
fo
r
a
b
in
ar
y
gr
ap
h
at
a
3%
eq
u
id
en
se
th
re
sh
ol
d
.
167
6. FUNCTIONAL BRAIN NETWORKS
6.5 Clinical correlations
Even though there were no between group differences in graph metrics, it may be
the variability within a group might explain clinical disease features. To assess
this, a repeated measures ANOVA was performed between clinical scores and
graph metrics at 1% and 10% equidense thresholds, shown in table 6.10. The only
significant relationships were in PD between cluster coefficient and MMSE, and
in PSP between the median edge distance and category fluency. These results
were uncorrected for multiple comparisons and must therefore be treated with
caution.
I went on to assess whether hub properties might show a relationship with
clinical disease measures using a repeated measures ANOVA, shown in table 6.11.
In PD only eigenvector centrality co-varied with category fluency and in CBS the
eigenvector centrality co-varied with the UPDRS III score. Again, these statistical
measures were uncorrected and must be assessed cautiously.
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6.6 Assessment against a random attack model
To assess whether the topological differences between control and disease groups
could could be explained by the loss of connection strength alone, I assessed the
effect of a random loss of connection strength on the control group. This analysis
assesses whether the results could be due to an artefact of using an equidense
threshold. In two networks where the edge weight differs, an equidense threshold
will result in graphs of the same number of edges and nodes. However, the less
connected graph will include weaker edges. In the most severe case where none of
the weaker edges are informative, the less connected graph can be considered to
be overlaid by a random network made up of weak edges. To model this process, a
fully connected weighted graph underwent a stochastic process where connection
strength was removed from random edge. To measure graph metrics, presented
in figure 6.22 the graph was thresholded at a range of equidense thresholds.
The comparison to a random attack model shows a qualitative difference be-
tween this model and all disease groups on all measures except hub local efficiency.
This demonstrates that the pattern of topological changes in PD, PSP and CBS
can not be explained by a random weakening of connection strength.
6.7 Discussion
In this chapter I have studied the brain’s functional organisation in PD, PSP
and CBS by applying network analysis using graph theory Bullmore and Sporns
[2009]. This approach provides a perspective on the relationship between brain
regions and the global topology of the brain’s functional network by exploring
the correlation of activity between large neuronal populations.
I began by examining global functional connectivity. Conceptually this pro-
vides an overview of integrative neuronal and synaptic functions. I found that
PD, PSP and CBS all caused a marked reduction in global functional connec-
tivity. The loss of connectivity between the control group and disease groups
was dramatic (PD 31.6%, PSP 22.5%, CBS 24.1%), suggesting that measuring
functional connectivity is likely to be informative in these diseases. However,
measuring the global connectivity alone gives no information about which brain
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Figure 6.22: The comparison of graph measures between a random attack model and
the patient groups. The plot demonstrates that the changes observed in graph measures
can not be simply attributed to the PD, PSP and CBS groups losing edges in a random
manner. The random attack model removed edge weights from a fully connected,
weighted graph, followed by graph analysis at a range of equidense thresholds in order
to mirror the process of graph measurements in the patient groups. The horizontal lines
indicates the 95% confidence interval of the mean connection strength in each group
and the vertical lines the 95% confidence interval of the mean for graph measures.
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regions are most affected or how the topology of the brain’s functional network
has changed and did not distinguish between disorders.
In order to answer the question of which brain regions were most affected
in a given disorder, I began by assessing connectivity change in hub regions.
The choice to examine hub regions was based on the importance of hubs to
the brain’s functional network Achard et al. [2006], that hubs are located in
metabolically active regions Bullmore and Sporns [2012]; Collin et al. [2013],
and they facilitate communication between brain regions Power et al. [2013]. As
topological network components, hubs play a key role in dictating the properties
of a network. Furthermore, previous studies have implicated hubs as susceptible
to Alzheimer’s disease Buckner et al. [2009]; Stam et al. [2009]. I found that both
PD and PSP caused a significant loss of functional connectivity in hub regions.
To validate these findings and to investigate the link between loss of hub
function and clinical disease, I correlated hub connection strength with motor
and cognitive scores. I found that verbal fluency scores across all groups declined
with the loss of hub-wise functional connectivity, whereas a motor measure of the
UPDRS III did not correlate with hub function. The contribution of hub integrity
to verbal fluency is unsurprising, since verbal fluency draws on widespread and
bilateral brain regions, particularly regions of the frontal lobe (see chapter 2)
Heim et al. [2009]; Shedlack et al. [1991]; Stuss et al. [1998].
However, several clinical measures did not correlate with the loss of hub con-
nectivity. The MMSE is a brief cognitive questionnaire that is a relatively insensi-
tive measure in PD, PSP and CBS (see chapter 2) and did not correlate with hub
connectivity. The UPDRS III is a measure of motor function and is tailored to
assess motor basal ganglia functions. The main motor deficit in parkinsonian dis-
orders lies in a cortico-thalamo-cortical loop Hoover and Strick [1999]; Middleton
and Strick [2000] which includes non-hub cortical areas of primary and secondary
motor cortices. Therefore analysis of hub regions alone may be insensitive to
changes in motor function measured by the UPDRS III.
Clinical scores correlated less with measures of graph theory measures of net-
work topology than with connection strength. There are several possible reasons
for the lack of correlation with graph measures. Firstly, it may be that there
is a loss of information when disregarding connection weights on moving from
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a measurement of connection strength to binary thresholded graphs. Secondly,
the choice of cognitive tests may not have been suitable, either because they are
insensitive tests (such as the MMSE), or patients performed at a floor level on
the tests (eg PSP subjects and verbal fluency Ghosh et al. [2013]) and therefore
there was insufficient variability to detect a correlation. Finally graph metrics
may not be sensitive to tests targeting specific brain regions because they reflect
global aspects of the brain’s functional network. It is possible the lack of correla-
tion reflects a type II error, but I consider this unlikely given the relatively large
number of subjects.
The finding of hub susceptibility is in keeping with studies in Alzheimer’s
disease Buckner et al. [2009]; Stam et al. [2009] and suggests that functional
hub susceptibility may be a feature across neurodegenerative diseases. Buckner
et al proposed that beta-amyloid deposition in Alzheimer’s might underlie hub
susceptibility, since beta-amyloid deposition in Alzheimer’s disease resulted in
an overlap with the location of hubs using the Positron Emission Tomography
(PET) ligand Pittsburgh Compound B (PiB). However, protein aggregation in
hubs would not explain the findings in PD where histological changes are seen
only in the latter stages in neocortical regions and tend to be widely distributed
Braak et al. [2003] and PSP where the majority of tau pathology is subcortical
and cortical pathology is predominantly in frontal and temporal lobes Williams
et al. [2007]. Nor would it explain why the CBS group had a non-significant
difference when CBS is more likely to be associated with underlying Alzheimer
pathology.
Two topological properties of hubs that might predict susceptibility are con-
nection strength and the distance of adjacent edges. It is therefore significant that
I found that connection strength in the control group to be a better predictor
of node-wise connectivity than distance. Connection distance in brain networks
has been related to axons and myelin Bullmore and Sporns [2012] and therefore a
reduction in distance may be interpreted as representing axonal loss. Connection
strength for a single edge may also represent axonal integrity since more axons
would increase the covariance between two regions, but may be influenced by
the integrity of neurons and by the integrity of synapses Buzsa´ki [2006]. Since
connection strength was a better predictor of connection loss, we can suppose
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that either neuronal loss or synaptic dysfunction might underlie the change in
disease groups. Neuronal loss would result in selective atrophy of hub regions,
which is not characteristic of PD Beyer et al. [2007]; Summerfield et al. [2005] or
PSP Josephs et al. [2008]; Paviour et al. [2006]. This leaves the possibility that
synaptic dysfunction is responsible for the observed functional hub susceptibility
in PD and PSP.
The lack of hub susceptibility in the CBS group suggested differences in con-
nection strength and in topology between groups, although there were no clear
differences between disease groups. The changes in node-wise functional connec-
tivity were not so marked in CBS in comparison to PD and PSP, despite a similar
global connectivity loss. CBS is a more varied syndrome clinically than either
PSP or CBS; for example the early syndrome may be predominantly motor, cog-
nitive, affective or language-related Armstrong et al. [2013]. Coupled with the
heterogeneity of pathologies underlying CBS Alexander et al. [2014]; Ling et al.
[2010], this suggests a greater variability in the distribution of local connectivity
changes in CBS compared to either PD or PSP.
Given the changes in connectivity and hubs, I went on to a to assess whether
the topology of the brain’s functional network was altered in PD, PSP and CBS
by using graph theoretical measures. The arrangement of the brain has been
shown to be efficient and robust, similar to a small world network Achard et al.
[2006]; He et al. [2007]. Indeed, in my data the changes in measurements of
small world properties were small compared to the overall loss of connectivity,
consistent with their robustness in the face of neurodegeneration. CBS was the
only group to demonstrate a trends toward changes in small world properties.
These relatively small changes demonstrate the robustness of the human brain to
neurodegenerative processes.
Since global measures were little different between groups, I looked at regional
measures of topology using node-wise graph measures. PD, PSP and CBS caused
a loss of hub properties of centrality and degree in the precuneus, parietal lobe
and parieto-occipital regions. A similar pattern was seen in nodes with a loss of
cumulative edge distance. Between disease group differences showed distinct loss
of hub properties in:
• PSP: sensorimotor cortex and the supplementary motor area,
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• CBS: inferior frontal cortex and anterior temporal lobes
The difference in distribution of node-wise graphs between PD and PSP is con-
sistent with pathological changes of neuronal loss and tau tangles in the motor
and pre-supplementary motor area areas in PSP and the relative absence of neu-
ropathology in these areas in PD Halliday et al. [2005]. The distribution of
difference between PD and CBS is not so readily explained by pathology, but
may relate to altered pharmacology. Speculatively, the observed findings may
relate to dopaminergic medication overdosing the inferior frontal cortex resulting
in greater connectivity Rowe et al. [2008].
All three disease groups had an increase in hub properties in the pre-supplementary
motor area, the basal ganglia and regions of the cerebellum. This is of particular
interest since these areas are part of the motor system and abnormalities in con-
nectivity may contribute to clinical symptoms of akinesia and rigidity. Increases
in graph metric properties in the context of disease have been reported previ-
ously, but can be difficult to interpret. One possibility is that these areas show
compensatory increases in topological organisation as a response to the loss in
other brain regions, similar to effects seen in the motor system in stroke Sharma
et al. [2009] or on the contralesional hemisphere in epilepsy Zhang et al. [2011].
A second possibility is that the areas of increase represent an artefact of ap-
plying an equidense threshold, whereby some weaker connections are necessarily
included during graph construction. To assess this possibility would require for-
mal modelling of connectivity loss with differential thresholding and the repeat
assessment of graph measures, or using dopaminergic drugs to examine changes in
graph metrics in the pre-supplementary motor area, basal ganglia and cerebellum.
At first glance, the smaller change of global graph measures in PD is rather
surprising, since the PD group had the greatest loss of connectivity overall. This
implies that loss of connectivity alone is insufficient to explain all of the network
changes observed. Only one previous study has examined local and global effi-
ciency in a cohort of PD, finding a reduction in both global and local efficiency
Skidmore et al. [2011], but with a smaller sample size (n=14) and no comment
on global functional connectivity. The results are difficult to compare the current
study, since the difference in node-wise local efficiency was noted only in a subset
of 30 nodes with the greatest local efficiency and group comparison was made at
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a single threshold (10%) in a coarser parcellation of 232 nodes.
Although the length of connections was not specifically associated with hub
susceptibility, there were global and local reductions in physical edge distance.
The link between distance and axonal loss Bullmore and Sporns [2012] is consis-
tent with white matter changes from structural neuroimaging studies in PD Rae
et al. [2012], PSP Ghosh et al. [2012] and CBS Borroni et al. [2008]. Therefore,
distance may also contribute to the susceptibility of axons to neurodegenerative
disease, even if these connections do not originate or terminate in hub regions.
Previous publications using graph analysis in neurodegenerative disease demon-
strate a lack of consensus on methodological issues such as parcellation, correla-
tion method and graph metrics used. This makes comparison challenging between
studies. For example, one previous study has examined global graph metrics in
Alzheimer’s disease Sanz-Arigita et al. [2010] finding global differences, but in
the opposite direction to the findings here in CBS; the study showed a reduced
path length in the Alzheimer’s disease group whereas I found a trend towards
an increased path length in CBS. There were differences in methodology, the
Alzheimer’s study used the synchronisation likelihood rather than wavelet corre-
lation, and an anatomical parcellation of 90 regions rather than a random par-
cellation of 471 regions in this analysis Sanz-Arigita et al. [2010].
Despite this, the techniques applied in this study would be applicable to sim-
ilar data collected in other neurodegenerative or neuropsychiatric syndromes.
The feasibility of this approach has been demonstrated by Crossley et al 2014
where a comparison was made between 26 brain disorders. This study used a
meta-analytical approach to demonstrate that hub regions were susceptible to
the effects of disease in many disorders. This study used a mixture of diffu-
sion tensor imaging, grey matter atrophy maps and task activation Functional
Magnetic Resonance Imaging (fMRI). The generic nature of association matri-
ces should allow for comparison between task-free studies in a similar manner,
although ensuring consistency in approach as detailed above would be critical to
ensuring a fair comparison between datasets. A major challenge to developing
such datasets is the recruitment of large numbers of subjects with neurodegen-
erative syndromes, although this is now being achieved through cohorts such as
the Alzheimer’s Disease Neuroimaging Initiative.
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A second major challenge in other neurodegenerative syndromes is the poten-
tially poor clinicalopathological correlation. Although I have demonstrated con-
sistent changes in the CBS group suggesting common consequences of pathology
in a pathologically heterogeneous syndrome, to develop an effective biomarker
requires that histopathological information is available. This is a particular
challenge in the syndromes associated with Frontotemporal lobar degeneration
(FTLD) pathologies. An approach that is being employed currently is to use peo-
ple with a genetic Frontotemporal dementia (FTD) syndrome and their siblings
where the pathology is associated with a known gene mutation. This approach is
being applied in the Genetic Frontotemporal dementia Initiative (GENFI) study.
A previous study of global connectivity in PD found reduced global efficiency
in an anatomical parcellation of 116 regions Skidmore et al. [2011] but did not
comment on global connectivity values. The authors chose 30 regions of interest
with the highest local efficiency and found a loss of local efficiency, although
do not comment on the remaining nodes. An assessment of the motor system
in PD found a loss of connectivity that was restored with levodopa Wu et al.
[2009]. No global assessments of small world characteristics have been performed
in PSP, though Gardner et al 2013 use a seed-based connectivity analysis with
the seed placed in the midbrain tegmentum to demonstrate widespread reduced
connectivity in medial frontal lobe, bilateral insular cortices and the thalamus.
There are a number of limitations to the data presented here. Firstly, the
diagnosis in each group was based on clinical criteria. In PSP and PD there is
evidence that the clinicopathological correlation is strong Bensimon et al. [2009];
Gibb and Lees [1988]; Hughes et al. [2002], but this is not the case in CBS
where only 50% of subjects have primary tau-associated Corticobasal Degen-
eration (CBD) pathology Alexander et al. [2014]; Ling et al. [2010]. A future
re-analysis with information from post-mortem data will be helpful to assess the
bias from mis-diagnosis.
The fMRI sequence used was several years old. Although this has the ad-
vantage of recruiting a sizeable cohort of subjects, more modern sequences may
offer other advantages. For example, multi-echo fMRI where de-noising can be
achieved Echo Time (TE)-dependence of artefacts Kundu et al. [2011]. Alterna-
tively, acquisitions with a greater temporal resolution and spatial resolution may
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provide better artefact removal and assessment of frequency information Uurbil
et al. [2013].
In examining functional networks, association matrices were built from corre-
lations; this is a form of functional connectivity. Functional connectivity analysis
does not distinguish between direct and indirect connections between regions. For
example, regions A and B may both be influenced by region C, but without a di-
rect connection between A and B. Correlational analysis would find a ‘functional
connection’ between A and B. Furthermore, it is not possible to tell the direction
of the connection using correlations alone. The issue of a direct connection may
be resolved using structural connectivity approaches such as Diffusion Tensor
Imaging (DTI). However, DTI imaging can not distinguish directionality and has
its own technical problems such as distinguishing crossing fibres Jeurissen et al.
[2013]. Effective connectivity methods, such as Psychophysiological Interactions
or Dynamic Causal Modelling, can establish influence between regions. However,
effective connectivity modelling is tractable with only a few regions of interest
and has only recently become possible in task-free imaging Friston et al. [2011].
I have chosen to use a set of commonly applied graph metrics, justified by their
association with underlying network properties outlined in chapter 5. There may
be other graph measures or network analysis approaches that are more sensitive
to disease changes or with a more immediate association with underlying patho-
logical changes or clinical disease measures. In particular, recent research has
highlighted the importance of dynamic changes in network graph properties to
underpin cognitive functions Cocchi et al. [2013]; Hutchison et al. [2013]. This
may be of interesting in the context of PD, PSP and CBS.
Finally, the p-values presented in the tables of graph measures were not cor-
rected for multiple tests or multiple groups (although node-wise tests were cor-
rected for multiple nodes). Choosing the correct for statistical analysis in this
dataset is challenging, since the graph measures used are not independent, as
demonstrated in chapter 5. Therefore, a simple FDR or Bonferroni correction
is likely to be too conservative. As the aim of this analysis is exploratory, at
least in part, I have decided to present uncorrected p-values. A better approach
may be to generate aggregated values based on a selection of non-independent
graph measures, or to use a Bayesian framework where the null hypothesis can
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be properly rejected.
6.8 Conclusions
This chapter described the global, hub-wise and node-wise changes of connectivity
in PD, PSP and CBS. A marked reduction in global connectivity characterises
these three diseases. Impaired verbal fluency correlated with hub connectivity
across all groups, though clinical scores did not correlate strongly with global or
hub-wise graph measures. Small world metrics collected at the level of the whole
brain were insensitive to differences between groups. Although node-wise charac-
teristics demonstrated a loss of local graph properties between disease groups and
controls, the differences between groups suggests that regional changes in func-
tional network properties might explain syndromic differences between parkinso-
nian syndromes.
To explored the potential for regional differences in the brain’s functional
organisation in PD, PSP and CBS, the next chapter will assess community and
network decompositions of the brain’s functional network.
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Chapter 7
Networks and modules
The previous chapter 6 demonstrated the impact of Parkinson’s disease (PD),
Progressive Supranuclear Palsy (PSP) and Corticobasal Syndrome (CBS) on func-
tional hub and other highly connected regions. Hubs are proposed to play a role in
mediating communication across the brain’s large scale functional network Power
et al. [2013]. Therefore, this chapter explores the impact of PD, PSP and CBS on
measures of topological communities and disease changes in functionally specific
covariance networks.
The brain’s functional network can be divided in to separable modules or com-
munities. These can be identified using functional connectivity measurements
and graph theory analysis, employing a community detection algorithm Newman
[2006]. This community structure can be used to assess network properties that
are informative about disease processes Alexander-Bloch et al. [2010]. A com-
munity detection approach has been applied in Alzheimer’s disease using Magne-
toencephalography (MEG) to demonstrate a loss of connectivity within specific
brain modules, and a greater loss of connectivity between modules de Haan et al.
[2012b]. It is also possible to identify functional networks in the brain using
temporal information.
An alternative to community detection is to consider the brain as a series of
spatially overlapping temporally derived functional covariance networks. Each
functional covariance network consists of co-varying, widespread neuronal popu-
lations, so that the connection of a brain region and a temporal network is termed
functional covariance. The timeseries of each network can be measured as fluctu-
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ations in brain activity. However, the timeseries of functional covariance networks
are mixed together in the signal obtained using functional Magnetic Resonance
Imaging (MRI). The challenge of identifying time signatures mixed together is
analogous to the cocktail party problem, where multiple conversations are ongoing
concurrently and the task of a guest is to tune in to a single conversation.
The solution to this problem is to separate the Functional Magnetic Reso-
nance Imaging (fMRI) signal using timeseries properties such as frequency and
phase, rather than parcellating the signal spatially as used in functional connec-
tivity approaches such as graph theory. One method to perform this analysis
is Independent Component Analysis (Independent Component Analysis (ICA)),
outlined in chapter 3. ICA has been used to demonstrate that a series of distinct
functional covariance networks can be identified using task-free fMRI Damoiseaux
et al. [2006].
Functional covariance networks reflect the patterns of activation found us-
ing task-related studies Smith et al. [2009], allowing functions to be ascribed to
each network. A common set of functional covariance networks are seen across
different subject populations using a variety of brain imaging techniques includ-
ing functional MRI Beckmann et al. [2005]; van de Ven et al. [2004], Electroen-
cephalography Chen et al. [2008] and Magnetoencephalography Brookes et al.
[2011].
The first recognised and most widely studied of the functional covariance net-
works is the default mode network Raichle et al. [2001]. Although the default
mode network was first identified because it is more active during rest and ‘de-
activates’ during a wide range of tasks Shulman et al. [1997], it has since been
associated with tasks of memory Sestieri et al. [2011]; Takeuchi et al. [2011] and
introspection Fransson [2005]. Furthermore, the default mode network appears to
have distinct physiological features. Firstly, it is selectively modulated by neuro-
transmitters including activation by glutamate, and deactivation by GABA and
dopamine Nagano-Saito et al. [2009]. Secondly, the default mode network has a
relatively high level of aerobic glycolysis Vaishnavi et al. [2010]
Connectivity of the default mode network has been studied in neurodegener-
ative disease, most notably in Alzheimer’s disease where findings are of deactiva-
tion Rombouts et al. [2005] and decreased covariance Gili et al. [2010]; Greicius
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et al. [2004]; Koch et al. [2012]. The default mode network in PD is reported to
show decreased covariance in the medial temporal lobe Tessitore et al. [2012], and
a single study in PSP, found decreased covariance in the thalamus and medial
frontal lobes of the default mode network Whitwell et al. [2011].
A second widely studied functional network is the salience network that has
increased connectivity across a range of cognitive tasks Downar et al. [2002];
Gitelman et al. [1999]. Disruption of the salience network has been reported in
Alzheimer’s disease and Frontotemporal dementia (FTD) using a correlational
functional connectivity approach Zhou et al. [2010]; Alzheimer’s disease caused
increased connectivity of the salience network, whereas FTD had decreased con-
nectivity.
Other networks may be important in explaining clinical symptoms and syn-
dromes. Therefore I investigated networks associated with functions known to be
impaired in PD, PSP and CBS:
• basal ganglia network, since all three diseases cause impaired motor func-
tion and parkinsonism and in PSP areas of both increased and decreased
covariance Whitwell et al. [2011],
• left and right executive control networks, since all three diseases are asso-
ciated with impaired executive function.
In this chapter I start by assessing the community structure of functional
brain networks in PD, PSP and CBS using a community detection algorithm and
graph metrics. To assess connectivity between networks, I then use correlational
analysis to assess the connectivity between defined functional networks of the
basal ganglia, ventral and dorsal default mode, anterior and posterior salience,
and the right and left executive control networks. I go on to examine these
functional covariance networks in more detail using ICA to measure functional
covariance, in particular examining the patterns of covariance within and beyond
network boundaries.
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7.1 Methods
This chapter includes task-free functional MRI imaging from subjects in the con-
trol (n=53), PD (n=28), PSP (n=41) and CBS (n=27) groups. Acquisition, pre-
processing, association matrix and graph construction are described in the meth-
ods chapter 3. In brief, all subjects underwent task-free fMRI imaging (Repetition
Time (TR) 2 sec, 3x3x3.75mm voxels). Following preprocessing, association ma-
trices were constructed using wavelet correlation. Graphs were constructed using
a 500 node grey matter parcellation.
All graph metrics were obtained using the Maybrain package (see chapter 4).
Definitions for the within module degree, participation coefficient, modularity
and number of modules are outlined in chapter 3.
To assess the correlation between functional covariance networks, a set of
independently generated network templates were obtained from the FIND lab
(http://findlab.stanford.edu/research.html) (with thanks to Prof Michael Gre-
icius and William Shirer). To label each functional covariance network, I have
adopted the naming convention of the FIND lab. One anomaly in the labelling
of the functional covariance networks is that the dorsal default mode network has
predominantly anterior (anterior cingulate and frontal lobe) components, whereas
the ventral default mode network consists of primarily posterior (precuneus and
parietal lobe) regions. These templates were generated from a cohort of 27 young
healthy subjects using a high-dimensional group-wise ICA Shirer et al. [2011].
To generate a pair-wise correlation between two networks in a single subject,
the subject’s task-free fMRI image was masked by the relevant network templates
to obtain a mean timeseries for each network. A correlation value between the
two timeseries used the Pearson correlation coefficient.
Functional covariance values for each functional covariance network were mea-
sured by ICA using the FSL melodic tool (FSL version 5.0.0), and group com-
parison using permutation testing with a dual regression approach, outlined in
chapter 3. In order to perform ICA, the number of volumes for each subject must
be identical, therefore the first 145 volumes were used in this analysis (140 after
discarding the first 10s of scanning time).
A discussion of the challenge of multiple comparisons between non-independent
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graph measures can be found in the methods section of chapter 6. Following this,
the p-values displayed in this chapter are uncorrected.
7.2 Community measures
To assess the impact of functional connectivity loss on the community structure
of functional networks in PD, PSP and CBS, graph measures were derived from
a community detection algorithm, shown in figures 7.2 and 7.3. Between group
comparisons in table 7.1 indicate a decreased within module degree in PD and
PSP. However, the distribution of node-wise reduction shown in figure 7.1 is
similar to the reduction in node-wise connection strength, suggesting that the
decrease in within module degree in hubs may reflect the loss of hub connection
strength rather than being a property of specific modules.
The CBS group had an increase in modularity. Given the covariance of mod-
ularity with small world measures demonstrated in chapter 5 (figure 5.2), this
decrease may reflect an increase in path length, ie a decrease in topological effi-
ciency.
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Figure 7.2: The group comparisons between global community derived graph met-
rics. The hub within module degree differed significantly between the control group
and the PD (p=0.0047) and PSP groups (p=0.039), reflecting the pattern of difference
in global connection strength. In addition, the modularity was greater in the CBS
group compared to the control group suggesting a reduction in the functional connec-
tivity between communities of brain regions in CBS subjects. There was a significant
difference in the number of modules obtained in a weighted graph between the PSP
and CBS groups (p=0.048). The x-axis indicates the equidense local threshold applied
to the association matrices to generate a graph. The y-axis shows the measure in each
group. All graph metrics were assessed in thresholded and weighted graph, indicated
by Wt.
Figure 7.3: The group comparisons between hub community derived graph metrics.
There were no significant differences between groups. The x-axis indicates the equidense
local threshold applied to the association matrices to generate a graph. The y-axis
shows the measure in each group. All graph metrics were assessed in thresholded and
weighted graph, indicated by Wt.
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To investigate the changes within specific modules or sub-networks of the
functional brain, a more direct measure of brain networks is required. The next
sections examine correlation between defined functional covariance networks and
changes in covariance within and outside these networks.
7.3 Between network connectivity
To determine the effect of PD, PSP and CBS on the interaction between func-
tional networks, correlations between the mean timeseries of each network were
measured in each individual. Of note, the timeseries used here were derived from
the preprocessed fMRI data masked by a network template before ICA analysis,
since ICA imposes a maximal independence between timeseries and therefore any
correlation between network regions might be lost. Comparing timeseries in this
way makes an assumption that the only data within a region masked by a net-
work template are the timeseries of the masked network and the timeseries of the
comparison network.
The correlation scores from PD, PSP and CBS were compared with the cor-
relation scores of the control group using t-tests, shown in figure 7.4. The basal
ganglia network was decreased in connectivity with the ventral default mode
network in all diseases (PD p=0.015, PSP p=0.028, CBS p=0.004, uncorrected
p-values), and in PSP and CBS additionally with the anterior salience network
(PSP p=0.0047, CBS p=0.0021) and posterior salience network (PSP p=0.05,
CBS p=0.004). These findings suggest the loss of long distance connections ob-
served in chapter 6 result in a loss of functional connectivity between the basal
ganglia and selected other functional covariance networks.
The anterior salience network had reduced connectivity with the posterior
salience network in all three diseases (PD p=0.026, PSP p=0.043, CBS p=0.011).
In contrast the anterior salience network had increased connectivity with the right
executive control network in PSP and CBS (PSP p=0.0021, CBS p=0.028) and
with the left executive control network in PSP (p=0.0097). This suggests a loss of
long distance anterior-posterior connectivity between components of the salience
networks, whilst the anterior salience network increased its connectivity with the
adjacent regions of the executive control networks.
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Figure 7.4: Between network correlations generated by masking individuals’ scans by
network templates to extract the spatial network associated timeseries. The anterior
salience and basal ganglia networks show significant changes in between network cor-
relation values in PD, PSP and CBS compared to the control group. The correlation
coefficient is reported for each comparison, with significance values indicated by the
shading of each square. Corrected p values used the FDR method. dDMN=dorsal de-
fault mode, vDMN=ventral default mode, antSal=anterior salience, postSal=posterior
salience, LEC=left executive control, REC=right executive control, BG=basal ganglia.
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7.4 Functional covariance
To investigate the reorganisation of these networks in more detail, I assessed
changes in functional covariance using ICA and dual regression in the basal gan-
glia network, the anterior and posterior salience networks, the dorsal and anterior
default mode networks and the left and right executive control networks. Al-
though a group difference in functional covariance may be significant, the effect
size may be small leading to type I error. Therefore, the parameter estimates
obtained from the ICA were plotted and used to measure receiver-operator curve
characteristics. In order to compare the extent of change in functional covariance
within each network and beyond the network boundaries, schematic represen-
tations of functional covariance changes are shown in Figure 7.9. The regions
differing in functional covariance are reported in tables 7.2, 7.3 and 7.4.
The basal ganglia had a loss of functional covariance within the caudate head
in all three groups, and more focal regions in the superior parietal and medial
frontal lobes in PD, and with the supplementary motor and pre-supplementary
motor areas in CBS (figure 7.5). These findings are in keeping with a loss of
connectivity between the basal ganglia and other functional networks. PD, PSP
and CBS all caused an additional reduction of functional covariance within the
basal ganglia network which is in keeping with the presence of basal ganglia
neuropathology.
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The anterior salience network had decreased functional covariance in distinct
regions of all three diseases, the right inferior frontal gyrus in PD, bilateral pos-
terior insula cortex in PSP and the right supramarginal gyrus in the CBS group
(figure 7.6). Regions of decreased covariance were almost exclusively within the
boundaries of the anterior salience network , whereas areas of increased covariance
extended beyond network boundaries. The loss of integrity of network borders
may explain the increased covariance observed with executive control networks
in PSP and CBS. The contrast of increased and decreased network covariance
suggests two processes within the anterior salience network
• loss of functional covariance in crucial regions of the network,
• a loss of integrity at the borders of the network.
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There were differing pattern of change in the dorsal default mode network
in PD and PSP in comparison to CBS (figure 7.7). Widespread increases in
functional covariance of the dorsal default mode network were seen in PD and
PSP, centred around the default mode network but with large regions extending
outward beyond network boundaries. Similar to the anterior salience network,
this suggests a loss of integrity at the boundaries of the dorsal default mode net-
work. In contrast, the CBS group had a marked decrease in covariance within the
dorsal default mode network, but an increased covariance in the ventral default
mode network. These findings imply that both anterior and posterior parts of the
default mode network are affected in PSP and PD, whereas the more posterior
regions of the default mode network are affected in CBS, since the ventral default
mode network contains more regions of the precuneus and parietal lobe.
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The CBS group had the most marked changes in the executive networks, with
increased covariance of both the right and left executive control networks (figure
7.8). A similar, but weaker, pattern was seen in the PSP and PD groups.
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Table 7.2: Between group differences in covariance for the Control vs Parkinson’s
disease comparison using ICA and dual regression. Results were corrected for multi-
ple comparisons at the whole brain level using Threshold Free Cluster Enhancement
(Threshold Free Cluster Enhancement (TFCE)), p<0.05. Only clusters of greater than
10 voxels are reported. Shaded results indicate where the control group showed in-
creased covariance.
Size COG Localisation
(vox) (mm)
Basal Ganglia
Control>PD
723 -15.3, 0.568, 25 Left superior caudate nucleus
298 16.7, -31.3, 62.6 Right pre- and post-central gyri
246 15.6, 15.4, 18.5 Right superior caudate nucleus
239 -36.5, -67.3, 4.71 Left deep occipital cortex
99 -27.4, -56.9, 33.4 Left precuneus
64 16.8, -50.2, 61.5 Right superior parietal lobule
44 11.3, 46.8, 1.18 Border zone between right superior frontal
gyrus and anterior cingulate cortex
44 -2.32, 1.55, -29.9 Pituitary gland
27 -2.07, 23.2, 7.04 Anterior corpus collosum
PD>Control
385 4.47, 10, -3.56 Inferior head of both caudates, extending to
right putamen
341 -34.5, 9.74, -4.56 Left insula cortex
182 31.7, -41.4, 15.9 White matter adjacent to right lateral ven-
tricle
67 20.4, -78.4, 42.4 Right superior parietal lobule
Dorsal Default Mode
PD>Control
55543 -0.702, -20.8, 12.8 Posterior cingulate cortex extending to right
angular gyrus and occipital cortices, in con-
tinuity with a region extending down the left
motor cortex and frontal regions
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184 27.6, -49.6, 60.3 Right superior parietal lobe
22 37.1, 8.18, 21.9 Right inferior opercular frontal gyrus
17 -35.9, 59.8, 12.1 Right anterior frontal gyrus
Ventral Default Mode
Control>PD
11 -33.3, -29.5, 48.7 Left primary motor cortex
PD>Control
1958 -7.39, -53.9, 49.7 Midline posterior cingulate cortex extending
to precuneus
1443 32.6, -51.8, 56.2 Right angular gyrus, extending to superior
parietal lobule
37 41.7, -63.8, 15 Right deep middle temporal gyrus
35 -6.06, -41, 75.7 Left superior post-central gyrus
Anterior Salience
Control>PD
111 40.1, 25.9, -11.1 Right inferior frontal gyrus
PD>Control
218 -48.7, 10, -27 Left anterior middle temporal gyrus
164 22.3, 8.78, -32.4 Right periamygdaloid and entorhinal cortex
129 -36.9, 34.4, -4.83 Left inferior frontal gyrus
92 4.25, -93.1, 12.7 Midline primary visual cortex
35 -9.88, 16.2, 31.8 Left dorsal anterior cingulate cortex
16 10.1, 1.12, 34.7 Right dorsal anterior cingulate cortex
Posterior Salience
Control>PD
130 44.4, -63.7, 49.9 Right angular gyrus
15 -30.1, -63.1, 35.1 Left inferior parietal lobule
PD>Control
4062 48.9, -52.9, 17.7 Right posterior superior temporal and mid-
dle temporal gyri extending to angular gyrus
1157 -5.36, -35.2, 42.8 Left precuneus and superior posterior cingu-
late gyrus
528 -54.5, -70.9, 12.3 Left occipital cortex
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468 -39.6, -47.1, 14.8 Left deep angular gyrus
404 18.5, -78.3, 32.3 Right primary visual cortex
344 28.5, 38.6, 32.3 Right middle frontal gyrus
271 48.5, -1.96, 41 Right primary motor cortex
136 -62.1, -33.4, 32.4 Left supramarginal gyrus
106 -7.92, 11.5, 30.8 Left dorsolateral prefrontal cortex
35 6.69, 18.6, 25.8 Right dorsolateral prefrontal cortex
28 -13.2, -80.9, 25.7 Left primary visual cortex
18 19, 16.9, 60.1 Right superior frontal gyrus
14 1, 31.4, 19.1 Midline anterior cingulate cortex
Left Executive Control
Control>PD
294 21.2, -56, 22.7 Right precuneus
120 -38.3, -27.7, 48.7 Right posterior insula
78 18.1, -77.5, 49.5 Left motor cortex - hand knob
26 38.2, -16.1, 2.15 Right posterior precuneus
PD>Control
9146 -49.4, -25, -3.03 Left inferior and middle temporal gyri
1972 -5, -60.8, 27.6 Posterior cingulate, extending to superior
parietal lobules bilaterally
1036 -17.3, 33.9, 6.41 Left superior anterior caudate, extending to
anterior left left middle frontal gyrus
198 16.2, 36.5, 49.5 Right anterior lateral superior frontal gyrus
189 46.7, -30.9, -3.58 Right superior posterior middle temporal
gyrus
172 45.2, 4.1, 43.4 Right posterior middle frontal gyrus
156 -50.7, 29.2, 23 Left superior inferior frontal gyrus
146 13.2, -78.2, -33.9 Right inferior semilunar lobule of cerebellum
140 11.8, 59.6, 6.83 Right superior frontal gyrus
72 12.8, -38.7, 56.8 Right superior frontal gyrus
53 -36.1, 15.2, 49.6 Right post-central gyrus
Right Executive Control
Control>PD
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404 -7.42, 9.31, 39.9 Left dorsal anterior cingulate cortex
145 2.77, -29.5, 48 Border zone between cingulate and superior
frontal gyri
107 51.3, -42.7, -20.9 Right inferior temporal gyrus
96 -14.5, -85.1, 40.9 Posterior left precuneus
89 -21.4, -68.2, 24.8 Left occipital cortex
47 8.85, 0.122, 38.5 Right dorsal anterior cingulate cortex
42 58.6, -30.1, 34.7 Right supramarginal gyrus
21 16.5, -2.95, 69.6 Dorsal tip of superior frontal gyrus
15 -17.9, -59.7, 7.2 Left cingulate cortex
PD>Control
2514 30.3, -60.5, 40.5 Right superior parietal lobule
102 34.3, 5.86, 60.3 Right dorsal tip of middle frontal gyrus
83 12.7, 39.6, 11.8 Right anterior cingulate cortex
23 -29.1, -33.7, 60.7 Left post-central gyrus
23 13.8, 39.5, -25 Right oribitofrontal cortex
19 13.8, -43.6, 29.7 Right posterior cingulate cortex
14 -22.9, -71.1, -30.9 Biventral lobe cerebellum
Table 7.3: Between group differences in covariance for the Control vs PSP comparison
using ICA and dual regression. Results were corrected for multiple comparisons at the
whole brain level using Threshold Free Cluster Enhancement (TFCE), p<0.05. Only
clusters of greater than 10 voxels are reported. Shaded results indicate where the
control group showed increased covariance.
Size COG Localisation
(vox) (mm)
Basal Ganglia
Control>PSP
529 15.1, 15.8, 17.2 Right superior caudate
347 -17.1, 8.37, 23 Left superior caudate
PSP>Control
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387 -19.6, -20.2, 9.1 Left lateral thalamus
100 30.2, 40.6, 23 Right middle frontal gyrus
67 -6.06, 26.4, 16.4 Left anterior cingulate cortex
64 -35.8, 26.3, 49.6 Anterior left middle frontal cortex
32 -16.9, 42.1, 51.6 Superior anterior surface of right superior
frontal gyrus
25 -0.0805, 9.92, 25.1 Dorsal anterior cingulate cortex
Dorsal Default Mode
PSP>Control
69133 -0.333, -20.2, 11.6 Widespread, incorporating all areas of the
default mode network
Ventral Default Mode
Control>PSP
1479 6.52, -67.2, 51.3 Midline precuneus, extending to right occip-
ital lobe
463 8.65, -34.9, 58.1 Midline/bilateral post-central gyri
164 -44.2, -67.7, 32.4 Left superior parietal lobe
32 -3, -28.9, 32.6 Left posterior cingulate cortex
PSP>Control
1034 -1.16, -54.6, 42.8 Superior part of posterior cingulate cortex
246 -2.91, -92.1, 13.6 Midline primary visual cortex
189 2.43, -22.6, 72.6 Midline primary motor cortex
131 -15, -78, 33.8 Left occipital lobe
115 -33.3, -77.4, -24.1 Left declive of cerebellum
22 -16, -100, 17.2 Left occipital cortex
Anterior Salience
Control>PSP
689 43.3, 8.76, -6.6 Right insula cortex
67 -38.1, -6.37, 2.27 Left insula cortex
PSP>Control
720 5.19, 33.8, 4.85 Midline anterior cingulate
356 -55, -23.9, 40.2 Left post-central gyrus
190 -9.64, 13.7, 31.5 Left dorsal anterior cingulate cortex
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89 10.4, 4, 35.1 Right dorsal anterior cingulate cortex
45 15.3, -14.7, 33.8 Midline anterior cingulate cortex
37 -53, -77, 0.86 Left surface of occipital cortex
26 5.85, -11, -15.5 Right cerebral peduncle
Posterior Salience
PSP>Control
1816 47.3, -33.6, 22.2 Left post-central gyrus
191 -8.06, -4.71, 35.8 Left mid-cingulate cortex
154 54.8, -71.3, 5.33 Right lateral occipital cortex
Left Executive Control
Control>PSP
174 14.2, -50.7, 12 Right posterior cingulate cortex
94 5.91, 6.95, 36.7 Right dorsal anterior cingulate cortex
12 -44.3, 21.7, 49.2 Left middle frontal gyrus
PSP>Control
579 -37.8, 4.19, 35.3 Left deep middle frontal gyrus
354 -44.2, -42.2, 3.79 Left middle temporal gyrus
128 -54.7, -71, 14.6 Left angular and supramarginal gyri
117 -36.7, 28.6, 17.4 Left middle temporal gyrus
66 42.4, -87.5, -9.66 Surface of right occipital lobe
65 -58.3, -64, -9.45 Posterior tip of left temporal gyrus
60 55.2, -64.8, -16.4 Posterior tip of right inferior temporal gyrus
Right Executive Control
Control>PSP
477 -35.8, -13.7, 54.5 Left primary motor cortex
413 50.6, 27.9, 30.3 Right middle frontal cortex
378 -24.2, -70, 26 Left occipital cortex
146 -49.3, -57.2, 52.6 Left surface of angular gyrus
PSP>Control
1708 28.5, 12.2, 49.9 Right middle frontal gyrus, supplementary
motor area extending to pre-supplementary
motor area
701 19, 52.5, 4.74 Right anterior cingulate cortex
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235 -60.2, -35.6, 20.7 Right parietal opercular, planum temporale
and superior temporal gyri
160 25.4, -87.7, 19.6 Right occipital cortex
140 -14.4, -19.7, 16.3 Left thalmus, reaching tail of left caudate
122 6.05, -79.5, 40.8 Border zone between right occipital and pre-
cuneal cortices
60 18.1, 45.1, 35.5 Border zone between right middle and frontal
gyri
49 30.2, -56.5, 57.8 Right angular gyrus
20 6, -20.6, 37 Right anterior part of posterior cingulate cor-
tex
12 35, -54.8, 43.5 Right angular gyrus
Table 7.4: Between group differences in covariance for the Control vs CBS comparison
using ICA and dual regression. Results were corrected for multiple comparisons at the
whole brain level using Threshold Free Cluster Enhancement (TFCE), p<0.05. Only
clusters of greater than 10 voxels are reported. Shaded results indicate where the
control group showed increased covariance.
Size COG Localisation
(vox) (mm)
Basal Ganglia
Control>CBS
3509 9.92, 4.25, 57.7 Right superior frontal gyrus extending to
middle frontal gyrus
2068 19.5, 19.9, -1.55 Right superior anterior caudate
1168 -13.5, -0.303, 20.3 Left superior anterior caudate
953 -1.45, -42.1, -11.8 Brainstem at level of the 4th ventricle
591 -39.5, 43.2, -3.38 Orbital and triangular parts of left inferior
frontal gyrus
375 43.6, -77.8, 7.98 Right lateral occipital cortex
224 39.4, -23.8, -22.1 Right fusiform gyrus
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161 -7.51, 47.4, 6.28 Left anterior cingulate cortex
122 55.7, 9.49, -14.8 Anterior right middle and superior temporal
gyri
97 -38.9, 14.9, 6.63 Left insula cortex
71 5.19, -65.1, 54 Right precuneus
35 23.4, 12.5, -5.71 Right putamen
16 -5.62, -67.2, -1.75 Left occipital (lingual) cortex
15 -39.5, -64.3, 3.87 Left occipital cortex
CBS>Control
24 -10.7, 15.1, 35.9 Dorsal anterior cingulate cortex
Dorsal Default Mode
Control>CBS
3350 11.3, -50.6, 5.09 Posterior cingulate cortex
2357 18.9, 9.25, 19 Right caudate extending to dorsal anterior
cingulate cortex
1047 -22.8, -8.41, 56.8 Left supplementary motor cortex
619 35.4, 19.1, -12.5 Right insula cortex
378 19.9, -8.81, 59.5 Right supplementary motor cortex
326 27.9, -24.8, -21.6 Right fusiform gyrus
144 -20.7, -62.6, 41.1 Left superior parietal lobule
110 -24.1, 47.3, 8.24 Deep left superior frontal gyrus
98 41.8, -56.4, 48.3 Right angular gyrus
92 2.57, 27.6, 56.1 Left superior frontal gyrus
87 -31.5, 24.9, 22.8 Deep left middle frontal gyrus
53 -22.4, -79.2, 31.4 Left occipital cortex
CBS>Control
455 -5.82, -44.9, 30 Posterior cingulate cortex
111 16, 49.3, 35.1 Right superior frontal gyrus
69 3.23, 26.5, 11.8 Midline anterior cingulate cortex
64 -37.4, 11.3, 54.2 Left middle frontal gyrus
32 11.7, 39.7, 15.6 Right anterior cingulate cortex
Ventral Default Mode
Control>CBS
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299 -32.4, 7.21, 63.5 Left middle frontal gyrus
179 0.538, -61.3, 66 Midline superior precuneus
CBS>Control
24884 -11.9, -27.6, 23 Precuneus
4422 39.6, -37.4, 25.5 Right angular gyrus extending to occipital
cortex and precuneus
1063 -50.6, 13.1, 14.1 Left superior part of inferior frontal gyrus
330 52.5, 12.3, 31.6 Right superior part of inferior frontal gyrus
181 -22.4, 30.5, -10.7 Left orbitofrontal cortex
123 45.7, -67.3, -16.9 Right lateral occipital cortex
120 -63.6, -14.8, 15.6 Left superior temporal gyrus
64 -17.2, -26.6, -28.8 Left lateral brainstem/cerebellar peduncle
46 -8.7, -77.9, 9.52 Left primary visual cortex
29 -35, 28.4, 26.9 Deep left middle frontal gyrus
19 10.8, -40.7, -24.6 Right anterior cerebellum
15 -38.7, 37.3, -16.8 Left oribitofrontal cortex
Anterior Salience
Control>CBS
111 68.5, -35.4, 22.5 Surface of right supramarginal gyrus
19 62.9, -15.9, 19.9 Right post-central gyrus
CBS>Control
10899 26.4, -50.3, 12.2 Right parietal lobe, extending to angular
gyrus and right occipital lobe
4537 1.79, -0.57, 45.4 Left dorsal anterior cingulate cortex
1905 -47.6, -58.7, 7.4 Surface of left lateral occipital cortex
409 -24.1, -21.9, -0.541 Lateral aspect of left thalamus, extending
across the lateral geniculate body reaching
edge of left hippocampus
319 -49.1, -25.3, -28.8 Left inferior temporal gyrus
283 -46.6, -2.19, -3.46 Left insula cortex
254 59.7, -35.4, -21.8 Right posterior part of inferior temporal
gyrus
148 43.2, -2.53, 2.61 Right insula cortex
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137 29.6, 36.5, 22.9 Deep right middle frontal gyrus
105 -45.9, 22.4, 23.4 Opecular part of left inferior frontal gyrus
93 3.18, -58.8, -38.4 Midline inferior cerebellum
91 -13.4, -11.3, -16.8 Left amygdala and medial edge of hippocam-
pus
56 -50.4, -10.8, 45.7 Left primary motor cortex
53 17.5, 61.9, 15.5 Right superior frontal gyrus/frontal pole
48 13.6, 64.9, -6.37 Right frontal pole
37 -14.8, 55.6, -13 Left frontal pole
13 -2.77, 25.8, 50.9 Medial superior frontal gyrus
Posterior Salience
Control>CBS
19 62.9, -15.9, 19.9 Left posterior tip of inferior temporal gyrus
Left Executive Control
CBS>Control
38958 -3.59, -17.4, 18.2 Left frontal lobe extending to left insula, left
putamen and left inferior temporal gyrus
3921 29.3, 45.3, 14.3 Right frontal lobe
322 -38.7, -69.2, -31.8 Left declive of cerebellum
150 1.16, -8.77, -37.1 Outside brain in front of brainstem
45 31.2, -20.4, 58 Right primary motor cortex
24 61.9, -19.2, 35.8 Right post-central cortex
Right Executive Control
Control>CBS
52 25.9, -65.7, 23.5 Right precuneus at border with occipital cor-
tex
CBS>Control
14368 24.7, -10.2, 26.2 Right parietal cortex
5931 -30.1, -10.1, 22.2 Right anterior cingulate cortex
3128 14.4, -74.6, -18.6 Right inferior semilunar lobule of cerebellum
2449 -53.5, -38.3, -22.4 Left inferior temporal gyrus
1068 -14.4, -61.3, -2.74 Left primary visual cortex
300 4.64, 43.7, 47.3 Right superior frontal gyrus
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206 -21.8, 30.7, 48.9 Left superior frontal gyrus
175 -44.4, -80.3, 23 Left lateral occipital cortex
162 -17.4, -27.4, 69.3 Left post-central gyrus
90 51.4, -14.4, -30.2 Right inferior temporal gyrus
72 42.3, -69.8, -48.5 Right lateral aspect of inferior semilunar lob-
ule of cerebellum
47 1.53, 24.3, 42.6 Midline paracingulate cortex
18 33.2, -55.7, -18.7 Right fusiform gyrus
11 -15.8, 45.1, 5.09 Left paracingulate cortex
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Figure 7.9: The comparison between the control group and PD, PSP and CBS groups
in covariance are shown schematically to represent changes inside networks and beyond
network boundaries. The PD and PSP group tended to have a decrease of covariance
within the networks, particularly in the basal ganglia network. In contrast the CBS
showed greater loss of covariance beyond network boundaries, particularly the dorsal
default mode network. The radius of each plot is fixed, so that the whole area of each
plot represents the total area of regions differing in functional covariance between the
control group and each disease group. The area of each wedge represents the proportion
of the difference that lies with a specific network, with the radius of each wedge divided
to demonstrate the proportion of change within the network (red) and outside the
network (blue).
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7.5 Covariance analysis and clinical scores
In order to assess the clinical relevance of the observed changes in functional
covariance networks, clinical scores were correlated with network functional co-
variance within each group for PD, PSP and CBS. This was achieved by repeating
a group ICA with only subjects from each disease group and modifying the sec-
ond part of the dual regression process to be a one-sample t-test, adding clinical
scores as a covariate. Therefore, it should be noted that the covariance networks
generated from the group ICAs are not identical to those reported above, partly
because control subjects were not included, and partly because clinical data was
not available for all subjects.
Clinical scores correlating with covariance changes in the PSP group are shown
in figure 7.10 and in table 7.5. The most striking correlations were seen for motor
severity measured using the Unified Parkinson’s Disease Rating Scale (UPDRS
III), where increased covariance in the anterior salience, ventral default mode and
left executive control networks correlated with increased severity. Of particular
interest in the anterior salience network, worse motor function was associated with
increased covariance of the pre-supplementary motor area and supplementary
motor area, and in the right executive control network worse motor function
was associated with an increased covariance in the right putamen, as well as the
superior temporal gyrus. These findings imply that increased covariance within
specific networks are associated with worse motor function in PSP.
Corresponding results showing for the CBS group are shown in 7.11 and 7.6.
In CBS worse motor function measured by the UPDRS III was specifically asso-
ciated with increased thalamic covariance to the basal ganglia network. In con-
trast, symptom duration was associated with increased covariance in widespread
regions of the dorsal default mode network, but also the anterior salience and
right executive control networks. Symptom duration was also associated with a
small region of decreased covariance of the right superior temporal gyrus with the
right executive control network. These observations imply that whilst the motor
function in CBS may be associated with focal network changes, the progression
of disease is associated with more widespread covariance changes in the default
mode and other networks.
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The increased correlation between the symptom duration and dorsal default
mode is surprising given the decreased covariance observed in the group-wise
comparison with control subjects. This may related to different labelling of the
default mode network between the two analyses, and therefore the component of
the default mode network that correlates with symptom duration is analogous
to the ventral default mode network from the group comparison where increased
covariance was observed.
No correlations were seen between network covariance and clinical scores in
the PD group.
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Figure 7.10: Correlations of ICA components generated in the PSP group alone with
using a one sample t-test with clinical scores as a covariate. Only significant correlations
(TFCE corrected p<0.05) are shown here.
Figure 7.11: Correlations with clinical scores in the PSP group generated by per-
forming a one sample t-test and adding clinical scores as a covariate. Only significant
correlations (TFCE corrected p<0.05) are shown here.
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7.6 Discussion
This chapter addresses whether changes in functional connectivity in PD, PSP
and CBS are reflected in the communication between groups of co-varying brain
regions.
The first approach I applied was to assess groups of nodes that are strongly
interconnected using a graph analytic community detection algorithm. This ap-
proach has been used to identify communities within social, transport and bio-
logical networks Blondel et al. [2008]; Girvan and Newman [2002], and within the
functional brain network in healthy individuals Power et al. [2013].
A brain region’s within module degree is a measure of the connectivity strength
of the brain region to other regions within the community as a proportion of the
total possible connections for that brain region within the community. The loca-
tion of brain regions having reduced within module degree in the PD and PSP
groups mirrored the findings of global reduced degree found in chapter 6 figure
6.12. This result suggests that the highly connected regions in occipital and
parieto-occipital regions tend to lose connectivity with each other. However, it
is possible is that the loss of within module connectivity reflects a change in the
distribution of connectivities which can influence the community structure Karrer
and Newman [2011].
I observed an increase in modularity in the CBS group. Conceptually, mod-
ularity is considered to represent how readily a network can be decomposed in
to constituent communities. However, the results from chapter 5 suggest that
modularity is closely aligned to small world measures of efficiency. Therefore the
observed changes in CBS may reflect a change in efficiency rather than community
properties.
The community measures I used in this chapter are derived from a community
partition, rather than directly measuring individual communities. To investigate
individual communities in more detail in order to better understand the interpre-
tation of the within module degree and the modularity, I would need to address
the challenge of identifying corresponding communities between subjects. This
could in principle be achieved using methods such as the multi-resolution spin
glass model Alexander-Bloch et al. [2010] or by comparing the results with those
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from other community detection algorithms. The community detection algorithm
I applied in this study is a commonly used method called the Newman algorithm
Newman [2006]. A recent development of this algorithm has suggested that it
could be improved by accounting for the broad degree distribution in functional
networks Karrer and Newman [2011]. Other methods have also been suggested
in brain networks including the Louvain Blondel et al. [2008] and Infomap Lan-
cichinetti et al. [2010] algorithms. The Louvain method is conceptually similar
to the Newman algorithm by assessing different community partitions in order to
optimise a measures of modularity. The Infomap algorithm uses a different ap-
proach by travelling along a random walk to build communities. These methods
have not been directly compared in neuroimaging data.
An alternative approach is to assess brain regions that covary together, for
which I turned to Independent Component Analysis (ICA) Calhoun et al. [2001];
Filippi et al. [2013]. The ICA approach is conceptually different to the graph the-
ory approach because a parcellation of the brain is achieved by extracting tempo-
ral information, rather than being imposed from a pre-defined template. In this
way, the value at each voxel relates a single voxel’s timeseries is to a distributed
network, rather than a pairwise connection between two regions. Considered in
a mathematical sense, ICA compresses the brain’s activity in to a finite series
of components. These components are related to real-world brain systems by a
comparison with known properties of the brain, for example using information
from task-fMRI studies Smith et al. [2009].
The analysis of co-varying brain regions with ICA has revealed a set of robust
functional covariance networks Damoiseaux et al. [2006]. I first assessed whether
connectivity between predefined networks was changed in PD, PSP and CBS. This
analysis implicated a loss of connectivity between the basal ganglia network and
other networks, and between the anterior salience network and other networks.
The loss of connectivity between networks was most marked in the PSP and CBS
groups. The loss of between network connectivity is consistent with the role of
hubs in coordinating between networks Power et al. [2013] and the observed loss
of hub properties in chapter 6 and in other neurodegenerative disease Buckner
et al. [2009]; Stam et al. [2009].
I also observed an increase in connectivity between the anterior salience net-
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work and executive control networks in the PSP and CBS groups. Increased con-
nectivity between networks has been observed in depression using a seed-based
approach Sheline et al. [2010] and was interpreted as representing a reduced abil-
ity to manage information flowing between networks. However, in my results the
increased between network connectivity was observed in networks that border
each other, specifically between the anterior salience and the left and right exec-
utive networks that border each other at the anterior part of the middle frontal
gyri bilaterally. This raises the possibility that shorter distance connections at
network boundaries are responsible for the observed increase in between network
connectivity.
To investigate this possibility and to explore the connectivity pattern within
functional covariance networks, I assessed between group differences in network
covariance patterns using a dual regression approach Filippi et al. [2013]. Dual re-
gression analysis starts with a group ICA analysis, thereby avoiding the challenge
of performing individual ICA where identifying corresponding networks between
groups is difficult and the degree of mathematical data compression performed
by ICA may differ between subjects. By performing a group ICA using subjects
from two groups, the final ICA components to be used as networks include vari-
ance from all subjects across both groups and therefore the subsequent group
comparison using dual regression ‘recaptures’ the contribution of each subject to
the networks identified.
In common between PD, PSP and CBS was a reduced covariance within the
basal ganglia and a decrease in connection strength to a wide range of other
functional covariance networks. The CBS group had the widest loss of covariance
with areas outside the basal ganglia network including the pre-supplementary
motor area and supplementary motor area, regions that atrophy in CBS Lee
et al. [2011] and are responsible for altered awareness of action control in this
syndrome Wolpe et al. [2014].
Whitwell et al 2011 suggested that thalamocortical connections explain the
loss of connectivity between the basal ganglia and cortex in PSP and the thala-
mus may contribute to imbalance in PSP Zwergal et al. [2011]. It is interesting
therefore that I found increased covariance in the thalamus of the basal ganglia
network (though only on the right side). The thalamus is an important nucleus
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receiving and sending connections across the cortex, striatum and other basal gan-
glia regions. If the thalamus were widely connected to other regions one might
expect its activity to reflect a mixture of cortical signals rather than other regions
of the basal ganglia. Therefore, an increase in thalamic covariance could reflect
reduced between network connectivity. In lay terms, the thalamus is ‘talking less’
with widespread cortical regions and ‘talking more’ to other regions in the basal
ganglia.
Thalamic connectivity may also play an important role in CBS, since motor
severity (UPDRS III) correlated with increased covariance of the thalamus to the
basal ganglia network.
In contrast, key regions of the salience network had decreased connectivity
in each disease. In PD the right inferior frontal gyrus had reduced covariance,
which is an area implicated in impaired motor control Swann et al. [2009]; Ye
et al. [2014]. The PSP group had reduced covariance of bilateral insular cortex,
which is atrophic in PSP in some studies Whitwell et al. [2011], but not others
Boxer et al. [2006]; Paviour et al. [2006]; Price et al. [2004]. The CBS group
had an area of reduced covariance in the lateral superior right parietal lobe,
which has a significant burden of neuropathology Dickson et al. [2002] and has
been shown to undergo atrophy in a voxel-based-morphometry study Boxer et al.
[2006]. Together, these findings suggest the anterior salience network plays an
important role in PD, PSP and CBS where the effect of pathology results in a
selected loss of covariance.
Other regions of the brain co-varied less with the anterior salience network, but
these regions were predominantly beyond the network boundaries. This pattern
was most marked in CBS where the thalamus, parietal lobe and superior frontal
gyrus all increased their covariance with the salience network. At first glance
this seems surprising, since the anterior salience network had the greatest loss
of between network connectivity in CBS. However, the regions with increased
covariance are not in the networks that had less connectivity in CBS with the
anterior salience network, namely the posterior salience network and basal ganglia
networks. Indeed, the anterior salience network had a significantly increased
between network connectivity with the right executive control network and non-
significant increased connectivity with the dorsal default mode and left executive
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control networks. These observations would be consistent with the hypothesis
that network boundaries become indistinct.
The correlation between motor severity (UPDRS III) and increased covari-
ance in the pre-supplementary motor area and supplementary motor area of the
anterior salience network in PSP imply that the observed changes in this net-
work are relevant to disease and contribute to the movement disorder of PSP.
The areas of the anterior salience network that co-varied with the UPDRS III are
located adjacent to regions of the anterior salience network template, similar to
the pattern of increased covariance seen in the group-wise comparison.
Zhou et al 2010 studied the salience network in Alzheimer’s disease and FTD,
finding increased covariance of the anterior salience network with the anterior
cingulate and left ventral striatum, whereas FTD subjects had decreased covari-
ance of the anterior salience network with areas in the insular cortex and mid-
cingulate. Taken together, these findings imply that the effect of neuropathology
on the anterior salience network is specific to particular syndromes. The question
remains open as to whether localisation and direction of covariance changes in
the anterior salience networks depend upon the underlying type of pathology or
the distribution of pathology.
There were distinct changes in the dorsal default mode network: PD and PSP
caused largely increased covariance; CBS caused decreased covariance. Because
the default mode network is usually deactivated during tasks Fox et al. [2005], it
has been suggested that failure to deactivate the default mode network is a sign of
neuropathology, for example in PD subjects who were less able to deactivate the
default mode network during a face emotion task Delaveau et al. [2010], during
task-fMRI in Alzheimer’s disease Greicius and Menon [2004] and those at risk of
Alzheimer’s disease Pihlajama¨ki and Sperling [2009]. To properly compare these
findings with those presented in this chapter, I would need to assess covariance
in the default mode network during task-fMRI which would be challenging in the
PSP and CBS cohorts.
The loss of covariance of the dorsal default mode network in CBS is consistent
with previous work in task-free fMRI of people with Alzheimer’s disease Greicius
et al. [2004]; Zhou et al. [2010]. Taken together with the pattern of change in
the anterior salience network, it could be speculated that network changes in the
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CBS group reflect underlying Alzheimer pathology in a proportion of subjects.
However, the dorsal default mode network had an increase in covariance with a
longer duration of disease. This could represent ambiguity of labelling the dorsal
and ventral default mode networks between the analyses of group-wise differences
with controls, and the single group analysis of correlation with clinical scores.
Alternatively, the difference may represent a non-linear effect of covariance in
the default mode network of CBS. It is possible that early in the disease the
dorsal default mode network loses widespread covariance, potentially caused by
synaptic and neuronal loss; later on in the disease the decrease of between network
connectivity may result in less modulation of the dorsal default mode by other
networks and a more covariant pattern might emerge, explaining the correlation
with symptom duration.
When interpreting these network changes, it is important to guard against the
possibility of a type I error in statistical analysis using effect sizes. A strength
of the ICA analysis in this chapter was the addition of effect size calculation
and ROC analysis. The differences in parameter estimates between groups were
consistently large, indicating meaningful group differences. This suggests that
a biomarker derived from functional covariance measures may have a diagnostic
role in PD, PSP and CBS. However, these large differences should be treated
with caution since the group differences generated using the dual regression ap-
proach depend on a group ICA of all subjects and the beta-values used to assess
effect size were extracted only from areas where there was a significant difference.
Therefore developing and applying a diagnostic classifier would require an inde-
pendent dataset to identify network components and regions of difference, and a
further cohort of patients and controls to assess diagnostic accuracy.
There are some limitations to the ICA approach I have used here. There
are thirteen networks described in the independently generate set of networks
that I have used defined by the FIND lab Shirer et al. [2011] and have selected
seven networks of interest related to parkinsonian disorders. However, other
networks may be relevant to the disease process, such as the sensorimotor or
visual processing networks. Furthermore, the network templates were defined in
young adults and may therefore not be optimal when applied to an older cohort.
ICA may have an advantage over correlation network analysis since noise from
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motion or cardiovascular effects should be partitioned in to components distinct
from neuronal signal Thomas et al. [2002]. However, despite the consistency of
task-free networks across studies, there is no easy way to assess the noise present
in a single component and therefore the influence of noise artefact is difficult to
quantify precisely. This is possible with multi-echo imaging where ICA can be
employed to find components and the noise in each component can be quantified
by its echo-time dependence Kundu et al. [2011].
This chapter and the previous chapter have described changes in functional
brain networks in PD, PSP and CBS, however they do not directly assess the
development of these changes over time or the underlying substrate of change in
network covariance.
Therefore, the next chapter will assess whether changes in genetic expression
of tau protein are related to functional connection strength and regions of reduced
connection strength.
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Chapter 8
Tau gene expression and
functional connectivity
Chapter 6 demonstrates that Parkinson’s disease (PD), Progressive Supranuclear
Palsy (PSP) and Corticobasal Syndrome (CBS) are associated with selective vul-
nerability of highly connected hub regions and long-distance connections within
distributed functional brain networks. In this chapter I investigate whether the
susceptibility of hubs may be linked to the expression of the tau gene MAPT.
Several neurodegenerative diseases have been associated with the hyperphos-
phorylation, misfolding and aggregation of the microtubule associated protein
tau, including PSP, Frontotemporal dementia (FTD) and Alzheimer's disease
Spillantini and Goedert [2013]. Genetic variation in the MAPT gene that en-
codes tau also increases the risk of PSP Baker et al. [1999], FTD Verpillat et al.
[2002], PD International Parkinson Disease Genomics Consortium [2011]; Martin
et al. [2001]; Satake et al. [2009] and cognitive decline in PD Goris et al. [2007];
Williams-Gray et al. [2009].
The link between tau and brain networks is suggested by the ability of mis-
folded and hyperphosphorylated tau species to provide a pathogenic template
for the propagation and spread of tau pathology. For example, in transgenic
murine models it has been shown tau can propagate via trans-synaptic spread
Ahmed et al. [2014]; de Calignon et al. [2012]; Liu et al. [2012] which promotes the
transformation of normally expressed tau to pathogenic species Clavaguera et al.
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[2013]. It follows that high levels of intrinsic expression of MAPT may enhance
this templating process since brain regions with a higher concentration of tau are
more likely to contain more abnormal tau, and thereby accelerate the pathogene-
sis attributable to tau, and propagation of the disorder through connected brain
networks.
Specifically, brain regions with a higher expression of tau in adulthood may
be more susceptible to loss of functional brain network connectivity in the hu-
man diseases that are associated with tau pathology such as PSP, or other neu-
ropathologies associated with MAPT such as PD.
To test the hypothesis that higher levels of tau are related to hub susceptibil-
ity, I examine the association between regional expression of MAPT in healthy
adults and go on to correlated microarray expression levels with loss of func-
tional connection strength in PD and PSP. CBS was not included in this chapter
because of its heterogeneous pathology.
8.1 Methods
This chapter includes task-free Functional Magnetic Resonance Imaging (fMRI)
imaging from subjects in the control, PD, PSP groups. Acquisition, prepro-
cessing, association matrix and graph construction are described in the methods
chapter 3. The principal measure of connectivity was the connection strength of
each region (the sum of connection weights to all other regions), derived from the
association matrix of covariance values.
For comparison with microarray data, a network was constructed using the
mean association matrix of each diagnostic group. The proportion of connectivity
loss between groups was calculated as the difference in degree for each node
normalised by the connectivity in the control group Achard et al. [2012].
For 284 of the 471 regions where data were available, I extracted the averaged
MAPT expression across from six subjects in the Allen cohort available from
the Allen Brain Institute (H0351.1009, H0351.1016, H0351.1015, H0351.2002,
H0351.1012, HF0351.2001), mean age 45.5 (range 24-57), all male, four right-
handed, one left-handed, one ambidextrous. Three subjects were Caucasian, two
African-American and one Hispanic.
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Four microarray probes for the MAPT gene are labelled in the Allen brain
atlas, taken from an Agilent 8x60K array, custom-designed by Beckman Coulter
Genomics. MAPT has 17 exons and is alternately spliced in to 6 isoforms, with
two main groups differentiated by three or four repeats of the binding domain as a
result of alternate splicing of exon 10. All four probes used in the Allen Brain At-
las identified both three and four repeat tau species. The specificity of each probe
was reassessed using nucleotide BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi)
to identify genes and translated nucleotide sequences associated with each probe's
sequence. Three of the four probes met our criteria: 100% homology with an
area within the MAPT gene and associated transcripts and no other regions of
homology, with very small E values to suggest good sensitivity. Three probes
matched regions in the MAPT gene, A 23 P207699 and A 24 P224488 homolo-
gous with the gene sequence to target complementary DNA and A 32 P143793
with the anti-sense sequence targeting complementary Ribonucleic Acid (RNA).
All probes recognized tau with both three and four repeats. The fourth probe
(CUST 449 PL1416408490) showed only 88% homology with MAPT and 80% ho-
mology with a region on chromosome 18, therefore we discarded this probe. Fur-
ther detail on microarray analysis is available from the Allen Institute (www.brain-
map.org). Two subjects had microarray data from both hemispheres totalling
1000 samples, the remainder between 400 and 500 samples from the left hemi-
sphere only.
For the microarray data, a spatial map of MAPT expression values was con-
structed for each subject using the Montreal Neurology Institute template (MNI)
coordinates provided. Because of the differing number of samples between Allen
subjects, MAPT expression levels were normalised across the brain within each
subject prior to taking the mean expression value at each sample across all sub-
jects with available values.
For each node of the functional network, the spatially nearest microarray
sample was identified, and vice versa. Only where the nearest neighbour matched
in both directions was a functional node paired with a microarray sample. The
microarray data sampling is more dense in the brainstem and cerebellum than the
functional parcellation, and less dense in frontal cortical regions. Connectivity
analysis was performed on the full 471 node functional network and values from
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unpaired nodes discarded. The comparison between functional imaging data and
the Allen atlas data used the Allen module in Maybrain.
Statistical analysis was performed in R (3.0.1). Correlation between MAPT
expression and node-wise connection strength used the Pearson correlation coeffi-
cient. The interaction between nodal connection strength and MAPT expression
on functional connectivity loss in disease was assessed using a one-way analysis
of variance with repeated measures to account for expression values from three
probes.
8.2 Results
There were positive correlations with each of the three MAPT probes between
MAPT expression and the connectivity strength in control subjects (see fig-
ure 8.1, A 24 P224488 r=0.19 p=0.003, A 32 P143793 r=0.17 p=0.0042, probe
A 23 P207699 r=0.14 p=0.019, p-values corrected for multiple comparisons us-
ing False Discovery Rate (FDR)) and when values from all three probes were
combined (r=0.20,p=0.0002).
Next, I investigated the association between connectivity and MAPT gene ex-
pression in the Allen Brain atlas in predicting the proportion of regional functional
connectivity loss. There was a significant interaction between MAPT expression
and connection strength of all nodes in both PD (F=4.1, Df=3, p=0.007) and
PSP (F=3.2, Df=3, p=0.02). There was a main effect of MAPT expression on the
proportional loss of functional connectivity in PSP (F=3.5, Df=3, p=0.02) with
a similar trend in PD (F=2.4, Df=3, p=0.07). These findings provide evidence of
an association between MAPT expression in healthy adult life and disease-related
connectivity loss.
The correlation between each subject’s region-wise connection strength and
the closest measurement of MAPT expression is reported in 8.1. The relationship
between connection strength and MAPT expression was consistent within each
subject, but not necessarily between subjects. The Pearson correlation coefficient
values varied from 0.004 to 0.45. All subjects except one (H0351.1009) demon-
strated a significant correlation between connection strength and MAPT value for
at least one probe at the uncorrected level and half of all subjects demonstrated a
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Figure 8.1: Tau expression vs connection strength. The top part of the figures shows
tau expression levels in the Allen Brain atlas for each probe. The size of each node was
scaled by the microarray expression value.
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significant correlation between connection strength and MAPT expression after
p-value correction.
8.3 Discussion
The results presented here show for the first time that the regional expression
of native MAPT gene predicts the distributed pattern of connectivity loss in
two neurodegenerative diseases. The human functional imaging data support
molecular and imaging hypotheses of network vulnerability to neurodegenerative
pathologies by showing that tau associated disease processes are facilitated in
highly connected brain regions that express greater levels of the MAPT gene.
Chapter 6 figure 6.9 demonstrates that the loss in functional connectivity
related to hubs has an impact on executive cognitive function in both PD and
PSP. It could therefore be speculated that the vulnerability of brain networks
attributable to MAPT expression contributes to a specific cognitive dysfunction.
This link demonstrates the usefulness of functional brain imaging as a biomarker
that reflects aspect of both a genetic susceptibility and a clinical symptom Meyer-
Lindenberg and Weinberger [2006].
The expression of MAPT was symmetrical, although PD presents with asym-
metric motor function. However, the rationale for examining MAPT expression
in PD is the effect on cognition rather than motor function. Therefore the ef-
fect of a change in MAPT may not play a role in the assymetrically affected
dopaminergic motor pathways, but rather may mediate an effect through other
systems such as the cortico-thalamocortical circuits and parietal cortex which are
implicated in cognitive decline in PD Williams-Gray et al. [2009].
The relative consistency of correlation values of connection strength and MAPT
expression within each subject lends weight to the argument that all three probes
target the same region. The subjects that had the least strong correlation were
at the extremes of the age limit, however the difference in ages between subjects
was rather small so it would be premature to draw any fiing conclusion from this
observation.
The selection of tau as a protein of interest is based on a strong prior hy-
pothesis, however there may be other proteins that contribute similar or greater
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Probe ID Subject Age r p-value corrected p-value
A 24 224488 H0351.1009 57 0.13 ns ns
H0351.1016 55 0.19 0.081 ns
H0351.1015 49 0.19 0.087 ns
H0351.2002 39 0.38 <0.00001 <0.00001
H0351.1012 31 0.30 0.0054 0.014
H0351.2001 24 0.25 0.0048 0.014
A 32 143793 H0351.1009 57 0.09 ns ns
H0351.1016 55 0.31 0.0018 0.0065
H0351.1015 49 0.45 <0.00001 <0.00001
H0351.2002 39 0.34 <0.00001 <0.00001
H0351.1012 31 0.13 ns ns
H0351.2001 24 -0.01 ns ns
A 23 207699 H0351.1009 57 0.04 ns ns
H0351.1016 55 0.23 0.031 0.056
H0351.1015 49 0.30 0.0064 0.014
H0351.2002 39 0.27 0.0006 0.0027
H0351.1012 31 0.28 0.0094 0.019
H0351.2001 24 0.13 ns ns
Table 8.1: The results from individual subjects for each probe. The pattern of signif-
icant values are consistent between probes demonstrating consistency of results within
each subject, although not necessarily between subjects. The r value is the Pearson
correlation coefficient between region-wise MAPT expression measured by microarray
analysis using the probe shown and connection strength from the closest brain region.
The correction for p-values includes all the statistical tests shown in the table using
the FDR method.
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susceptibility to disease. Therefore an extension of preliminary finding will con-
sider other proteins that may be related to neurodegenerative disease.
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Chapter 9
General Discussion
In this discussion chapter I will review the themes presented in the introduc-
tion, outlining the potential utility of clinical and functional network measures
as biomarkers of neurodegenerative disease. In particular, I will focus on the
effect of neurodegenerative disease on multiple levels of the brain’s organisation.
The association between protein disorders and the impact on network organisa-
tion and function has led to the concept of molecular nexopathies Warren et al.
[2013].
In this thesis I have examined Progressive Supranuclear Palsy (PSP) as a pro-
totypical primary tauopathy, alongside Corticobasal Syndrome (CBS) which has
a more heterogeneous pathology but is also associated with a primary tauopathy
in the pathology of Corticobasal Degeneration (CBD). These primary tauopathies
are contrasted with Parkinson’s disease (PD), in which there is an intriguing asso-
ciation between tau haplotype and the risk of disease and cognitive decline Goris
et al. [2007]; Williams-Gray et al. [2009].
The key hypotheses I addressed were:
• clinical and functional network biomarkers would change in disease and
potentially provide diagnostic information,
• the spatial distribution of functional network changes would reveal regions
of susceptibility to tau associated pathological processes
• clinical disease measures would correlate with changes in connectivity and
topological network measures, and with regional covariance within specific
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functional covariance networks
9.1 Biomarkers
The development of effective biomarkers is fundamental for clinical and transla-
tional studies, but may also help to understanding disease and the development
of new disease treatments. The importance of biomarker development is reflected
in large public-private partnerships to fund the development of biomarkers such
as the biomarkers consortium (www.biomarkersconsortium.org) funded by the
National Institute of Health, the Federal Drug Administration and the Pharma-
ceutical Research and Manufacturers of America. The ability of biomarkers to
inform about the disease process in an individual is being used develop therapeu-
tics and to stratify patients in clinical trials Hamburg and Collins [2010]; Trusheim
et al. [2007]. However, any biomarker that is taken to the clinical realm must
first be practical and measurable in a clinical population.
I have shown that it is possible to collect and analyse cognitive and functional
imaging biomarkers in PD, PSP and CBS. Extensive cognitive testing in neurode-
generative disease can be challenging because of fatigue. I have shown that two
relatively short tests are practical to implement and provide sufficient informa-
tion to assist diagnosis in the case of the Addenbrooke’s Cognitive Examination-
revised (ACE-R) and to make inferences about the underlying disease process
in both the ACE-R and saccadometry. Specifically, I have shown that a two
minute test in verbal fluency effectively discriminates between PD and PSP with
a sensitivity of 87% and specificity of 89%. These changes can be related to
distributed underlying anatomical networks, meaning that these simple clincial
measures meet the criteria for being a biomarker by identifying differences in
disease and reflecting the underlying disease process.
Using Functional Magnetic Resonance Imaging (fMRI) imaging I demon-
strated the practicality of acquiring a 5-10 minute scan in PD, PSP and CBS,
and that this information can be informative even in the absence of a task. In
addition to allowing a broad range of possibilities for analysis, the task-free na-
ture of this imaging technique is beneficial in the severly disabled patient groups I
have studied. A combination of fatigue, concentration and cognitive impairment
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makes all but the simplest tasks difficult to perform, and even more challenging
to implement in an Magnetic Resonance Imaging (MRI) scanner. Although the
preprocessing and analysis steps in task-free fMRI continue to be developed, I
have demonstrated the ability of this approach to detect group level group differ-
ences between control subjects and disease groups. However, the demonstration
of a group difference is insufficient to use these measures as biomarkers since
these measures also need to reflect the underlying disease processes. In the next
section I will review the links between functional imaging measures and under-
lying neuropathology. In particular, I will assess how network analysis provides
an insight in to the levels of disease outlined in figure 1.1, chapter 1. I will begin
by outlining the changes I have observed in functional brain networks, and go on
to relate these ‘upwards’ to clinical disease measures and clinical syndromes, and
‘downwards’ to underlying pathology, particular the role of soluble proteins and
protein aggregates.
9.2 Functional network changes
In chapter 6 I demonstrated that PD, PSP and CBS lead to the loss of global
connectivity. I show that the loss of connectivity in PD and PSP is focused on
highly connected hub regions of the brain, and that in all three disease groups
node-wise connectivity loss correlated with connection strength in the control
group. The concept of connection strength predicting connectivity loss extends
beyond hub regions to all brain regions, and the more highly connected regions of
the parietal and parieto-occipital cortex had the greatest loss of topological hub
and efficiency properties in PD, PSP and CBS.
There was also a loss of long distance functional connections. The length of
hub connections did not predict the loss of connectivity in a given brain region,
suggesting that distance influences the risk of edge-wise connectivity loss rather
than node-wise connectivity loss.
In comparison, measures of the efficient small world architecture changed
very little in PD, PSP and CBS, showing the resilience of the brain’s functional
arrangement to neurodegenerative disease Bullmore and Sporns [2009]. Further-
more, I have shown that these topological observations can not be accounted for
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by a random loss of connection strength, in keeping with previous studies Raj
et al. [2012]; Stam et al. [2009].
The loss of connectivity in hub regions and the loss of long range connections
are consistent with the analysis of functional covariance networks in chapter 7,
where PD, PSP and CBS were shown to cause a breakdown in network connec-
tions of the basal ganglia and anterior salience networks to other well-defined
functional covariance networks. I propose that the long distance connections
weakened in PD, PSP and CBS are connections that mediate communication
between functional covariance networks.
Whole brain graph measures were much less sensitive to differences between
groups than connection strength, which represents the signal correlation between
brain regions, although node-wise graph measures did demonstrate between group
differences. In comparison to measuring connection strength, the measurement of
whole brain graph measures requires three key steps where an abstraction process
is applied with the aim of extracting important aspects of the underlying data.
These steps lead to the generation of a connectome that is designed to represent
an top-level architecture of the brain. Firstly, a threshold is applied to remove
weaker connections on the assumption the stronger connections may be more
relevant. Secondly, the graph is binarised on the assumption that the topological
arrangement of connections rather than the strength of an individual connection
is the important element. Finally, the totality of the structure is reduced to a
single value in a whole-graph measurment such as average shortest path length.
It may be that these abstractions reduce the information available beyond the
available signal in the data. This calls in to question the viability of whole-brain
measures as relevant and useful disease biomarkers, though regional measures
may fair better.
However, the pattern of change in local connectivity, covariance and topology
is not one of a uniform loss of connections. Indeed, in PSP and CBS the anterior
salience network showed increased covariance with adjacent executive control net-
works, and in PD and PSP there was a marked increase of covariance spreading
beyond the boundaries of the dorsal default mode network. These findings sug-
gest that the borders of functional covariance networks may become less distinct
in the context of disease. Node-wise topological properties of degree, cumulative
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edge length and measures of node centrality also showed increases in the dis-
ease groups, particularly in the pre-supplementary motor area, basal ganglia and
inferior frontal regions.
Covariance analysis with Independent Component Analysis (ICA) revealed
a more widespread increase in functional connectivity than using the graph ap-
proach, consistent with increasing strength of short distance connections since
covariance analysis assesses voxel-by-voxel connectivity over a few millimetres,
whereas graph analysis measures larger a more coarse parcellation and therefore
assesses distances in the centimetre range.
In summary, across PD, PSP and CBS there was a weakening of long-distance
connections and loss of connectivity in more strongly connected regions with an
associated loss of between network connectivity. In addition, there were local
regions of network-specific increased covariance, increased between network con-
nectivity and enhanced topological properties in each of PD, PSP and CBS. In
the next section I consider the significance of these changes on clinical disease
measures.
9.3 Functional connectivity and clinical measures
I found that the global measure of hub connection strength correlated with ver-
bal fluency scores across all three groups. This finding is consistent with the
distributed nature of verbal fluency that draws on frontal executive and tempo-
ral language regions of the brain. This observation suggests that other poorly
localised symptoms in neurodegenerative diseases could be assessed by their cor-
relation with global or hub-wise functional connectivity measures, for example
social anxiety which is commonly reported in neurodegenerative disease and has
been assessed using functional connectivity analysis in otherwise healthy individ-
uals Liao et al. [2010], or apathy which is a major feature of PSP Aarsland et al.
[2001].
In contrast, one can examine local changes within specific covariance networks
in relation to clinical measures. The analysis of functional covariance showed
correlations with the UPDRS score and symptom duration in localised regions of
specific functional covariance networks, but not for verbal fluency scores. These
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findings suggest that the vulnerability of specific functional covariance networks
could contribute to differences between clinical syndromes.
To explain the susceptibility of hub regions and specific functional covariance
networks, the underlying pathology must be understood. The following section
addresses the change in functional connectivity in the context of the proteins that
aggregate in neurodegenerative disease, focusing mainly on the tau protein.
9.4 Protein aggregation and axonal instability
One hypothesis set out in the introduction is that toxic proteins might explain
functional network changes in PD, PSP and CBS. The effects of tau on neu-
rons as they degenerate are shown in figure 9.1. Below I will review the poten-
tial pathogenic mechanisms associated with tau, starting by examining how well
functional network changes fit with patterns of neuronal loss and protein accu-
mulation, then assess whether tau-related axonal dysfunction may contribute to
connectivity changes, and go on to discuss whether synaptic dysfunction from
oligomeric protein species may play a role in functional network changes.
A common approach to explaining functional imaging changes in neurode-
generative disease is to locate an area using imaging and to assess atrophy (eg
voxel-based morphometry) or to compare with regions of cell loss. This approach
is limited, since neuronal loss and a resulting change in brain structure is consid-
ered a late consequence of neuropathology Jack et al. [2010] and therefore relying
on atrophy alone might miss the early signs of disease. Furthermore, the observed
hub susceptibility in my data in PD and PSP can not readily be explained by
neuronal loss since the pattern of connectivity changes was not related to patterns
of atrophy in PD Beyer et al. [2007]; Summerfield et al. [2005], PSP Paviour et al.
[2006] or CBS Boxer et al. [2006]; Josephs et al. [2008].
Could protein aggregates explain the pattern of connectivity changes? Neu-
ropathology studies show relatively little early or specific accumulation of protein
in the precuenus or parieto-occipital regions defined as hub regions in the patho-
logical entities of PD Braak et al. [2003], PSP Dickson et al. [2007] or CBD
Dickson et al. [2002]. However, other regions where protein aggregation occurs
did have reduced functional covariance and altered functional connectivity.
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Figure 9.1: An outline of tau in neurodegeneration. A: one of the roles of tau in
the normal state is to bind to microtubules located in the axonal compartment of the
cell. B: in the early stage of disease tau is released from microtubules and relocates to
the cell body. Tau becomes hyperphosphorylated and misfolded, going on to aggregate
and form oligomers that promote further oligomeric formation and inhibit synaptic
function. C: finally neurofibrillary tangles form, centred around an oligomeric nucleus
and the neuron undergoes cell death.
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One such region is the thalamus. Tau aggregation in the thalamus is a feature
of both CBD Dickson et al. [2002] and PSP Henderson et al. [2000] patholo-
gies. In PSP the thalamus showed increased covariance with the basal ganglia
network, consistent with a loss of cortical connections (discussed in chapter 7).
Although I did not find any clinical correlations with thalamic connectivity in
PSP, previous reports have linked connectivity change of the thalamus in PSP
to postural instability Zwergal et al. [2011] and executive dysfunction Whitwell
et al. [2011]. In CBS I found increased covariance of the thalamus in the basal
ganglia network was associated with more severe motor symptoms measured by
the Unified Parkinson’s Disease Rating Scale (UPDRS III). These findings imply
that regions of protein aggregation may be associated with altered connectivity
that are associated with specific features of disease.
Identifying similar areas with focal pathology in PD is more challenging, since
by the late stages of disease (ie Braak stage 5) a large proportion of subcortical
nuclei and almost the entire cortex is affected by Lewy Body disease. Following
the Braak stages, earlier pathology should appear first in the brainstem nuclei,
then in the amygdala, thalamus and ventral claustram, but spreading to the
anteromedial temporal cortex and on to the remaining cortex. I did not observe a
pattern that clearly reflected this progression of pathology, or that identified clear
nuclei of the basal ganglia in PD that showed change in functional covariance.
There may be technical reasons why the brainstem and basal ganglia nuclei did
not show more differences between PD and control subjects because the signal-
to-noise ratio in the basal ganglia of fMRI is poorer than cortical areas and the
voxel-size was close to the size of affected brain-stem nuclei. It may be that a
more fine-grained parcellation of the basal ganglia is required to properly assess
connectivity between basal ganglia nuclei and their connections to cortical regions
Lambert et al. [2012]. Even taking these technical issues in to account in the basal
ganglia, the pattern of cortical changes in PD can not be easily explained by the
accumulation of alpha-synuclein or tau alone.
One possible explanation linking the roles of tau to PD, PSP and CBS is
the loss of axons, given the role of tau in stabilising microtubules and the early
shift of tau to the cell body Lindwall and Cole [1984]. The observed reduction
in the median distance of edges in PD, PSP and CBS would be consistent with
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the hypothesis that microtubule instability and axonal dysfunction are a feature
of these neurodegenerative diseases. However, whilst the susceptibility of func-
tional connections may be related to their length, the susceptibility of nodes to
connectivity loss was linked to connection strength rather than the length of their
connections.
9.5 Oligomeric proteins and synaptic dysfunc-
tion
If node-wise connection strength, rather than distance, confers susceptibility to
connectivity loss in disease, then synaptic dysfunction may explain these changes.
A candidate agent to cause the changes in synaptic function in tauopathies are
oligomeric tau species, which are small soluble aggregates of tau protein.
Firstly, tau oligomers may pass from cell to cell trans-synaptically Clavaguera
et al. [2013] and cause synaptic dysfunction Lasagna-Reeves et al. [2011]. These
findings were demonstrated in mouse models, but are supported by evidence
of neuropathology occurring in anatomically connected regions in the human
disease Seeley et al. [2009]; Zhou et al. [2012]. This would be consistent with
my observation of hub susceptibility, since if tau travels between anatomically
connected regions then the regions with the most connections would bear the
largest burden of disease.
Secondly, the changes in covariance networks I observed were network specific,
suggesting that functional covariance networks undergo distinct pathological pro-
cesses. This pattern could be achieved by a propagating disease agent, such as
oligomeric proteins, but would be unlikely if the disease arose de novo in multiple
brain regions where a more homogeneous spread of connectivity change would be
expected.
Finally, in vitro work has demonstrated that amyloid-beta oligomers can in-
duce the production of damaging reactive oxygen species and synaptic dysfunction
in the absence of cell death Narayan et al. [2014]. This particular study suggests
a therapeutic target, since the synaptic dysfunction could be restored using clus-
terin, an extracellular chaperone protein that selectively binds oligomers.
However, the link between connectivity changes and protein oligomers remains
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controversial. It is not possible at present to directly image tau oligmers in vivo
in humans. There are no published studies where mouse models of tau prop-
agation and neuropathology undergo functional brain imaging and connectivity
analysis. Although Positron Emission Tomography (PET) imaging in models of
beta-amyloid deposition have suggested cortical hypoperfusion and reduced cere-
bral blood flow that arises independently of beta-amyloid deposition Dodart et al.
[1999]; Niwa et al. [2002], as yet this change in metabolism has not been linked
to oligomeric protein species.
An alternative explanation of hub susceptibility proposes that the high metabolic
activity of hub areas may explain connectivity loss in a wide range of diseases
Crossley et al. [2014]. This proposal has been framed in terms of cost of par-
ticular brain regions Bullmore and Sporns [2012]. In this context, cost refers to
metabolic activity and to the maintenance of long distance axons. It is proposed
that hubs are the most costly components of the brain’s functional network and
therefore they are the first to succumb to any disease process.
9.6 Genetic influence on disease and functional
connectivity
An initial attempt to link the observed changes in functional connectivity directly
to the tau protein is found in chapter 8. The MAPT gene that encodes the tau
protein was expressed in greater levels in more highly connected brain regions,
ie those areas susceptible to connectivity loss in disease. This analysis is prelim-
inary and will require further assessment to see whether other proteins are also
implicated in hub regions and whether other susceptible brain regions also have
a greater expression of MAPT or other disease-related genes.
An alternative approach to assessing the genetics of neurodegenerative dis-
ease has been to study cohorts of patients with a known gene mutation. These
studies have been invaluable in establishing the presymptomatic natural history
of dementias such as Alzheimer’s disease Ridha et al. [2006]. However, building
up a cohort of patients is time-consuming, requiring many years of follow-up, and
ultimately the genetic versions of these diseases may not always reflect mecha-
nisms in the sporadic forms of the same clincial syndrome. Furthermore, genetic
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cases of PSP and CBS are extremely rare. Therefore, examining the genetics of
the sporadic disease remains the current approach in these disorders.
In order to examine a wide range of sporadic diseases, it is possible to use net-
work analysis to consider the associations between proteins of disease-associated
genes using protein-protein interaction networks Baraba´si [2007]; Baraba´si et al.
[2011]. In this way, the function of genes associated with a specific disease can
be related to a molecular pathway, and potential therapeutic targets can be iden-
tified. In addition, the similarities between diseases can be assessed. This is
beyond the scope of this thesis.
Assessing the similarity between the genetics of different diseases may be par-
ticularly important when considering the role of tau in neurodegeneration. Whilst
tau accumulates in PSP, CBD, Frontotemporal dementia (FTD) and Alzheimer’s
disease, there are differences in the tau isoforms associated with specific diseases
and the conformation of tau accumulations associated with distinct pathologies
Ahmed et al. [2014].
The role of tau in PD is even more uncertain, since tau accumulation is not
a prominent feature of PD, and yet tau deposition in the striatum has been
linked to PD dementia Wills et al. [2010], and tau has been linked to the genetics
of PD as a risk factor through GWAS International Parkinson Disease Genomics
Consortium [2011] and susceptibility to PD and PD dementia of the H1 haplotype
Baker et al. [1999]; Williams-Gray et al. [2009].
In this thesis I have emphasised the commonalities between neurodegenerative
diseases associated with tau pathology. However, I have recognised the hetero-
geneity within this group of disorders that relate to different tau isoforms and
different types of tau aggregate. The influence of these molecular differences on
functional brain networks remains largely unexplored. One intriguing study in
mice found that homogenates from different tau-associated diseases induced the
formation of disease-specific tau aggregates when injected in to mice expressing
humanised tau Ahmed et al. [2014]. However this did not influence the pattern
of trans-synaptic spread of tau, suggesting that the network specific effects of
different tau isoforms may be small.
251
9. GENERAL DISCUSSION
9.7 Future directions
Future work in this field needs to cover technical improvements and extensions to
the analysis of task-free fMRI data, and address several key challenges remaining
in the field of the tauopathies.
A major challenge to the reliable analysis of task-free fMRI imaging is effective
de-noising, in particular adressing motion artefact. In this thesis I have outlined
a preprocessing algorithm that was able to quantify noise at the whole-brain level
using frame-wise displacement and the motion dependence of the Blood Oxygen
Level Dependent (BOLD) signal. This allowed subjects with excess motion to
be removed. However, up to 20% of subjects were removed potentially biasing
the results and reducing statistical power. Newer methods of motion correction
using wavelet analysis and voxel-wise denoising may allow better assessment and
removal of noise, and the inclusion of a greater number of subjects using the
current data Patel et al. [2014]. Alternative acquisitions such as the multi-echo
sequence may also allow for more effective identification and removal of noise
from the BOLD signal Kundu et al. [2011].
Other methods of brain imaging may have advantages over task-free fMRI.
Whilst fMRI has a good spatial resolution and can assess deep brain regions,
electrophysiological techniques of Magnetoencephalography (MEG) or Electroen-
cephalography (EEG) have better temporal resolution, allowing for the assess-
ment of network differences in distinct frequency bands. Task-based imaging,
though challenging, has been completed in tauopathies, for example the men-
tal imagery of standing has been used to assess gait and the connectivity of the
thalamus Zwergal et al. [2011]. Using tasks in this way may have benefits for
assessing questions about specific functional networks or brain regions.
It would be valuable to repeat the analysis presented here in an independent
dataset, preferably using data from another centre. Whilst the topological char-
acteristics and functional covariance networks I have obtained are consistent with
other studies Achard et al. [2006]; Damoiseaux et al. [2006]; Smith et al. [2009],
it remains to be seen whether between group differences in functional networks
are stable across studies, between centres and between cohorts. I will now turn
to the further research questions in the tauopathies.
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A key challenge in neurodegeneration is to understand the link between clin-
ical syndromes and underlying pathology. I have demonstrated the potential of
clinical measures and functional network measures as biomarkers by considering
neurodegenerative diseases as molecular nexopathies, but there are still many
uncertainties in the links between the levels of brain organisation.
Future studies could extend this work to explore in greater detail the links be-
tween underlying pathology and functional network change. For example, explor-
ing the genetic association between MAPT and the tauopathies and to consider
other genes of interest, such as alpha-synuclein and beta-amyloid. The approach
could be modified to discover new genes of interest by exploring correlations for a
wide array of genes within areas of functional network change, although the large
number of genes would require careful consideration of the mutliple comparisons
problem.
In this thesis I have used clinical diagnostic criteria. However, a number of
subjects in this study have come to post-mortem and have pathological confir-
mation of the diagnosis. In time, this information can be used to aid the clas-
sification of diagnostic group and to assess whether functional network changes
are syndrome specific or pathology specific. A pathological diagnosis would be
particularly helpful in the CBS group where the clinicopathological correlation
is uncertain. This would require a long-term retrospective approach building on
the current cohort of patient groups.
Finally, it would be valuable to assess potential mechanisms of network ‘de-
generation’ in silico (ie using computational models). Figure 6.22 in chapter 6
shows a random attack model of network change. In order to assess the contri-
bution of edge distance and node-wise connectivity to the loss of connectivity in
PD, PSP and CBS, it would be possible to design targeted models that change
the network according to topological properties. By applying these models to
the control group, it may be possible to assess which topological characteristics
or combination of characteristics might recapture the changes observed in the
disease groups.
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9.8 Conclusions
In conclusion, I have addressed the key hypotheses of this thesis by showing:
• clinical and functional network biomarkers would change in dis-
ease and potentially provide diagnostic information.
I have shown that clinical measures of cognition and saccadometry show
changes in disease. In particular, verbal fluency is a promising diagnostic
biomarker to distinguish between PD and PSP, and cognitive biomarkers
are potentially useful for tracking the progress of disease in CBS and PD.
Using measures of functional connectivity, I have shown a widespread loss
in connection strength, most readily detectably in highly connected hub
regions in PD and PSP. The connection strength is the strongest candidate
biomarker identified in this thesis. In particular, it shows differences be-
tween the control group with both PD and PSP groups (chapter 6), and may
relate to underlying genetic influences such as MAPT (chapter 8). However,
ROC curve analysis in figure 6.6 did not support the use of the aggregated
measure of hub connection strength as a diagnostic biomarker. By assess-
ing functional covariance using ICA I have identified both increased and
decreased covariance in a wide range of functional covariance networks that
show a large effect size between control and disease groups.
• The spatial distribution of functional network changes would re-
veal regions of susceptibility to tau associated pathological pro-
cesses.
I have demonstrated the susceptibility of more highly connected brain re-
gions to neurodegenerative pathology, and related the changes in these re-
gions to expression of the MAPT gene for tau.
• Clinical disease measures would correlate with changes in con-
nectivity and topological network measures, and with regional
covariance within specific functional covariance networks.
Using functional connectivity measures, the loss of hub connection strength
correlated with reduced performance on a widely localised cognitive task
of verbal fluency. By assessing functional covariance networks, specific net-
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work changes in PSP were associated with motor severity, particularly in-
creased covariance of the pre-supplementary motor area and supplementary
motor area with the anterior salience network; in CBS with the duration
of symptoms was associated with increased covariance of regions to specific
networks, most notably regions of the dorsal default mode network, and
motor severity was associated with increased covariance of the thalamus to
the basal ganglia network.
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